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Abstract
There has been a significant increase in pig production in the Eastern and Southern
Africa region during the past decade (Githigia et al., 2002), (Thuranira, 2005),
especially in rural, resource-poor, small holder communities. Accompanying this has
been the emergence of porcine cysticercosis as a problem in many of these areas
including western Kenya (Mutua et al., 2006).
Objectives: The objective of the study was to determine the prevalence of
neurocysticercosis among epileptics in Busia District, Western Province, Kenya and
investigate the risk factors associated with neurocysticercosis (NCC).
Methods: A group of 628 epileptics were identified using hospital and Special
School records, key informant interviews and snowball survey techniques and a
standard questionnaire to assess risk factors for neurocysticercosis or taeniasis,
administered. Household information was also collected and an asset index
formulated for each patient's household (n=471). Sera was taken from 630 subjects
and tested for exposure to T. solium using an antigen enzyme-linked immunosorbent
assay (Ag ELISA). The sera was also tested using an antibody (Ab) ELISA which
tested for cysticercosis (metacestode exposure) and enzyme-linked immunotrarisfer
blot assay (EITB, Western Blot) which tested for taeniasis and cysticercosis.
Univariate and multivariate analysis was conducted to investigate the factors
associated with seropositivity.
Results: There was one positive case of neurocysticercosis found by Ag
ELISA and 209 subjects tested positive for exposure by Ab ELISA. There were 10
positive results using the EITB, 6 were positive using ES38 and 4 using Lentil Lectin
purified glycoprotein (LLPG).
Conclusion: T. solium infections have multiple societal impacts including human
health and productivity as well as livestock production and there needs to be further
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Chapter 1 - Introduction
1.1 Introduction
Zoonotic cysticercosis is emerging as a serious problem in many developing
countries in Latin America, Asia and Africa, causing economic livestock and human
productivity losses, particularly amongst rural, poor, smallholder farmers (Phiri et
al., 2003). There are indications that with the increase in pig production in East
Africa (Thuranira, 2005), porcine cysticercosis is also on the rise. In East Africa,
porcine cysticercosis has been reported in Tanzania, (Nsengwa, 1995), (Ngowi et al.,
2004), Kenya (Githigia et al., 2002), (Mutua, 2005) and Uganda (Anyanzo, 1999),
(Mafojane et al., 2003). Research in six districts in Western Kenya has shcfwn
evidence of porcine cysticercosis in all districts (Mutua et al., 2006) with rates as
high as 36% in Kimili Division using lingual examination - a method which is
approximately 40% - 50% effective thus the true prevalence is probably much higher
(Ngowi et al., 2004). In Busia District in Western Kenya, prevalence rates for
porcine cysticercosis were found ranging from 10-14% using the same diagnostic
technique (Githigia, 2000). In Mbulu District, Tanzania, the prevalence rate was
found to be 17.4% using lingual examination, so could in fact be as high as 35%
(Ngowi et al., 2004).
The disease is caused by the pork tapeworm Taenia solium which is a zoortotic
parasite. The risk factors associated with the disease are common amongst poor,
marginalised communities and include poor sanitation, free ranging pigs, lack'" of
proper meat inspection or slaughtering facilities, and lack of health education
concerning cysticercosis and other zoonotic parasite and helminth prevention
strategies. In addition to cysticercosis, these communities are also subject to
outbreaks of transboundary animal diseases such as African Swine Fever (ASF), a
lethal, viral haemorrhagic disease of domestic pigs which has devastating economic
consequences (Lubisi et al., 2005). According to the International League Against
Epilepsy (ILAE), human cysticercosis (neurocysticercosis) is probably the most
common cause of acquired epilepsy in the developing world, where prevalence rates
Chapter 1 2
of active epilepsy are twice those of developed countries (ILAE, 2006). Cysticercosis
is important in smallholder farming communities because it exacts a price by:
• Causing infections in humans affecting their physical and psychological
health, social life and productivity;
• Seriously reducing farmers' potential to participate in commercial markets for
pig trading due to the barring of infected pigs by traders
• Compromising a valuable, relatively inexpensive source of protein in
rendering pork unsafe to eat.
Pig keeping is a valuable tool for poverty alleviation in developing countries. In
smallholder communities pigs are considered low-input livestock which do not
require the same level of care or space as cattle, for example. In addition, pigs are
omnivorous; and accomplished scavengers who can grow to market size on minimal
feed inputs from the farmer. Thus cysticercosis is a serious constraint for improving
the livelihoods for smallholder farmers in developing countries. There has been a
significant increase in pig production in the Eastern and Southern Africa region
•
(Githigia et al., 2002) (Thuranira, 2005) during the past decade, especially in rural,
resource-poor, smallholder communities. In Uganda and Kenya, the establishment of
piggeries and increased pig production by rural farmers is encouraged by both
respective governments forms part of the plan for the modernization of agriculture
under the Ministry of Agriculture in Uganda and is part of the Busia District
Development Plan, (Government of Kenya, 2002). In Uganda, the local governments
are supplying piglets to the poor rural communities to rear in order to promote an
i
alternative source of income. '
Although cysticercosis in theory is relatively easy to prevent and control, many
developing countries lack critical information concerning prevalence data, public
health awareness of the problem, suitable diagnostic tools, surveillance systems and
impact assessment data concerning the true burden of the disease.
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This study aims to investigate and assess the burden of neurocysticercosis by
establishing the prevalence rate of the disease in Busia District, Kenya and assessing
the impact various risk factors have on acquisition of the disease.
The following section of the introduction provides background information on
zoonoses - in general and with respect to poverty, porcine cysticercosis and
neurocysticercosis and the various diagnostic and treatment options that are available
for the disease. The next section examines neurocysticercosis-acquired epilepsy,
focussing on its economic and social impact on people in the rural areas of
developing countries. The subsequent section of the introduction looks at the
importance of livestock keeping in general for smallholder farmers, disease control
priorities in the developing world and an overview of helminth control strategies and
Taenia solium control strategies specifically.
1.2 Zoonoses - general
In a comprehensive literature review of 1415 species of infectious organisms known
to be pathogenic to humans, 868 or 61% are zoonotic. In the same study, of the 175
pathogenic species associated with diseases considered to be "emerging", 132 or
75% are zoonotic. Overall, zoonotic pathogens are twice as likely to be associated
with emerging diseases than are non-zoonotic pathogens. Five major taxonomic
divisions of pathogens were used within the study: viruses (including priotis),
bacteria (including rickettsia), fungi, protozoa and helminths (cestodes, nematodes,
trematodes and acanthocephalans) (Taylor et al., 2001). Three categories'* of
transmission routes to humans were distinguished, these being: direct contact
(including via wounds, sexual contact, vertical transmission or inhalation), indirect
contact (via food or an environmental reservoir, and vector borne (biting or
mechanical transfer by arthropods).
As the world's population continues to grow in an unprecedented fashion, emerging
zoonotic diseases are amongst the most important public health problems facing
humanity. One of the more prominent zoonoses to come to public attention in recent
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years has been BSE or bovine spongiform encephalopathy and its human
manifestation, Creutzfeld-Jakob disease. This particular outbreak disease occurred in
a developed country and media attention focused largely on economic losses • to
farmers. There are many zoonoses, however, that occur in developing countries and
go largely unnoticed as systems are not as highly developed for the monitoring of
such diseases. While zoonoses themselves are difficult to diagnose (Pal et al., 2000),
in that they sometimes present few symptoms in both the animal and the human,
0
even when symptoms are obvious, diagnostics are limited or prohibitively expensive
(Dorny et al., 2003). According to a report by the Secretariat of the World Health
Organization which discussed policies and methods for the control of cysticercosis,
"diagnostic criteria based on objective clinical, imaging, immunological and
epidemiological data have been proposed for different levels of the health care
system, but are not generally used in areas endemic for the disease" (WHO, 2002) In
addition, there is often a lack of collaboration between the veterinary and medical
organs of government resulting in information not being shared (Domingo, 2000).
One of the greatest threats that zoonoses pose is in their ability to cross species
barriers. Some of these diseases include influenza, human immunodeficiency viruses,
filoviruses, Nipah virus and leptospirosis and more recently H1N5 avian flu and •
H1N1 swine flu (Pastoret et al., 2000).
While traditionally it has been thought that rural livestock keepers were at most risk
from zoonotic infections, with the increase in urban populations in developing
countries expected to rise by 2030 to more than 50% of the population in Africa and
Asia living in urban areas (Population Reference Bureau, 1999), diseases such as
rabies (Cleaveland, 1998), water-borne zoonoses, and T. solium cysticercosis will be
of particular importance. It is estimated that the number of people obtaining part of
their food from Urban Agriculture in six East and Southern African countries will
rise from about 25 million to 40 million by 2020. Urban Agriculture includes market
garden vegetables but also livestock keeping such as cattle and poultry. The
relationship between Urban Agriculture and the rural-urban transmission of zoonotic
diseases remains under-researched, but as in many countries livestock keeping is not
even officially allowed in urban areas, there is a clear need for urban policy for
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delivery of human and animal health services to address this situation (UNHCS,
2001).
«
1.2.1 Zoonoses and Poverty
Zoonoses make up 61% of all species of infectious organisms known to be
pathogenic to humans and are defined as those that are capable of "natural
transmission between animals and humans" (WHO, 1959), thereby rendering their
classification as zoonotic (Taylor et al., 2001). In tropical regions, zoonotic diseases
impose a considerable burden on human health and include, among others, sleeping
sickness (Chambers & Conway), brucellosis, tuberculosis, hydatid disease, Taenia
solium cysticercosis/taeniosis and rabies. In addition to their effect on human health,
the impact of zoonoses extends to huge economic losses associated with the
infections in the animal host (Coleman, 2002). As livestock and traditional
production systems involving livestock are central to the livelihoods of the poor-in
developing countries (Delgado et al., 1999); (LID, 1999), the poor are at risk both
from the economic loss associated with being infected with the disease and the
effects of the disease on their livestock (e.g. pastoralists and M. bovis exposure,
(Moda et al, 1996) and sleeping sickness and trypanosomiasis in Eastern Uganda
(Fevre et al., 2001).
The poor in every country bear a disproportionately high burden of disease (Gwatkin
& Guillot, 2000; Sachs & Steele, 2001). According to the Food and Agriculture
Organization of the United Nations (FAO),"although in the future there will be a
dichotomy of issues and approaches in intensive versus traditional livestock systeips,
the impact of zoonotic diseases and food-borne infections and intoxications on health
and wellbeing will be greatest among the 800 million food-insecure livestock
keepers, consumers, traders and labourers" (FAO, 2002a). In the case of zoonotic
disease, there are a number of reasons why their burden falls particularly heavily on
poor people which go beyond the usual reasons of access, affordability and
vulnerability.
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Poor people are at more risk of contracting many zoonoses as they live in close
proximity with their animals - the reservoirs of disease. Crowded living conditions,
poor hygiene and sanitation services and practices characteristic of slums or shanties
can increase the transmission of disease between humans, but also between animals
and humans. In the case of zoonotic tuberculosis or mycobacterium bovis, human
beings are infected from livestock kept for meat and milk production, especially
bovines, but also including goats, sheep, buffalo and camels. The crowded slum
areas around the larger cities in Asia, Africa and South America, where animals-are
kept in close proximity to humans, the transmission of this disease has the potential
to increase drastically, should public health regulations not be enforced (Moda et al.,
1996). In addition, infected animal products are likely to be more appealing to the
poor as they are sold more cheaply than uninfected, thus perpetuating the poverty
and disease cycle. Examples of this include pork infected with cysts which cannot be
sold legitimately at market, unpasteurised milk, meat from dying or infected animals
sold off at slaughterhouses or the slaughter of animals that occurs in households
without the presence of a meat inspector in the developing world (Mutua, 2005).
Evidence also indicates that poverty may be a significant risk factor in the seeking of
proper treatment once infection is acquired. Zoonoses are often contracted by remote,
marginalised populations making diagnosis a problem - lack of tools and facilities -
and cost of transport to treatment facilities and the treatment regime itself becoming
prohibitive. In an analysis of the determinants of vulnerability to malaria,
tuberculosis and HIV, it was found that at the community and household level,
malaria disproportionately affects lower socio-economic groups and that they are less
likely to seek treatment or take preventive measures (Bates et al., 2004). In sub-
Saharan Africa, a diagnostic test for Taenia solium cysticercosis is available only in
Zambia, making it virtually impossible for a smallholder farmer to have access to it,
notwithstanding the procurement of the sample and the cost of transportation.
Poverty also contributes to the livestock themselves being more vulnerable to
disease. According to a study which looked at the delivery of veterinary services to
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the poor in Kenya, "few herders and farmers were spending close to the estimated
'ideal' on livestock drugs and the majority of expenditure was on curative rather than
preventative treatments. Although apparently willing, the ability of the poor to pay
for treatments appears to be a limiting factor. Knowledge regarding livestock health
was poor, further contributing to the overall low uptake of veterinary goods and
services. Both access and the quality of advice regarding the use of livestock drugs
were considered problematic" (Heffernan & Misturelli, 2003). Many resource-poor
farmers cannot afford or do not have access to public and private veterinary
interventions or the necessary feed inputs to keep their animals in sanitary, disease-
free conditions.
In a study carried out by the International Livestock Research Institute (ILRI) in
2002 (Perry et al., 2002), diseases were ranked in order of those with the greatest
importance to the livelihoods of the poor in each livestock productions system in
their region. The diseases were then ranked by the identification and quantification' of
their impacts on the poor. Then, three major impacts of each disease or syndrome
were identified and scored. These were socio-economic impacts (primarily
production losses and control costs incurred by the poor), zoonotic impacts and
national impacts (a combination ofmarketing impacts on the poor with public sector
expenditure on disease control). A weighting was applied to the scores for each
disease relating to the importance of different impacts on the poor (for example,
socio-economic impact was given a weighting of 85% and national impact, 15%).
Zoonotic diseases were ranked separately due to the difficulty of measuring the
monetary value of human health impacts. The table below illustrates the top 20
diseases or pathogens ranked according to their impact on the poor, by species:
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Table 1: Top 20 diseases ranked according to their impact on the poor, by species































































































































Source: (Perry ef a/., 2002)
The two graphs that appear below illustrate the disease impact that zoonoses have
both in terms of scope of incidence and severity of impact to the individual. The first
graph represents an overall world-wide perspective, while the second is divided by
region. It is acknowledged that diseases that impact livestock productivity, the
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marketing of livestock and their products, and human health, have greater impacts on
poverty than those having an impact on only one of these areas (Perry et al., 2002).
Figure 1: Disease impact index for zoonoses
Source: (Perry eta/., 2002)
Figure 2: Disease impact rankings for zoonoses bv region
Source:(Perry et al., 2002)
□ Scope of Incidence
■ Severity to Indvidual
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1.2.2 Zoonotic Disease Control: A question of "Divided Constituencies"
One of the problems facing a unified strategy for zoonotic disease control has been
that medical and veterinary professionals and sectors have traditionally focussed on
the improvement of human health and on livestock production as their primary but
separate objectives (WHO, 2006). Zoonoses often fall, overlooked, into the gap
between veterinary responsibities and medical needs. For many zoonoses, it is the
risk to human health that is considered of greatest importance, while the most
effective control route is through the animal. It is clear that these two sectors need to
work in tandem in order to operate most effectively, however, there needs also to be
the appropriate mechanisms in place to support this effort. These include strong legal
and regulatory frameworks to help enforce disease prevention and control laws and
regulations such as meat inspection and vaccinations. Policy frameworks for both
sectors must also adopt a unified approach to human and animal disease control.
1.3 Cysticercosis
1.3.1 History
Cysticercosis was originally a ubiquitous disease occurring wherever pigs and
humans existed in association, and is probably a disease of great antiquity - Aristotle
gives a clear description of the condition as it occurs in pigs (Cook & Zumia, 2003).
Although cysticercosis has been known for many years, its relationship with the adult
tapeworm appears not to have been clear until it was demonstrated by Kuchenmaisler
in 1855 when he fed condemned prisoners with cysticercosis-infected pork and
recovered young tapeworms at the autopsies (Henneberg, 1912). There is, however,
some evidence to suggest that as early as the 6th century there may have been some
knowledge about it as illustrated by the example of Anthinus who reported to
Theodoric, King of the Franks (511-534), that "tapeworms were excreted after the
consumption of raw fatty pork" (Gach, 1926). Even if this connection had been
established, there is no evidence that a link was made between the tapeworm
transmitted and its effects on humans.
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Figure 3: Life Cycle of Taenia solium
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Source: (Prasad eta/., 2008)
1.3.2 Life Cycle of Taenia solium
T. solium has a complex two-host life cycle. Human beings are the only definitive
host and harbour the adult tapeworm (taeniosis), whereas both people and pigs can
act as intermediate hosts and harbour the larvae or cysticerci (Garcia et ah, 2003a).
When a human eats contaminated pork which contains cyst, they develop into adult
worms in the small intestine. The adult worm attaches itself to the mucous
membranes in the intestines by a scolex which is equipped with suckers and a
rostellum which contains 25-50 hooklets. The proglottids which are full of eggs are
discharged into the environment by excretion of faeces by the human. The eggs are
spherical in shape and extremely small (30-40 pm in diameter). After they are free
from the proglottids, the eggs can then be ingested by pigs, man or other animals.
Once in the intestine, the protective coating around the eggs is broken down by
gastric and pancreatic enzymes and embryos or oncospheres are released. Aided by
their hooklets, the oncospheres cross the intestinal wall and local venules, enter
systemic circulation and are carried to different organs of the host (skeletal muscles,
central nervous system (CNS), subcutaneous tissue, eye, etc.). Here the oncospheres
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lose their hooklets, acquire a vesicular shape and evolve into cysticerci by gradual
evagination of the protoscolex (invaginated scolex) over a period of two months
(Escobar and Neito 1972). The life cycle is completed when undercooked pork
infested with cysticerci is eaten by human beings. It is possible, however, for
someone who has never eaten pork to contract NCC. Man may also become an
intermediate host and develop the larval stage of the disease in one of three ways: »(i)
by heteroinfection, the most common route, in which eggs present in food
contaminated by the faeces of Taenia carriers are ingested; (ii) by exogenous
autoinfection, due to ano-oral contamination in patients harbouring the adult worm;
(iii) by endogenous autoinfection, in which the eggs of the adult tapeworm living in
the small intestine return to the stomach due to reverse peristalsis. The last two
modes of autoinfection are far less frequent as it is quite uncommon to find patients
having simultaneous infestation with cysticercosis and taeniasis in more than 10-15%
cases (Rabiela-Cervantes et al 1982). In humans, the parasite can become lodged in
the Central Nervous System, resulting in NCC (Del Brutto and Satelo 1988). The
larval stage also infests other tissues like skeletal muscle, diaphragm, heart and
peritoneum, pleura and subcutaneous tissue (Shankar et al 1994). Mammals other
than swine have also been reported to harbour cysticerci of T. solium. In Indonesia,
examination of two sero-positive dogs revealed cysticerci of T. solium in their brain
and heart (Ito et al 2002). C. cellulosae have also been recovered from the brain of a
cat (Schwan et al 2002).
1.3.3 Geographical Distribution
Taenia solium is found worldwide. Because pigs are intermediate hosts of the
parasite, completion of the life cycle occurs in regions where humans live in close
contact with pigs and eat undercooked pork. Taeniasis and cysticercosis are very rare
in Muslim countries, but it is important to note that human cysticercosis is acquired
by ingesting T. solium eggs shed in the faeces of a human T. solium tapeworm
carrier, and thus can occur in populations that neither eat pork nor share
environments with pigs (CDC, 2004).
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:igure 4: Global Distribution of Taenia solium cysticercosis/taeniasis
] Imported cases (human cysticercosis transmission)
] No information available/no evidence
Source: (WHO, 2002)
1.4 Porcine cysticercosis
In East Africa, the porcine cysticercosis has been reported in Tanzania, Kenya and
Uganda. In Tanzania, a retrospective study of slaughter records in Mbulu district
from 1985-1989 indicates a prevalence increasing from 0.4 to 4.9% during that time
(Nsengwa, 1995). In a more recent study of the risk factors associated with
cysticercosis in Mbulu District, pigs raised in a total of 436 households were
examined in the 21 selected villages in the district. Out of the 770 pigs examined,
134 had visible T. solium larvae, giving an overall prevalence of 17.4% (95% CI =
12.5, 22.3). The prevalence in the 21 villages ranged from 3.2 - 46.7%, showing a
large variation in villages (Ngowi et al., 2004).
In Kenya, the disease has not been considered endemic for several decades but recent
surveys indicate that T. solium is emerging as a problem in small-holder pig keeping
communities of south-western Kenya where ante-mortem lingual examinations in
different locations in the area have indicated at least 10-14% of the pigs surveyed to
be infected (Githigia et al., 2002). According to the Annual Reports of the Ministry
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of Health (MOH), the prevalence of human taeniosis in the rural areas is estimated to
be 2% (Mafojane, 2003) but could be as high as 4-10% in Busia District as hospital
records suggest (Busia District Hospital, 2001).
In Uganda, there is not enough data to quantify the prevalence of cysticercosis, but
according to a post-mortem survey conducted in 1999 in northern Uganda, 34-45%
of the pigs slaughtered were infected. Given the increases in pig-keeping in Uganda
over the past 20 years and the prevalence of porcine cysticercosis in neighbouring
countries, it is likely that there will soon be a public health problem (Mafojane,
2003).
The disease has been reported in West African countries such as Benin, Burkina-
Faso, Ghana, Ivory Coast, Senegal and Togo and is expected to be present in most
pig-raising regions of other West African countries. In the Nsukka.area of Enugu
State in Nigeria, over 20% of 2358 trade pigs examined were found infected with
porcine cysticercosis and the overall prevalence of taeniid ova in the 1525 human
stool samples analysed was 8.6% with most of the cases (78.6%) occurring adults
aged >30 years (Onah & Chiejina, 1995). Although economic losses are associated
with the decreased value of a pig infected with cysticercosis (Zoli et al., 2003a), it
has to be noted that in some villages in West Cameroon, pork infected with cysticerci
is considered to have a better flavour than healthy meat. Therefore, pork harbouring
cysticerci is sometimes sold at a higher price than uninfected meat (Zoli &
Tchoumboue, 1992).
1.4.1 Diagnostic Tools for Porcine Cysticercosis
1.4.1.1 Lingual Palpation
For detection of pigs infected with cysticerci of T. solium, there is a well-known
traditional method involving examination of the pig's tongue. It is based on the
identification of putative parasitic lesions in tongue muscles of pigs. A pig is
restrained in lateral recumbency and the head stabilized by the use of a pig snare.
The mouth is opened by the aid of a wooden rod twisted across the upper and lower
jaw and the tongue gently pulled out using a piece of a cotton cloth. The under-
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surface of the tongue is examined for the presence of T. solium larvae. Mature viable
T. solium larvae are oval, fluid-filled, and with a central whitish spot, which is the
protoscolex. Immature larvae are smaller, fluid-filled and no protoscolex can be
distinguished. The fluid content is absent in degenerated cysts and such cysts can
easily be confused with other conditions such as abscesses (Ngowi et ah, 2004). This
i
is the most common way for ante-mortem detection of infected pigs in the majority
of developing countries where NCC is endemic (Gonzalez et ah, 2001; Ito et ah,
2003a), but as previously described, does require a certain level of technical skill.
Although tongue palpation is reported to be highly specific, it is only moderately
sensitive, especially in light infections (Gonzalez et ah, 1990). In a more recent study
in Zambia comparing the specificity and sensitivity of tongue inspection and carcass
inspection, the specificity of tongue inspection was 100% but both methods failed to
detect the infection in 83.9% and 61.3% of infected pigs, respectively, thus rendering
the sensitivity very low (Phiri, 2006). According to a study in which a Bayesian
approach was used to estimate the sensitivity and specificity of various diagnostic
tests, the sensitivity of tongue inspection was 21% and the specificity 100% (Dorny
et al., 2004). In a study conducted in Brazil, none of the experimentally infected
animals slaughtered after 140 days of the infection showed clinical aspects of
cysticercosis or cysts by tongue palpation (Gomes, 2007). These studies further
illustrate the degree to which swine with a low cyst burden can be missed by
palpation and the extent to which the prevalence of cysticercosis in pigs in endemic
regions may be underestimated.
1.4.1.2 Post-mortem carcass inspection
Post-mortem meat inspection for slaughter pigs with respect to cysticerci of T. solium
generally relies on visual examination of different sites in the carcass considered to
be predilection sites for the parasite including the heart, diaphragm, masseters,
tongue, neck, shoulder, intercostal and abdominal muscles (Gracey, 1986). The
masseters, followed by the pterygoid and the triceps muscles, have been found to
have the highest number of cysticerci per lOOg and are thus determined to be
predilection sites (Mendez, 1986). One of the factors affecting detection of cysts is
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the density of cysts which can determine whether the cysts are visible to the naked
eye during inspection.
While this method is considered effective in determining infected pigs, it relies
heavily on farmers bringing their animals to be inspected at government inspection
facilities. In the rural areas of many African countries it is very difficult to enforce
inspection as slaughter inspection points are not easily accessible (personal
observation) leading many farmers slaughter to within their homesteads and consume
the meat in situ. In addition, in some countries such as Tanzania, pigs are generally
slaughtered in the early hours of the morning when light for inspection of dressed
carcasses is often inadequate (Boa et al., 2002). It has also been noted that when
farmers suspect their pigs to be positive for cysts, they tend to slaughter their pigs at
home and eat the pork at home or share with neighbours or later sell the meat
through informal channels rather than risk their condemnation at the slaughter
facility (The Cysticercosis Working Group in Peru, 1993). Although meat inspection
is a viable means of cyst detection, the fact that many carcasses escape inspection
due to a variety of reasons renders this method less effective as a means of detecting
porcine cysticercosis within a population. One of the reasons that prevents
necroscopy from being frequently conducted, especially in regions where poverty is
endemic, is that the best routinely used exam requires several meat-screening cuts,
damaging the product for commercial purposes and thereby decimating the income
of the prospective farmer or trader (Gomes, 2007). The performance of this test in
Zambian local pigs was 22% sensitive and 100% specific, a statistic similar to that of
tongue inspection (Dorny et al., 2004).
1.4.1.3 Enzyme-linked Immunoelectrotransfer Blot (E1TB)
This test is derived from the EITB developed for the immunodiagnosis of human
cysticercosis (Tsang et al., 1989). It is based on the identification of specific
glycoproteins and uses either the Taenia solium cysticercus antigen prepared by
purification on lentil-lectin sepharose and ultracentrifugation which is difficult to
obtain in many developing countries (Pathak et al., 1994) or a crude Taenia solium
extract which is easier to prepare (Gottstein et al., 1986). In developing countries,
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ELISA is preferred because of its better availability, simplicity and lower cost
compared with immunoblot (Rosas et al., 1986).
The EITB with crude Taenia solium metacestode extract has been shown to have a
sensitivity of 90% and a specificity of 100% (Pathak et al., 1994), however, in that
particular study, the number of pig sera tested was low (20 pigs). The EITB
glycoprotein technique employed by Tsang et al. (1989) was evaluated and produced
a sensitivity and specificity of 100% (Gonzalez et al., 1990). The laborious and
expensive purification of glycoprotein antigen from the cysticerci, however, makes
the former method using crude cysticercus antigen more feasible and practical for
laboratories in developing countries. The lentil-lectin-purified glycoproteins from T.
solium Ag (LLGP) EITB has proved more useful in determining infected pigs with a
very light cyst burden (86% positive) than has the Ag ELISA (57% positive) and the
Ab ELISA, while the EITB using fluid from T. crassiceps Ag proved as effective
diagnostically as the Ab ELISA (Basanez; Basanez et al., 2004) (Gomes, 2007).
1.4.1.4 Enzyme-linked immunosorbent assayfor the detection ofspecific antibodies
(Ab ELISA)
Immunoassays for antibody (Ab) detection can be used prior to slaughter, primarily
to isolate the non-infected animals from those more likely to be infected (Gomes,
2007). In pigs, the benefits of immunodiagnosis are:
i) tests offer diagnosis on live animals;
ii) blood sampling followed by serological testing is more sensitive than the
classical tongue examination; and
iii) the tests are relatively inexpensive and easy to
perform on large numbers of serum samples (Dorny et al., 2003).
In a study carried out in India using the infected carcasses of pigs and cysts
transported from the UK, sera from 20 pigs with parasitologically confirmed
cysticercosis were tested by both EITB and Ab ELISA assays. Specificity of the tests
was examined by testing 25 serum samples from the UK, where cysticercosis is not
endemic and sera from pigs with Echinococcus granulosus (15), Fasciolopsis buski
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(six), or Trichinella spiralis (five) infections. All but two of the samples from cases
of confirmed cysticercosis were positive by EITB and none of the samples from
healthy controls or heterologous infections reacted to any of the diagnostic bands.
Thus, the test was 90% sensitive and 100% specific. The sensitivity of the ELISA
was 70% with 73% specificity, cross-reactions occurring with sera from E.
granulosus infected pigs. Four polypeptides (8, 11, 16 and 23 kDa) were identified
by SDS-PAGE and EITB that were specifically recognized by pigs with confirmed
cysticercosis (Pathak et al., 1994).
1.4.1.5 Enzyme-linked immunosorbent assayfor the detection ofspecific antibodies
(Ag ELISA)
The Ag ELISA used to determine porcine cysticercosis was initially developed for T.
saginata cysticercosis (Brandt et al., 1992) and is also used to determine human
cysticercosis
1.4.2 Treatment
The treatment of porcine cysticercosis is potentially beneficial to farmers, but in
many communities, farmers regard their pigs as zero-input animals and are reluctant
to spend money on curing the pig. Many pig owners are not interested in knowing
the parasitic burden the animal carries and will slaughter and eat the pig, regardless
ofwhether it is sick or not (Rodriguez-Canul et al., 1998).
Human anti-helminthics have been used in treatment of porcine cysticercosis with
some success. These include albendazole, praziquantel, flubendazole and
oxfendazole (Flisser et al., 1990), (Gonzalez et al., 1995), (Gonzales et al., 1996).
Albendazole and praziquantel drugs, however, have produced some side effects in
pigs, including anorexia, fatigue and lethargy (Gonzalez et al., 1995) and are
prohibitively expensive to a smallholder farmer. In 2001, the price of albendazole,
flubendazole or oxfendazole ranged from US$ 1.20 to 1.60 per dose (Gonzales,
1998), (Gonzalez et al., 2001).
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An alternative to these drugs could be the use of an injectable, specifically veterinary
drug such as albendazole sulphoxide (ABZSO). The use of this drug has been
evaluated in a chemotherapy study carried out in Mexico (Peniche-Cardena et al.,
2002). In this study, seven naturally infected pigs from 6 to 12 months of age were
divided into 2 groups - treated (n=4) and control (n=3). The treated animals received
a subcutaneous injection in their forelegs and thighs of 15 mg/kg per body weight of
albendazole sulphoxide (ABZSO; Pisa, Mexico) once per day for 8 days. At the same
time, the control group received a subcutaneous injection of saline solution (9%
NaCl). After 12 weeks, all the animals were slaughtered and at least 200
metacestodes were isolated from the muscles and brain of each animal. It was found
that treatment of pigs with a 15 mg/kg dosage of subcutaneous ABZSO (Pisa,
Mexico), applied daily for 8 days was 100% effective in the control of muscle
cysticercosis. This dosage was insufficient, however, to affect the morphology and
viability of cerebral cysticercosis. There was evidence that the parasites were killed,
however, more time is needed for complete disappearance of the degenerated cysts
from the animal. The study concluded that the potential for use of ABZSO is
encouraging. The price of the drug (US$ 0.20 per dose) should not be a hindrance as
it is 100% effective in treating muscle cysticercosis and would allow farmers to limit
their economic losses.
1.5 Taeniasis
Taeniasis is the stage of human infection which occurs after ingestion of raw or
poorly cooked meat which is either infected with Taenia solium cysticerci or Taenia
saginata cysticerci. In the life cycle, only humans are capable of harbouring the adult
tapeworm, whereas both humans and pigs may act as intermediate hosts and harbour
the larvae or cysticerci (CDC, 2004). This stage involves the larvae evaginating in
the small intestine and the head or scolex attaching to the mucous in the intestine.
Adult tapeworms then begin to develop over a two month period and can be from 2
to 7 m in length. These tapeworms form approximately 1000 proglottids (each
carrying around 50,000 to 60,000 eggs) which can detach from the distal end of the
worm and be excreted in the faeces of the carrier (at a rate of approximately. 6 per
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The adult tapeworm can live in the small intestine for many years with few or mild
symptoms (Schantz et al., 1998).
1.5.2 Diagnostic Tools for Detection of Taeniasis
1.5.2.1 Coproantigen
Classically, taeniasis has been detected by direct parasitologic examination of stool
samples. Detection methods, based on microscopic observation of eggs or proglottids
in feces, are neither sensitive nor specific (Diaz et al., 1992a),(Schantz, 1994). Direct
examination and detection of Taenia eggs is dependent on the skill of the technician
and requires examination of expelled proglottids for this distinction (Eldson-Dew &
Proctor, 1965). A coproantigen detection assay has been developed and has been
found to greatly increase the sensitivity of detecting taeniasis cases (Allan et al.,
1990; Allan et al., 1992). This assay, which can detect parasite antigens expelled in
stool, has been used successfully in field situations (Allan et al., 1993) and was
shown to be 99% sensitive and greater than 99% specific for Taenia sp. One of the
few disadvantages of this technique is that it is unable to distinguish T. solium and T.
*
saginata infections (Allan et al., 1990).
1.5.2.2 DNA Probes
A method using DNA probes specific for T. solium or T. saginata was developed that
uses species-specific primers to differentiate these two tapeworm infections
(Harrison et al., 1990; Chapman et al., 1995). This technique relies on the
amplification of parasite DNA obtained from parasite eggs or proglottids present in
the stool sample.
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Although the polymerase chain reaction can detect the presence of a single egg
(Chapman et al., 1995), the fact that passage of the eggs in the stool is erratic limits
the usefulness of this assay.
Regardless of the detection method used, the collection and examination of stool
samples for identification of taeniasis cases is associated with several problems.
Primarily, collection of fecal samples carries with it the potential for exposure to and
#
infection with Taenia eggs present in the sample and the sample must be tested
within a specific time period for it to remain viable. In addition, collection of stool
samples is often difficult and culturally unacceptable in many places where
epidemiologic studies on cysticercosis and taeniasis are conducted (Wilkins et al.,
1999).
1.5.2.3 EITB for Taeniasis
Humans can be infected with both the adult worm and larval forms of the cestode
Taenia solium, causing taeniasis and cysticercosis, respectively. Identification and
treatment of taeniasis infections can be difficult to detect since they are usually
asymptomatic. Therefore, accurate and sensitive detection of taeniasis cases becomes
a critical element for developing successful control strategies for cysticercosis
(Schantz et al., 1993; Gilman et al., 1996).
A serologic EITB assay for detection of taeniasis in humans has been developed by
(Wilkins et al., 1999) which uses excretory/secretory (ES) products from T. solium
tapeworms (TSES) that detect tapeworm carriers in a sensitive and specific manner.
The specificity of the TSES immunoblot assay has also been examined with respect
to differentiation of T. solium and T. saginata infections. There were no cross-
reacting antibodies present in any T. saginata samples that recognized any TSES
antigens, including the TSES diagnostic antigens. In order to examine, the
performance of the assay with respect to cross reactions with other parasite diseases,
serum samples from patients with other parasitic diseases were also examined for
antibodies to the TSES antigens (Table 2). None of the 193 samples examined
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contained antibodies that reacted with the target ES antigens. The serum battery
included 69 serum samples from patients with echinococcosis, and seven serum
samples from patients infected with Hymenolepis nana. Some serum samples from
echinococcosis patients contained antibodies that reacted with other higher molecular
weight antigens in the ES mixture, but not with the diagnostic antigens, indicating
the assay is 100% specific. Elsing serum samples collected from persons with
confirmed T. solium tapeworm infections, the test was determined to be 95% (69 of
73) sensitive (Wilkins et al., 1999).
Table 2: ES diagnostic proteins for effectively detecting only Tsolium taeniasis
Specificity of the Taenia solium ES diagnostic proteins for detecting
only T. solium taeniasis
No. of No of





T. saginata taeniasis S 0
Echinococcosis 69 0









* Filariasis sera weie collected from individuals infected with onchocerciasis {n = 26)
and lymphatic filariasis (n = 4, caused by Wuchereria bancrofit). Schistosomiasis infection
sera were collected from persons with S. mcmzom (21), 5. haematobium (8), and S japon-
ieion (8) infectious.
Source: (Wilkins eta/., 1999)
1.6 Neurocysticercosis
Neurocysticercosis (NCC) is a parasitic infection that can affect the nervous system
caused by Taenia solium, which is common, but preventable. In both humans; and
pigs, a therapeutic does of drugs is the most common form of treatment but often
detection is under-reported (Tsang & Wilson, 1995) and better surveillance and
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monitoring is necessary to control the infection. Infection with T. solium is widely
prevalent in human and pig hosts in many developing countries of Latin American,
Africa, and Asia (Sarti & Rajshekhar, 2003).
Humans are the only natural definitive host while pigs are the intermediate host. Man
may become an intermediate host from ingestion of the eggs of the adult tapeworm,
resulting in a condition known as human cysticercosis. The cysticerci of T. solium
may lodge in the brain causing cerebral cysticercosis (neurocysticercosis), resulting
in headaches, epileptic seizures, blindness and mental disturbances (White, 2000). In
addition, the cysticerci may cause other neurological afflictions such as meningitis,
encephalitis, ventricular disease, spinal disease and ocular cysticercosis, although the
most common manifestation still remains epilepsy (Cook & Zumia, 2003).
1.6.1 Diagnosis of Neurocysticercosis
According to the diagnostic criterion set out in "The Current Consensus Guidelines
for the Treatment of Neurocysticercosis" (Garcia 2002), patients who exhibit cystic
lesions showing the scolex of the parasite on a CT scan or an MRI fit the "absolute"
criterion. The presence of cysts in the brain indicates a definitive diagnosis.
Definitive diagnosis - these are patients who have one absolute criterion or those
who have two major plus one minor and one epidemiologic criterion, or
Probable diagnosis - those patients who have one major plus two minor, those who
have one major plus one minor and one epidemiologic condition, and those patients
who have three minor plus one epidemiologic condition (Del Brutto 2001).
1.6.2 Diagnostic Tools for Neurocysticercosis
According to (Dorny et al., 2003), antibody detection tests (e.g. ELISA and EITB)
are the most appropriate tools for measuring exposure to T. solium in sero-
epidemiological surveys and for confirmation of T. solium as the etiological agent of
epilepsy, but antigen detection tests are more useful for other purposes such as the
detection of active cysticercosis or the follow-up ofNCC patients after treatment. As
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Ag ELISAs only detect cases of active cysticercosis (i.e. the presence of living
cysticerci) (Erhart et al., 2002), (Garcia et al., 2000), (Nguekam et al., 2003), which
is important for deciding on the appropriate antiparasitic treatment (according to the
guidelines proposed by (Garcia et al., 2002)), when identifying T. solium as the
etiological agent of epilepsy, antibody detection is more appropriate than Ag-ELISA
because dead cysts are more-often responsible for epileptic seizures than those
caused by living cysts (Zoli et al., 2003b). However, in sero-epidemiological studies,
antibody detection tends to overestimate the prevalence of cysticercosis because
antibodies are no longer detected in serum within 1-3 years in 30-40% of patients
sero-positive for T. solium in endemic countries (Garcia et al., 2001). This reflects a
transient antibody reaction in patients after exposure to T. solium eggs or is a result
• '
of self-cure by the patient.
A study was carried out by (Prado-Jean et al., 2007) to evaluate the benefits of the
detection of both circulating antibodies (Ab) and antigens (Ag) for the diagnosis of
cysticercosis in people with epilepsy. Serum samples were collected from subjects in
a matched case-control study for epilepsy in the Kiremba area, Burundi, between
March and April 2001 (epileptic cases 14 303; controls without epilepsy 14 606). The
enzyme-linked immunosorbent assay (ELISA) was used for the detection of
antibodies (Ab ELISA) and circulating Ag (Ag ELISA). The Ab ELISA revealed
58.7% positivity in epilepsy cases and 31.4% in healthy controls; and Ag ELISA
revealed 38.3% positivity in epilepsy cases and 20.0% in controls. The matched odds
ratios were 3.6 (95%CI: 2.5^1.9) for Ab-ELISA, and 2.9 (95%CI: 2.1-4.3) for Ag
ELISA. Both Ag and Ab ELISA detected a significantly higher number'of
seropositives among people with epilepsy than among controls. The risk of epilepsy
was high in cases with a positive Ag ELISA, although less important than in cases
with positivity for Ab ELISA. Dead or degenerating cysticerci appear to be more
frequently associated with epilepsy than living cysts.
(Ito & Craig, 2004) continue the debate about the efficacy and purpose of antibody
and antigen tests, as they claim that antibody assays are suitable for detecting cases
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of active cysticercosis with or without a history of epilepsy. This is also supported by
data obtained from tests involving blind controls in humans (Wandra et al., 2003),
pigs (Sato, 2003) and dogs (Ito et al., 2002). More detailed molecular information on
candidate T. solium antigens in order to develop a suitable Ag-ELISA and further
research, in addition to phenotypic work on cysticercosis, should resolve this issue.
1.6.2.1 EITB
Currently, the most reliable immunological test for the diagnosis ofNCC is an EITB
assay with serum samples using Lentil Lectin Glycoprotein (LLGP) antigens
extracted from the metacestode of T. solium and is reported to have a high
•
specificity (100%) for the detection of antibodies in serum and CSF (Tsang et al.,
1989), (White, 1997). Although, 90% sensitivity has been reported in patients with
more than two lesions; it declined to 50-70% with a single lesion (Del Brutto et al.,
1992) and as low as 28% has been found in cases with single cysts in the brain
(Wilson et al., 1991). EITB is an expensive, complex technique, requires expertise
and moreover, facilities may not be available at various diagnostic laboratories or in
field settings in the developing countries. This diagnostic technique has been
previously discussed in the section dealing with porcine cysticercosis diagnostic
tools but was first developed for use in humans, and not animals.
1.6.2.2 Ab ELISA
The Ab ELISA uses cmde antigen for the detection of antibodies to T. solium in
serum or cerebrospinal fluid (CSF). Antigens used in these tests are either cyst fluid
or crude homogenates of T. solium cysticerci or crude preparations of the related
parasite T. crassiceps , which can be maintained in laboratory rodents (Pardini et al.,
2002). These unpurified antigens have moderate sensitivities and relatively poor
specificities (Schantz & Sarti, 1989), (Fleury et al., 2001). In surveys on
cysticercosis, antibody detection systems have been useful in identifying the risk
factors associated with transmission of Taenia solium ; a high seroprevalence in a
community indicates a "hot spot" where preventive and control measures should.be
applied (Dorny et al., 2003). The screening for Ab ELISA used in this study-was
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done as described by (Guerra et al., 1982). The antigen used for coating the
polystyrene ELISA plates was a crude soluble extract of T. solium cysticerci.
The antigens used in the Ab ELISA, however, do react with antibodies from other
helminthic infections, namely amoebas, filarisis and others as shown in the table
below. These cross reactions limit the specificity of the Ab ELISA.
Table 3: Reaction of the blood of patients presenting with known heterological and
homologous (T. solium) infections with the antigen Taenia solium
Known Infections Number of sera samples Number of sero¬
tested positive results (%)
Filaria 08 06 (75) 5 6(75)
Strongyloses 05 02 (40) 5 2(40)
Amoeba 05 02 (40) 5 2(40)
Fasciola 05 03 (60) 5 3(60)
Schistosoma 05 02 (40) 5 2(40)
Echinococcus 06 06 (100) 6 6 (100)
C. cellulosae 07 07 (100) 7 7 (100)
Toxocara 08 02 (25) 8 2(25)
Plasmodium 07 01 (14,28) 7 1(14)
Source: Dorny, Pierre - personal communication
1.6.2.3 Ag ELISA
Originally this assay was developed for the detection of bovine cysticercosis and is
based on a "sandwich" of 2 monoclonal antibodies raised against excretory/secretory
products of Taenia saginata metacestodes (Brandt et al., 1992; Dorny et al., 2000).
The adult tapeworm does not produce these antigens, and therefore, the test is very
specific in detecting human T. solium cysticercosis with sensitivity and specificity of
92.3% and 98.7% respectively (Erhart et al., 2002). The antigen ELISA seemsto be
a valuable tool in epidemiological studies of human cysticercosis. It may also be
valuable as a confirmatory or initial test for individual diagnosis. Studies on bovine
cysticercosis indicate that this test demonstrates infection with viable cysts only; this
may also apply to human cysticercosis. The test may also be of use in the follow-up
of neurocysticercosis patients. In Latin America, (Garcia et al., 1998) and (Cornea,
1999) also demonstrated the usefulness of serum antigen detection in cerebrospinal
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fluid or serum for clinical diagnosis and monitoring of neurocysticercosis. Validation
of the present monoclonal antibody-based antigen ELISA is in progress; preliminary
results showed that serum samples from 34 of 36 cases of cysticercosis (94.4%), who
had been confirmed by CT scan, biopsy of subcutaneous nodules, or both," gave
positive results. Out of 41 patients with filariasis (three), amoebiasis (three), malaria
(seven), schistosomiasis (three), trypanosomiasis (eight), hydatidosis (12) and
cerebral tumors (five) only one cross-reaction was observed resulting in a specificity
of 97.6%. Out of 84 documented cases ofNCC, 74 (88.1%) were detected using the
Ag-ELISA (Dorny et al. unpublished observation).
1.6.1.4 Neuroimaging techniques - Computed Tomography (CT) andMagnetic
Resonance Imaging (MR1)
The diagnosis of neurocysticercosis has been greatly improved by the introduction of
computed tomography (CT) and magnetic resonance imaging (MRI). These
techniques demonstrate the number and topography of lesions, their stage of
involution, and the degree of inflammatory reaction of the host against the parasites
and have largely replaced previous radiological procedures such as plain
roentgenograms, pneumoencephalograms, cerebral angiography and myelography. In
general, MR! provides better image detection and definition. The possibility of
multiplanar reconstruction of images, its capability to visualize the posterior fossa
without bone artifacts, and its high contrast resolution (far superior to that of CT)
allow MRI to recognize many forms of cysticercosis not visualized on CT. HoweVer,
the costs of MRI are high and the equipment is scarcely available in many endemic
countries, and its sensitivity for the detection of calcified lesions is poor. CT remains
the best screening neuroimaging procedure for patients with suspected
neurocysticercosis, and MRI is the imaging modality of choice for the evaluation of
patients with intraventricular cysticercosis, brainstem cysts and small cysts located
over the convexity of cerebral hemispheres. Its better image definition also suggests




There is no standard regimen for the treatment of neurocysticercosis but the
treatment varies with the type of involvement and the presence of other factors.
Management of neurocysticercosis includes the use of symptomatic medication
(including anticonvulsants), anti-inflammatory drugs, anti-parasitic drugs, or surgery
(Murrell 2005). The table below illustrates the criteria guiding clinical management
of the disease.
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Table 4: Treatment Management Guidelines for Neurocysticercosis
Parenchymal neurocysticercosis
Viable (live cysts)
One to five cysts Anti-parasitic treatment with corticosteroids
More than five cysts Anti-parasitic treatment with corticosteroids
Anti-parasitic treatment, with high-dose corticosteroids
Alternatively, chronic steroid management No anti-parasitic
treatment, neuro-imaging follow-up
Enhancing lesions (degenerating cysts)
Mild or moderate No anti-parasitic treatment. Neuroimaging follow-up
Alternatively anti-parasitic treatment with corticosteroids
and as a second alternative anti-parasitic treatment
Corticosteroids only if side effects develop
Heavy (cystlcercotic encephalitis) No anti-parasitic treatment. High dose corticosteroids and
osmotic diuretics
Calcified cysticerci
Any number No anti-parasitic treatment
Extraparenchymal neurocysticercosis
Ventricular cysticercosis Neuroendoscopical removal, when available If not available
then CSF diversion followed by an anti-parasitic treatment
with corticosteroids, and as a second alternative, open
surgery (mainly for cysts in the fourth ventricle)- . . '
Subarachnoid cysts including giant cysts Anti-parasitic treatment with corticosteroids. Ventricular
or "racemose" cysts on neuroimaging shunt if there is hydrocephalus
Hydrocephalus with no visible cysts on Ventricular shunt. No anti-parasitic treatment
neuroimaging
Other locations
Spinal cysticercosis. intra or extramedullar Primarily surgical Anecdotal reports of successful use
of albendazole with corticosteroids
Ophthalmic cysticercosis Surgical resection of cysts
Source: (Murrell, 2005)
1.7 Riskfactors associated with taeniasis and cysticercosis
t
Most of the risk factors associated with cysticercosis are associated with pig rearing
and husbandry practices, hygiene and santitation practices and the consumption of
pork. In addition, significance of risk has been associated with tapeworm infection in
general and a tapeworm carrier in the household. Poverty is also associated with
disease in general and the acquisition of helminthic infections. This chapter aims to
establish risk factors for taeniasis/cysticercosis prevalence in order to identify those
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with the most influence and to aid in diagnosis. The following sections of the
introduction explore the literature to put factors that are investigated in this chapter
into context. The factors under consideration will in some cases be associated with
both human taeniasis/cysticercosis and porcine cysticercosis. Factors to be explored
are: hygiene and sanitation practices (source and treatment of household water,
presence and use of latrine, ingestion and preparation of pork), household, level
indicators (age, education level, presence of tapeworm carrier in household), factors
associated with pig keeping (occupation, grazing practices, types of feed, inspection
of carcass after slaughter), and knowledge of tapeworm (nodules observed in humans
and pigs, observation of passing of proglottids).
1.7.1 Hygiene and Sanitation Practices
1.7.1.1 Source and Treatment ofWater
The source and treatment of water used in the household have been identified as risk
factors in the transmission of cysticercosis. Cysts in humans develop at the end of a
cycle which previously relies on the ingestion of ova of Taenia solium which are
excreted by human carriers in their feces. The risk of contamination with Taenia ova
is related to the contact with Taenia solium carriers. The most common means of
transmission, however, is ingestion of Taenia solium eggs from contaminated food or
water (Antoniuk, 1999). Water that is collected from a source such as a river or
uncovered well could easily be contaminated with faeces and thus contain eggs.
Studies from Central and Latin America have identified drinking unboiled water and
not properly washing hands before and after eating as risk factors for cysticercosis
(Garcia et al., 1995), (Sarti et al., 1996). In a community-based study in Shandong,
China, drinking unclean water, not washing hands after defecation and eating food
with dirty hands indicated a two-fold greater odds of cysticercosis morbidity, the
findings ofwhich indicated an overall prevalence of 3.2% (Cao et al., 1996).
1.7.1.2 Latrine Use and Presence and Defecation Habits
Not using a latrine when defecating and defecation in pigstys have a significant
effect on cysticercosis prevalence in humans (Cao et al., 1996). If pigs are allowed to
ingest human faeces contaminated with the Taenia solium tapeworm, they acquire
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porcine cysticercosis and the cycle of transmission is perpetuated. In a study of
prevalence and risk factors for taeniasis and cysticercosis in humans and pigs in
Mexico, infection rates of porcine cysticercosis increased with the age of pigs, and
were habitually higher in pigs that had access to latrines or were fed human faeces
(Sarti et al., 1992). In another study which examined the epidemiology and
prevalence of Taenia solium taeniasis and cysticercosis in Guatemala, however, no
significant relationship between seropositivity and risk factors such as water supply
and the absence/presence or type of toilet was observed. The results of this
immunoblot study indicated a prevalence of 17.3% in one community and 10.1% in
the other. It was observed that the community that recorded the higher rate of
seropositivity was the community which was consistently poor socieconomically,
with lower adult literacy rates, more households defecating in the open, having no
means of waste water removal from the home (waste water generally poured on to
the ground around the house) and fewer houses with piped water (Garcia-Noval et
al., 1996). Similarly, a study in Mbulu District, Tanzania, also reported no significant
association between the absence of latrines and the prevalence of infection (OR =
0.23; 95% CI = 0.06, 0.91) (Ngowi et al., 2004). This difference in significance of
risk factor can also largely be dependent on the condition of the latrine if present- If
the latrine is present and clearly in use, but does not have barriers to restrict the
access of pigs, having a latrine may in fact increase the odds of pig cysticcerosis.
1.7.1.3 Ingestion ofand Preparation ofPork
Eating raw or inadequately cooked pork is strongly associated with the risk of
acquiring taeniasis caused by Taenia solium. The intestinal tapeworm infection is
acquired when larval forms (cysticerci) are ingested in raw or insufficiently cooked
pork. Studies from Mexico and Peru have identified the consumption of uncooked or
infected pork as being strongly related to seropositivity for taeniasis (Sarti et al.,
1992; Garcia et al., 1995). In another study in Mexico City which examined the
prevalence and risk of cysticercosis and taeniasis amongst and urban population of
soldiers and their families, relatives of the soldiers positive for cysticercosis and
taeniasis markers ate more pork from street vendors than restaurants or markets
compared with relatives of soldiers without these indicators of infection (Garcia-
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Garcia et al., 1999). Pork that is prepared in an informal setting has a greater chance
of being poorly cooked or has potentially never been inspected for disease owing to
the lack of enforcement of food hygiene regulations and may therefore contain
cysticerci which are then consumed. In a study in Zambia, the majority of farmers
(92.3%) consumed pork and the prevalence rate for porcine cysticercosis showing
seropositivity by Ag ELISA was 37%. Such a high rate of porcine infection and pork
consumption suggests the human infection rate might be high as well (Sikasunge et
al, 2007).
1.7.2 Indicators at Household Level
1.7.2.1 Age
The age of human cysticercosis seropostiive subjects has generally had an
association with seropositivity in studies of prevalence and risk factors (Diaz et al.,
1992a; Sarti et al., 1994; Garcia et al., 1997). In a study of pig and human
cysticercosis in Nigeria, in which the overall prevalence of taeniid ova in the 1525
human-stool samples analysed was 8.6%, most (78.6%) of the cases occurred in
adults aged > 30 years (Onah & Chiejina, 1995). In a study or rural households in
Bolivia, seroprevalence increased gradually with age, with a high of 44% for ages
51-60 (Carrique-Mas et al., 2001). This can be explained by the fact that the longer
people are exposed to T. solium eggs in an endemic environment, the more chances
they have to become infected (Zoli et al., 2002). Conversely, in a study of 317
villagers in Peru, in which Taenia solium specific antibodies were detected in 21% of
the sample, although the frequencies of seropositivity were similar for males and
females, (24% and 18% respectively) the subjects aged 4-29 years were more likely
to be seropositive than the older subjects (P<0.001). A positive result in the EITB
assay was significantly associated with being aged <30 years in both the univariate
and logistic regression analysis (Moro et al., 2003). This unusual distribution may be
explained by an early, intense exposure to T. solium eggs in a heavily contaminated
environment or that some of the positives to the EITB were in fact false positives to
T. solium and the subjects contained antibodies against Echinococcus granulosus.
This latter theory, however, would call into question the specificity of the EITB,
which has consistently been reported to be 100% (Tsang et al., 1989; Wilson et al.,
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1991). The association between younger age groups and increased prevalence of
active cysticercosis was also found in a hyperendemic area of Venezuela, a study in
which Ferrer et al. (2003) did find more cases in individuals aged < 30 years. The
explanation for this relative anomaly was that in older individuals cysts can start to
die and calcify, resulting in late onset epilepsy and the Ag ELISA would therefore
not have detected viable cysts in older age groups, merely the presence of live cysts
in younger patients (Ferrer et al., 2003).
1.7.2.2 Education
The level of education in subjects has been shown to have an association with
prevalence rates of taeniais in studies from Central and Latin America. In a study
carried out in Peru, results from a multiple logistic regression analysis for best fit
with a positive electroimmunoblot transfer result (EITB) as outcome showed an
almost three fold greater odds of being positive when the subject possessed' an
education level of no more than elementary level (Moro et al., 2003). In a study in
the Bolivian Chaco, seroprevalence was negatively associated with level of
education, the data being analysed for people over 26-years-old only: it was 16/39
(41%) in illiterates, 25/90 (27.8%) in those with primary education only, 7/34
(20.6%) for secondary educated and 3/19 (15.8%) for university educated people
(Carrique-Mas et al., 2001). There are, however, several studies in which there is no
statistical significance between education levels and prevlance of Taenia solium
cysticercosis (Garcia et al., 1995; Cao, 1997; Goodman et al., 1999). In the case
control study by Goodman et al., in which both the cases and controls had similarly
high levels of education (17% and 20% respectively high school or above), 12 % of
•
the cases and 4 % of the controls were seropositive by EITB, indicating that a high
level of education does not necessarily correlate negatively with a high prevalence.
1.7.2.3 Presence of tapeworm carrier in household
Data from the Americas indicates that the main risk for both human
neurocysticercosis and swine cysticercosis is the presence of a tapeworm carrier in
the household (Flisser et al., 2003). In 1988, a survey performed in the community of
El Sotano in Mexico showed for the first time the association of the parasite's life
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cycle with pigs, humans and tapeworms, as people with a history of passing
proglottids or with Taenia eggs in their stools were detected in the same houses with
people that had anti-cysticercus antibodies and with pigs that had cysticercosis (Sarti
et al., 1988). Another study reported the finding of carriers of the adult T. solium
who had significant numbers of people with anti-cysticercus antibodies living in
close proximity (Diaz-Camacho et al., 1990), thus reinforcing the close association
of the life cycle - tapeworm carriers, pigs with cysticercosis and seropositive people
all occurring close to each other. Other studies from Bolivia, Ecuador and Guatemala
»
indicate this same association (Cruz et al., 1989; Garcia-Noval et al., 1996; Bern et
al., 1999). In a study of the rural population in Peru, (Garcia et al., 2003b)) found 0-
6.7% (median 2.5%) taeniasis cases by copro-antigen ELISA, while the
seroprevalence for cysticercosis by EITB in the same population varied from 7.1 to
26.9% and persons living with tapeworm carriers had 4.3 times greater odds of
testing positive than those living without a tapeworm carrier. Further corroboration
of the increased risk of locally acquired cysticercosis is borne out by a study
conducted to determine the potential for infection from immigrant domestic workers
of an orthodox Jewish population in New York City. Adherence to dietary laws that
prohibit the ingestion of pork is the norm of this population thereby implying
maintenance of the life cycle of Taenia solium solely within members of this
community is not possible. Almost all (99.6%) domestic employees were immigrants
and 97% were from Latin America. For housekeepers employed in the last five years,
a Central American country of origin was associated with seropositive households
(RR=2.7, P=0.0001). Of the 1,789 members of the community studied, 23 (1.3%)
were seropositive by EITB assay. Being female was also associated with
seropostivity which reinforces the influence of the domestic worker as a risk factor.
In this community females do not traditionally work outside the home so would have
the most potential for contact with the domestic worker. Somewhat surprisingly,
children of less than five years old had a significantly lower EITB seroprevalence
than other age groups but a greater frequency of contact with the infected domestic
worker. This, however, could reflect the shorter time at risk for exposure as children
aged 6-10 years had a seroprevalence of 1.7% (Schantz et al., 1992; Moore et al.,
1995).
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1.7.3 Factors associated with Pig-keeping
1.7.3.1 Raising Pigs
In a study of epileptic patients in Leon, Nicaragua, the only statistically significant
association for seropositivity for taeniasis/cysticercosis by EITB or ELISA was the
subject living in a household in which pigs were raised (OR = 5.18, CI = 0.8-41.6; P
< 0.05) (Bucardo et ah, 2005). This significance is borne out by several other studies
conducted around the world. In China, in a population-based case-control study of
rural respondents in Shandong Province, those who raised pigs had an almost 3 fold
greater association with seropositivity, a relationship which was statistically
significant (OR = 2.6, CI = 1.2-5.7; P < 0.05) (Cao, 1997). In Peru, raising pigs,
irrespective of the number, was associated with being seropositive (232/1,562, 14.9%
versus 123/1,021, 12.0%; OR 1.27; CI 1.01, 1.61; P < 0.043) (Garcia et al., 1995;
Garcia et al., 2003b). In India, where it was found that 78% of children of pig
farmers passed taeniid eggs in their stools (Banerjee et al., 1994), having no separate
place to keep pigs apart from the household space and having epilepsy in the family
were identified as risk factors for NCC clustering in a family (Prasad et al., 2009).^
1.7.3.2 Pig Husbandry Practices
Allowing pigs access to human faeces is an independent risk factor for cysticercosis
morbidity, whereas raising pigs is independently associated with seropositivity,
according to a study carried out in China (Cao et al., 1996; Cao, 1997). In the study
area, pigs are raised in households and most are allowed to graze on human faeces;
this can be responsible not only for a high rate of porcine infection, but also favours
the transmission of human cysticercosis within the community as pigs can help
spread the parasite eggs in the environment. In a study conducted in Mbulu District
in Tanzania, 96% of pigs tested for cysticercosis ranged free. The prevalence- rate
obtained for this study was 17% by lingual examination, a method which has lower
accuracy than serology (Ngowi et al., 2004). Husbandry practices such as tethering
some of the time or fencing the pigs separately from the household have been shown
to have a negative effect on serological association as pigs do not have access to
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faeces, which can potentially break the life cycle of the parasite (Cao, 1997). Free-
ranging pigs can be fed at minimal cost since the majority of their food is obtained
by scavenging. However, corralling pigs, thus restricting their access to human feces,
although more expensive in the short term, can be promoted as cost-effective because
a cyst-free pig is generally sold at much higher prices than an infected one. Since
sanitary conditions (latrines, sewage disposal, and potable water) are difficult to
achieve and unlikely to be generally improved in rural communities of developing
countries, control of cysticercosis through sound pig husbandry practices appears to
be the most accessible and cost-effective target for control programs (Garcia et al.,
1995).
One of the main indicators of success in controlling cysticercosis is environmental
contamination as measured by the level of swine cysticercosis (Gonzalez et al.,
1994). A study performed in the community of Coapeche in Veracruz showed that
none of the pigs (53) examined by tongue palpation had cysticercosis and no
antibodies were detected by western blot. The survey showed that all pigs were
restrained and that 91% of houses had latrines (Flisser et al., 2003). Economics can
also play a motivating factor in control of pigs as people have learnt that if pigs are
restrained and have no access to faeces, the meat can be sold at a higher price as it is
uncontaminated (Sarti et al., 1997b).
1.7.3.3 Meat Inspection
Lack of inspection of pork before and after slaughter contributes to the continuing
spread of cysticercosis and management of such can be looked at as an entry point
for control of the disease (Ngowi et al., 2004; Boa et al., 2006). In many areas ofDar
es Salaam in Tanzania, slaughtering pigs is almost an exclusively backyard operation
(Airey, 1995), and many pig keepers sell pork directly to their neighbours and friends
on a pre-order basis. Lack of slaughter facilities and meat inspection in many areas of
the country is a threat to food safely and guidelines for inspection of pork for porcine
cysticercosis are not present within the national meat inspection regulations of
Tanzania, although provisions have been made for bovine cysticercosis (Boa et al.,
2006). A recent study conducted in Mbulu District found that detection of porcine
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cysticercosis in slaughter pigs is low when the current pork inspection regulations are
followed (Boa et al., 2002). In Zambia, pigs are mainly raised by resource-limited
farmers. In the Eastern province, pigs are raised mainly for home consumption, while
most of the pigs raised in the Southern province are transported to Lusaka where they
are sold and slaughtered at an illegal slaughter slab. Recent (unpublished)
observations showed a high prevalence of T. solium cysticercosis in pigs presented at
this slaughter slab (Phiri, 2002).
1.7.4 Knowledge of Tapeworm
1.7.4.1 Nodules observed under skin (pigs or humans)
There is a strong association with nodules observed under the skin and positive
serology for human cysticercosis. In a study in Irian Jaya, Indonesia, of the 31
patients reporting to a local health centre with epilepsy and subcutaneous nodules,
Immunoblot analysis revealed that 12 (67%) of 18 and 20 (65%) of 31 cases,
respectively, were serologically confirmed as cysticercosis (Wandra et al., 2000).
The failure of people to recognize the presence of cysts in pigs as being positively
associated with cysticercosis morbidity contributes to the lack of control of the
disease. In a study in Zambia, observation of cysts by farmers was high in all
districts, but did not deter them from eating or selling pork. Most of the respondents
(83.3%) had observed cysts in pork. Of the respondents that observed cysts in pork,
20.1% ate and 18.3% sold the meat. Of the 659 farmers who observed cysticercosis,
43.8% acknowledged pork measles as just being a pig disease, 6.5% referred to it as
being husks or maize bran (because they think that porcine cysticercosis results from
feeding pigs with maize bran or husks) whereas, 48.3% had no idea of what cysts
seen in pork was indicative (Sikasunge et al., 2007).
1.7.4.2 Awareness ofdisease or tapeworm
In a health awareness intervention study carried out in Mexico designed to educate
the community on the life cycle of the parasite, the diseases and control measures
regarding cysticercosis, (Sarti et al., 1997b) found that community awareness of the
disease can play an important role in control of porcine cysticercosis. The
prevalences of cysticercosis in pigs at the start of the education intervention were
Chapter 1 38
2.6% and 5.2% by lingual examination and antibody detection (immunoblot assay),
respectively, and approximately one year after the intervention they were 0% and
1.2% (P < 0.05). These changes were accompanied by significant reductions in the
»
reported access of pigs to sources of infection and freedom to roam. The study
concluded that health education, developed along with community involvement,
reduced opportunities for transmission of T. solium in the human-pig cycle (Sarti et
al., 1997a). In a study conducted by (Ferrer et al., 2003), paradoxically, higher
seroprevalences were recorded in the two communities that were most aware, and
informed of the risks presented by Taenia solium. Evidence of taeniasis, which was
indicated by passing of tapeworm proglottids, was also higher in these two
communities. Although sanitary education had been carried out, behavioural change
had not necessarily followed. The habit of eating potentially infected pork and the
lack of sanitary facilities or latrines presented ideal conditions for porcine parasite
transmission. In this case, sanitary education alone was not sufficient to control the
disease.
Individuals without knowledge on infected meat have a higher risk of getting
taeniasis and may subsequently get cysticercosis. In a study in Shandong Province,
China, this risk factor is significant for seropositivity as well as cysticercosis
morbidity (OR = 11.7, CI = 1.9 - +INF; P < 0.01). This lack of awareness may
continue to play a role in the future as with the establishment of a freer market
economy in China, many people have gone into business selling pork on the local
market and at the same time regulations for inspection of meat have become less
stringent. Presently meat can be sold without official examination, allowing
cysticerci-containing pork to readily be obtained (Cao, 1997). The link between lack
of knowledge of association between infected meat in pigs and cysticercosis in
humans is further reinforced by data from a study in Zambia. In this study, 85.5% of
the farmers in the Eastern province and 98.0% in the Southern province did not know
that there exists a link between human taeniasis and porcine cysticercosis. Of the
farmers interviewed, 87.3% in the Eastern province and 98.5% in the Southern
province did not know that tapeworm infection in humans was due to eating infected
pork. Ninety-seven percent of the farmers did not know that pig cysticercosis was
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due to pigs eating human faeces contaminated with T. solium eggs (Sikasunge et al.,
2007).
1.7.4.3 History ofpassingproglottids
In studies from Central America, a history of passing proglottids or tapeworm
sections in faeces is significantly associated with seropositivity to an EITB for
human cysticercosis (Sarti et al., 1992; Ferrer et al., 2003). In a survey of 1,552
persons queried during a household survey, 90 (5.8%) reported a history of passing
tapeworm proglottid in faeces (this question was further explained by showing the
respondents pictures and fixed specimens of proglottids). The principal risk factors
associated with a history of passing proglottids in faeces were having owned infected
pigs (OR = 2.65, CI = 1.37-5.12; P < 0.004) and having eaten infected pork (OR =
1.93, CI = 1.0-3.76; P < 0.05). Goodness of fit analysis confirmed that seropositive
persons (but not infected pigs) were significantly clustered within households,
particularly in households in which a member reported a history of have passed
proglottids (x2 = 31.95, P < 0.005). In a study examining neurocysticercosis in
endemic villages in Peru, a significantly high proportion of those tested stated a
history of passing proglottids. Of those with a positive EITB (Tsang et al., 1989),
47.8% (11/23) reported having passed proglottids (Garcia et al., 1997). It must be
noted, however, that in this study there was a lack of specificity when asking the
question regarding passing of proglottids and no visual tools were used, therefore
allowing for some degree of error or confusion with the answers. Nonetheless, since
there was a significant association between such a history and a positive EITB result,
*
auto infection may be important in the acquisition of neurocysticercosis within'the
population (Garcia et al., 1997). Similarly, in a study carried out in a rural pig
farming community in India, factors associated with taeniasis on the multivariate
analysis were above age 15 yrs, history of passing Taenia solium segments in stool
(OR = 3.31, CI = 2.31-4.76; P < 0.001), undercooked pork consumption and poor
hygiene in hand washing (Prasad et al., 2007). The presence of Taenia carriers living
within the community is a potential threat as is borne out by literature on the
previously described risk associated with taeniasis/human cysticercosis and living in
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close proximity to a tapeworm carrier (either within the household or in close
association) (Garcia et al, 2003b).
1.8 Epilepsy
1.8.1 General Background
The word "epilepsy" derives from the Greek verb "epilambanein", meaning "to be
seized, to be overwhelmed by surprise" and captures well the sudden, usually
unpredictable and intrusive nature of most seizures. Neurologists define epilepsy as:
"a condition in which individuals experience paroxysmal changes in behaviour
caused by abnormalities in the electrical activity of the brain" (Asbury, 1992). In
other words, epilepsy is the name given to a group of functional disorders of the
brain that are characterized by repetitive seizures. Seizures involve abnormal,
excessive electric discharges of groups or assemblies of nerve cells (neurones) in the
brain (WHO, 2004a).
Epilepsy is the most common serious neurological disorder and is one of the most
prevalent non-communicable disease in the world (Scott, 2001). The WHO
Neurosciences Research Protocol for studying the prevalence of neurological
disorders in developing countries defines epilepsy as two or more afebrile seizures
unrelated to acute metabolic disorders or to withdrawal of drugs or alcohol
(Senanayake, 1993). According to the WHO "Out of the Shadows" - Global
Campaign Against Epilepsy, in all areas of the world, no less than three out of ever}'
thousand people - and in several places over 40 per thousand (4%) are affected.
Approximately 2.5 million people worldwide carry adult T. solium (Burneo, 2001).
The prevalence of epilepsy in industrialized countries is about 3-9 per 1000
population. The prevalence in developing countries, data which is based largely on
community surveys of rural populations, is as high as 49 per 1000 population in
Liberia and 57 per 1000 in Panama (Senanayake, 1993).
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1.8.2 Prevalence in Sub Saharan Africa
The prevalence of epilepsy for sub-Saharan Africa varies considerably, with smaller
studies showing in general a higher prevalence and larger studies showing prevalence
nearer that in the developed world. The median prevalence found using door-to-door
studies is 15 per 1000 people (Preux, 2005). The table below illustrates varying rates
of prevalence using door-to-door studies in sub-Saharan Africa.
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Table 5: Prevalence of Epilepsy in sub-Saharan Africa using door-to-door surveys
Country Reference Year N
Prevalence (per
1000) 95 % CI
Benin
(Agbog borne) (Gbenou, 1995) 1995 530 24.5 10.9-38.1
Benin (Savalou) (Avode, 1996) 1996 1,443 15.2 8.7-21.7
Benin (Zinvie) (DeBrock, 2000) 2000 3,134 33.5 22.3-44.3
Burkina Faso Debouverie, 1993) 1993 16,627 10.6 9.1-12.2
Cameroon (Nkwi, 1989) 1989 500 70.0 46.3-93.6
Cameroon
(Bilomo) (Dongmo, 2000) 2000 1,900 58.4 46.9-69.1
(Tekle-Haimanot, •
Ethiopia (Butajira) 1990) 1990 60,820 5.2 4.6-5.8
Ivory Coast (Kouassi, 1998) 1988 1,176 7.6 2.5-12.7
43.0-
Ivory Coast (Kouadjo, 1990) 1990 309 74.4 104.9
Ivory Coast
(M'Brou) (Kaudjhuis, 1995) 1995 920 59.0 43.0-75.0
(Kaamugisha &
Kenya (Nakuru) Feksi, 1998) 1988 2,960 18.2 13.2-23.2
Liberia (Goudsmit, 1983) 1983 4,436 28.0 23.0-33.0
(Andriantseheno, •
Madagascar 2004) 2001 925 20.8 11.3-30.3
Mali (Farnarier, 2000) 2000 5,243 15.6 12.2-19.0
Mali (Bamako) (Traore, 2000) 2000 4,074 11.3 8.0-14.6
Nigeria (Longe, 1989) 1989 2,925 6.2 3.3-9.1
Nigeria (Aiyete) (Osuntokun, 1982) 1982 903 37.0 24.2-49.8
Nigeria (Igbo-Ora) (Osuntokun, 1987) 1987 18,954 5.3 4.2-6.4
Senegal (Ndiaye, 1986) 1986 7,682 8.3 6.2-10.4
Senegal (Diop, 1996) 1996 2,803 21.0 15.5-26.5
Tanzania (Rwiza, 1992) 1992 18,183 10.2 8.7.-11.7
Togo(Akebou) (Grunitzky, 1996) 1996 4,182 13.1 9.6-16.6
Togo (Kioto) (Grunitzky, 1991) 1991 19,241 12.3 10.7-13.9
Togo(Kozah) (Dumas, 1989) 1989 5,264 16.7 13.1-20.3•
Togo(Tone) (Balagou, 2000) 2000 9,143 18.6 15.7-21.5
Uganda (Kaiser, 1996) 1996 4,743 13.0 9.7-16.3
Zambia
(Chikankata) (Birbeck, 2004) 2004 55,000 12.5 11.5-13.5
Source: (Preux, 2005)
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It is estimated that 10% of the burden of brain and mental disorders in the world is
caused by epilepsy, calculated in disability-adjusted life years (DALYs), which is
very significant. This calculation includes premature deaths and the loss of healthy
life due to disability (World Bank, 1993). Every year, among every 100,000 persons,
there will be 40-70 new cases (WHO, 2003c). Of the 50 million people in the world
who have epilepsy, approximately 35 million have no access to appropriate
treatment. This is in most cases because services are unaffordable or non-existent and
in some cases because epilepsy is not viewed as a medical problem or as a treatable
brain disorder (WHO, 2001b).
1.8.3 Burden of Disease Estimates for Epilepsy
The burden of disease (BOD) estimates for epilepsy include epilepsy and status
epilepticus. (Mathers, 2003) estimate the DALYs for epilepsy as 6,223,000, with
slightly higher rates for males (3,301,000) than for females (2,922,000). Many risk
factors for epilepsy are linked with a lower level of economic development; thus, the
burden is highest in South Asia followed by Sub-Saharan Africa (Table 4). A nota'ble
observation is the reportedly low burden in the Middle East and North Africa, despite
parts of that region being relatively underdeveloped. Epilepsy imposes a large
economic burden on patients and their families. It also imposes a hidden burden
associated with stigmatization and discrimination against patients and even their
families in the community, workplace, school, and home. Social isolation, emotional
distress, dependence on family, poor employment opportunities, and personal injury
add to the suffering of people with epilepsy (Jamison, 2006).
Chapter 1 44
Table 6: Disability-Adjusted Life Years by Cause and Region, 2001 (x1000)
Global total
Europe Latin Middle South Sub- High-
Mixed Males Females East & America East & Asia Saharan income
sexes Asia & Central & the North Africa Countries
Condition Pacific Asia Caribbean Africa Countries
AD and other 17,108 6,092 11,016 4,110 1,612 1,215 292 1,955 450 7,468
Dementias
Epilepsy 6,223 3,301 2,922 1,303 354 737 248 1,741 1,373 464
PD 2,325 1,124 1,202 435 228 90 81 303 100 1,086
Cerebrovascular 72,024 35,482 36,542 25,832 12,616 3,936 1,948 13,184 5,125 9,354
Disease
Source: (Mathers, 2003)
More than 80% of patients with epilepsy live in developing countries and most of
these live in sub-Saharan Africa (WHO, 2001b). Data on the incidence of and
prognosis for epilepsy in sub-Saharan Africa are scarce but prevalence data show
that epilepsy is two to three times more common than in industrialized countries in
non-tropical areas (Preux, 2005).
1.8.4 Definitions for Epilepsy Diagnosis
Epileptic seizure. A clinical manifestation presumed to result from an abnormal and
excessive discharge of a set of neurons in the brain. The clinical manifestation
consists of sudden and transitory abnormal phenomena which may include
alterations of consciousness, motor, sensory, autonomic, or psychic events, perceived
by the patient or an observer.
Epilepsy. A condition characterized by recurrent (two or more) epileptic seizures,
unprovoked by any immediate identified cause. Multiple seizures occurring in a 24-h
period are considered a single event. An episode of status epilepticus is considered a
single event. Individuals who have had only febrile seizures or only neonatal seizures
as herein defined are excluded from this category.
Status epilepticus. A single epileptic seizure of >30-min duration or a series of
epileptic seizures during which function is not regained between ictal events in a
>30-min period.
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"Active" epilepsy. A prevalent case of active epilepsy is defined as a person with
epilepsy who has had at least one epileptic seizure in the previous 5years, regardless
of antiepileptic drug (AED) treatment. A case under treatment is someone with the
correct diagnosis of epilepsy receiving (or having received) AEDs on prevalence
day.
Epilepsy in remission with treatment. A prevalent case of epilepsy with no
seizures for > 5 years and receiving AED at the time of ascertainment.
Epilepsy in remission without treatment. A prevalent case of epilepsy with no
seizures for >5 years and not receiving AED at the time of ascertainment.
Single or isolated seizure. One or more epilepticseizures occurring in a 24-h period.
Febrile seizure. An epileptic seizure as herein defined, occurring in childhood after
age 1 month, associated with a febrile illness not caused by an infection of the CNS,
without previous neonatal seizures or a previous unprovoked seizure, and not
meeting criteria for other acute symptomatic seizures.
Neonatal seizure. An epileptic seizure as herein defined occurring in the first 4
weeks of life.
Febrile seizure with neonatal seizure. One or moreneonatal seizures in a child who
has also experienced one or more febrile seizures as herein defined.
Nonepileptic events. Clinical manifestations presumed to be unrelated to an
abnormal and excessive discharge of a set of neurons of the brain, including:
• disturbances in brain function (vertigo or dizziness, syncope, sleep and
movement disorders, transient global amnesia, migraine, enuresis), and
pseudoseizures (nonepileptic sudden behavioral episodes presumed to be of
psychogenic origin; these may coexist with true epileptic seizures).
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All definitions have been taken from the Commission on Classification and
Terminology of the International League Against Epilepsy (ILAE, 1989).
1.8.5 Treatment ofEpilepsy
A large proportion of the 50 million people affected by epilepsy remains untreated
(Ellison et al., 1988). In India, for example, of the 10 million people thought to have
epilepsy, 5 million of them remain untreated (Gourie-Devi et al., 1999). This
treatment gap has been measured by the International League against Epilepsy as the
difference between the number of people with active epilepsy (two or more
unprovoked seizures on different days in the previous year) and the number whose
seizures are being appropriately treated in a given population at a given point in time,
expressed as a percentage (Meinardi et al., 2001). It should also be noted that while
four-fifths of the potential market for antiepileptic drugs is in the developing wdrld,
up to 90% of people with epilepsy in developing countries receive no treatment at all
(Shorvon & Farmer, 1988), (Kale, 1997).
In a review of pharmacological treatment therapy in Africa, the ILAE found that In
French-speaking areas, phenobarbitone is prescribed in 65-85% of treated cases. In
English-speaking countries, phenytoin (PFIT) is also frequently prescribed.
Carbamazepine (CBZ) is the second drug, but is prescribed in only 5-20% of treated
cases. Valproate (VPA) is prescribed in 5-15%, but is less widely available, and
costs are also much higher than those of the aforementioned drugs. For status
epilepticus, injectable PB or diazepam (DZP) is used when available (Meinardi et al.,
2001).
A study conducted in rural and semi-rural areas around Nakuru, Kenya, looked at
(amongst other indicators), the clinical effectiveness of a treatment programme in
terms of seizure control, toxicity and compliance and whether control of generalized
tonic-clonic seizures inthis group is more difficult when started late. The study put
patients on a regimen of drug therapy of carbamazepine or phenobarbitone, the
patient and drug having been selected at random. The results of the study included
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the findings that either drug was effective in reducing seizure frequency (P < 0.05)
and there was no difference in the effectiveness of treatment with respect to the
length of history of epilepsy and the lifetime number of seizures (Feksi et al., 1991).
1.8.6 Social Effects of Epilepsy
The hypothesis generally is that epilepsy is a disease incurring considerable social
disadvantage, not to say stigma, a hypothesis borne out in the experience of most
researchers (Shorvon & Farmer, 1988). It is also a disease about which many
sufferers are reluctant to discuss. Research in Nigeria which concentrated on
obtaining evidence from the patients themselves on the social disadvantages of the
disease, found that this information was not forthcoming since sufferers are likely to
be reluctant to admit to such sensitive problems.
Epileptics often face problems of stigmatization from their own communities. In
Ethiopia, patients were treated as lepers and banished from the community (Geil,
1968). Patients in native American communities in the United States have been
accused committing incest, an offence which has resulted in acquiring the disease
(Levy et al., 1979). In Madagascar, epileptic patients were buried separately
(Osuntokun, 1977). In Nigeria, nonepileptic respondents asked to compare patients
cured of psychosis with epileptic ones discriminated on the whole in favour of the
ex-psychotics (Arawatife et al., 1985). Questionnaires administered in Kenya and
Ecuador to nonepileptic controls and community leaders revealed some realistic
assessment of epilepsy both as a disease and a social condition, but also much
prejudice. Informants claimed they would not let their children play with known
epileptics, would not marry them, or let their children do so. Epileptic patients are
thought to be uneducable, unemployable, a danger to the community. The inability to
get married, breakups of marriages and problems with employment seem factors in
the lives of epileptic sufferers almost everywhere, but by no means invariably
(Shorvon & Farmer, 1988).
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1.9 Summary ofResearch Objectives
The aim of this study is to find the prevalence ofNCC-related epilepsy in a group of
previously identified epilepsy sufferers in Busia District, Western Kenya. The study
will assess known risk factors for taeniasis and NCC which have been discussed in
this chapter, using a questionnaire and administer serological testing within the study
population, using tests known to be specific and sensitive for the presence of Taenia
solium in humans. The study attempted to find a correlation between the presence of
these risk factors and a positive test result.
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This chapter aims to describe the study area, namely Busia District. As the District
had reported increases in pig - keeping in recent years (Thuranira, 2005), it was
possible that with this increase would have accompanied a potential increase in the
incidence of neurocysticercosis. Participants for the study were selected on the basis
of an epilepsy diagnosis by a qualified professional and were taken from all areas of
the District. A brief description of the District with its Divisions and Locations
follows.
2.2 Study Area General Description
2.2.1 Location and Administration
Busia District is located in Western Kenya, bordering Uganda on the west side, Teso
District to the north, Siaya and Mumias Districts to the east and Lake Victoria to the
south. Busia District falls within the Lake Victoria Basin.
The altitude varies from 1,130 m above sea level on the shores of Lake Victoria to 1
375 m above sea level in the central part. The northern divisions (Butula and
Nambale) occupy a plain characterised by low flat divides. These are often capped
by laterites and shallow incised swampy systems. The peneplain has fertile soils
suitable for growing maize, Robusta coffee and sugar cane.
The southern part, which covers parts ofMatayos Division, Funyula Division and the
northern part of Budalang'i Division is covered by a range of hills comprising the
Samia Hills, which run from northeast to southwest, culminating at Port Victoria.
The Yala Swamp is found in the extreme south of the district, an area which forms a
colony of papyrus growth broken by irregular water channels and occasional sijiall
lakes with grassy islands (CBS, 2000; Government of Kenya, 2002).
The district is divided into six divisions: Funyula, Butula, Nambale, Matayos,
Budalang'i and Busia Municipal or Town. These are further divided into 30 locations
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and 99 sub-locations with individual villages within these sub-locations being the
smallest administrative units. This study involved participants from all divisions.
Figure 5: Map of Kenya showing Busia District
The following maps show Busia District divided into Divisions (Figure 6) and the
locations of the study subjects (Figure 7). .
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According to the latest statistics from the Ministry of Gender, Children and Social
Development, Busia District has a population of 271,173 females and 213,065 males.
Life expectancy in 2005 for females was 46.6 years for females and 41 years for
males. The majority of the population is Luhya speaking (of which there are many
different sub-groups - Idaho, Samia, Ikhosa etc) and is of Bantu ethnicity. The
district borders Siaya District, which is made up mainly of Luo speaking lowland
Nilotics. There is a reasonable amount of intermarriage between the two groups. The
% of households that are female-headed is 30.6%. There are 102,370 women of child
bearing age (15-49yrs) (Government of Kenya, 2008). The urban population was
154,348 in 2002 and was expected to rise to 184,678 by the end of 2008. The
majority of the urban population lives in Busia Town (57,863) (Government of
Kenya, 2002).
Table 7: Population Densities by Division - Busia District
Division 1999 2002 2008
Area
(km2)
Population Density Population Density Population Density
Budalang'i 306.5 53 356 174 58 363 190 69 836 228
Butula 245.2 95 489 389 104 450 426 124 970 510
Funyula 281.2 73 875 263 80 808 287 96 687 344
Matayos 173.7 55 186 318 60 365 348 72 227 416
Nambale 232.5 67 544 291 73 883 318 88 401 380
Township 22.2 25 158 1 133 27 519 1 240 32 926 1 483
Totals 1 261.3 370 608 294 405 389 321 485 047 385
Source: (CBS, 1999) and District Statistics Office, Busia, 2001.
There is widespread poverty in Busia District and the majority of the population lives
in food poverty and hardcore poverty - 61.4% and 50.6% respectively. According to
the Welfare and Monitoring Survey (WMS III) of 1997, the prevalence of overall
poverty in the district was 66% of the population. This poverty manifests itself in
various forms: malnutrition amongst children, inability to pay for health care, poor
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general health of the population, few assets, few or no livestock, land that barely
sustains subsistence as it is mineral and nutrient depleted but not replenished,
brewing and partaking of illicit brews and loss of faith in future (Government of
Kenya, 2002).
2.2.3 Climate
The rains fall in two distinct periods during the year, the long rains starting in March
and continuing to May, and the short rains season starting in late August and
finishing in October. The mean annual rainfall for the district is 1,500 mm with most
parts of the district receiving between 1,270 mm and 1,790 mm. Budalang'i and
Funyula Divisions are closest to Lake Victoria and receive annually between 1,020
mm and 1,270 mm. Budalang'i experiences periodic flooding during the rainy
seasons and has large dykes constructed to keep the lake from encroaching on the
land.
The annual mean maximum temperatures range from 26°C to 30°C while the annual
mean minimum temperatures vary between 14°C and 18°C. As the district is very
close to Lake Victoria, with some areas of Budalang'i Division only being accessible
by the lake, the district records high rates of evaporation - between 1,800 mm and
2,000 mm per year (Government of Kenya, 2002). Humidity levels are therefore high
and species such as riverine tsetse flies Glossina fuscipes fuscipes (G. f. fuscipes)
flourish and Busia District forms part of a continous tsetse fly belt which extends
into southeast Uganda (Ford & Katando, 1973). It is also the ideal habitat for the
Anopheles gambiae complex mosquito which is implicated in the spread of malaria
in Africa and prefers areas in which annual rainfall is above 1,000 mm (Coetzee et
al., 2000).
2.2.4 Agriculture
The long and the short rains support two distinct cropping seasons, however, crops
are grown throughout the year. Crops that take longer to mature are grown in the
long rains. These are crops such as maize, sorghum, sweet potatoes, soya bean, cow
Chapter 2 55
peas, green gram lentils and beans. These same crops are grown in the short rains,
but with the addition of those that mature more quickly such as kale, simsim (sesame
seeds) and sunflower. Sugarcane is also a major crop in the area as well as napier
grass, cassava, avocados, oranges and bananas.
The soils within the district are of low fertility and are rocky and stony well-drained
red clay. Parts of Nambale and Butula Divisions are more fertile with well-drained
deep brownish sandy soils which hold water better. Around Lake Victoria the soils
are poorly drained and are heavy clay which is hard to cultivatre and perennially
flooded. There have been several attempts by various governments to start rice
growing schemes in Budalang'i, with varying measures of success.
The district has approximately 924,200 ha of agricultural land. The average farm size
within Busia District is 2.5 ha for a small scale farm, of which there are 44,000.
Agriculture contributes 35.4% (KSh 1,820.10) to the average monthly household
income of KSh 5,141.80. The total acreage under food crops is 58,165 ha and the
total acreage under cash crops is 4,935 ha (CBS, 2000; Government ofKenya, 2002).
2.2.5 Livestock
In Busia District in particular, in the last 5 years, two formal Livestock Censuses
have been carried out, one by the Government of Kenya and one by Farming in
Tsetse Controlled Areas (FITCA) which produced differing results. There have also
been informal surveys conducted by the District Veterinary Officer which produced
yet another count of livestock which yielded different results from either of the two
formal censuses.
The first Livestock Census was carried out in 2000 and 2001 by the (FITCA) project
in Busia District. The census covered both Busia and Teso Districts and produced the
following figures 3 and 4 for livestock numbers and poultry numbers respectively in
Busia District.
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:igure 8: Population of livestock: cattle, sheep, goats, donkeys, pigs and rabbits
Population of livestock: cattle, sheep, goats, donkeys, pigs and rabbits
District/ Cattle Sheep Goats Donkeys Pigs Rabbits
Divison zebu exotic/ Total
crosses
Busia 73111 1707 74818 28194 50141 2118 21280 16814
Budalangi 9823 17 9840 2704 9483 77 812 1628
Butula 23350 235 23585 9175 12582 184 2853 4577
Funyula 7118 89 7207 2666 8738 57 2481 1861
Matayos 11248 115 11363 4705 6526 178 5618 2352
Nambale 12648 88 12736 4082 4115 1091 4050 2697
Township 8924 1163 10087 4862 8697 531 5466 3699
Source: (Mosi & Nyandega, 2002)
The FITCA livestock census reported a total of 21,280 pigs in Busia District in 2000-
2001. An informal survey carried out by Dr Murukefu, the Busia District Veterinary
Officer, found a total of 24,277 pigs in 2003 in the district. The most recent
Livestock Census which was carried out by the Government of Kenya (GoK) in late
2003 but has yet to be published.
Figure 9: Population of poultry - chickens, turkeys, ducks, geese, pigeons and quails
District/ TOTAL
Dvision Chickens Turkeys Ducks Geese Pigeons Quails POULTRY
Local Exotic Total
Busia 592550 17747 610297 7461 46938 2321 13646 7112 687775
Budalangi 77491 635 78126 316 11100 112 423 65 90142
Butula 165452 826 166278 1594 11675 272 1861 1645 183325
Funyula 89340 583 89923 291 3192 240 1797 59 95502
Matayos 81213 1439 82652 559 3882 117 790 311 88311
Nambale 83800 952 84752 2665 7067 1074 2801 1253 99612
Township 95254 13312 108566 2036 10022 506 5974 3779 130883
Source: (Mosi & Nyandega, 2002)
As in other parts of sub-Saharan Africa, livestock are regarded as an insurance policy
to offset unforeseen expenses or as a ready source of cash to pay for medical
expenses or school fees. Small livestock such as sheep or goats and poultry are
readily sold to pay for school fees, uniforms, household items of necessity, however, <v:,,.
cattle are only sold as a last resort, when the expense is too large to be met by the
former livestock (Thuranira, 2005).
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Pig keeping is on the increase in Busia District as well as other areas of Western
Kenya. According to livestock surveys conducted 18 months apart during 2001-2002
indicated a 171.9% increase in the number of pigs compared to 13.5%, 8.5%, 3.5%
and 11.8% increases in cattle, sheep, goats and poultry, respectively (Thuranira,
2005). The figure below illustrates the increasing trend within Eastern and Southern
African countries in the pig populations.
Figure 10: Trend in the total pig population in the Eastern and Southern Africa















In these communities pigs are considered low-input livestock which do not require
the same level of care as cattle, for example. In addition, pigs are omnivorous; and
accomplished scavengers which can grow to market size on minimal feed inputs
from the farmer. Smallholder pig production in western Kenya is one of the
livelihood strategies used by the local communities as a way to generate income in
this poverty prone area.
2.2.6 Constraints to Livestock Production
The Busia District Development Plan (2002-2008) lists some of the constraints to
livestock development as being: limited genetic potential of the zebu herd (zebu are
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the traditional cattle of the region which are small and require few veterinary inputs
to stay alive, however yield very little in terms of milk and meat), poor animal
nutrition due to inadequate roughage, inadequate extension coverage, high incidence
of animal disease, poor market organisation and traditional animal husbandry
practices limiting potential genetic diversity offered by artificial insemination
(Government of Kenya, 2002). In addition, "lack of credit or capital" has been
identified by the poor as one of the biggest constraints to acquisition of livestock
(LID, 1999). These constraints are described in further detail below.
2.2.6.1 Disease
The poor in the developing world are particularly at risk from livestock disease. This
is largely because the areas of the world in which the majority of the poor live are
within the tropical and sub-tropical regions where climates and eco-systems play host
to a number of parasitic infections, many of which are not found in the more
temperate climates of the world (Perry et al., 2002). Poverty also contributes to the
livestock themselves being more vulnerable to disease. According to a study which
looked at the delivery of veterinary services to the poor in Kenya, "few herders and
farmers were spending close to the estimated 'ideal' on livestock drugs and the
majority of expenditure was on curative rather than preventative treatments.
Although apparently willing, the ability of the poor to pay for treatments appears to
be a limiting factor. Knowledge regarding livestock health was poor, further
contributing to the overall low uptake of veterinary goods and services. Both access
and the quality of advice regarding the use of livestock drugs were considered
problematic" (Heffeman & Misturelli, 2003). Many resource-poor farmers cannot
afford or do not have access to public and private veterinary interventions or the
necessary feed inputs to keep their animals in sanitary, disease-free conditions. Poor
animal health has been recognised as the most important constraint to livestock
production in Africa (WIIAD, 1992) with disease estimated to cause loss of animal
livestock output of up to 30%, which is twice that observed in developed countries
(FAO, 1990).
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Epidemic diseases of livestock such as rinderpest and foot and mouth diseases are
considered diseases of trade and therefore receive a lot of public sector attention and
involvement in treatment. Endemic diseases such as helminth diseases,
trypanosomiasis and East Coast fever have the greatest effect on small scale farmers
as although the losses may not be as dramatic as those of epidemic diseases, they are
continually present within livestock and the attrition of this disease makes them
significant not only at the community level, but also at the national level if one takes
into account the aggregation of loss to disease (Perry et al., 2002). Zoonotic diseases
such as Taenia solium attributed cysticercosis and Mycobacterium bovis tuberculosis
cause both productivity losses and human health impacts but their impact is largely
•
felt in the public health sector even though the high level of parasitosis present in
pigs can cause long term economic losses such as those found in other endemic
diseases and is often not noted as significant.
2.2.6.2 Grazing
In Busia District, animals are usually tethered within compounds or taken
individually to communal grazing lands. Unlike Uganda, herds are not grazed
communally. As the average farm size is 2.5 ha, the competition for grazing and crop
production is intense and grazing is land is often poor (Government of Kenya, 2002).
Communal grazing lands are located around land that is not deemed productive, is
«
frequently overgrown and near swamps, rivers or streams. This puts animals at risk
for trypanosomiasis and other diseases (Murray et al., 2004) and poor grazing leads
to poor nutritional status, reducing milk yields, draught power, weight gain and
lowered productivity (Perry et al., 2002).
2.3 Background to Taenia solium porcine cysticercosis and
neurocysticercosis in Busia District
2.3.1 Perception of Cysticercosis in Busia District
In 2005, DFID funded a study to determine the prevalence of porcine cysticercosis in
some districts in Western Kenya, including Busia District. In total, 250 households
were surveyed. A few (18%; 46 / 250) of the respondents had heard of a disease in
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pigs that could be transmitted to humans, most of whom could not report the exact
disease(s) though some made guesses. Among the guesses mentioned were
ectoparasites, foot infections, skin infections, and general worm infections. A total of
44 farmers reportedly slaughtered pigs in their compounds, 23 farmers did not have
the slaughtered pigs inspected (Mutua et al., 2006).
2.3.2 Cysticercosis in Pigs
In this same study, a total of 320 pigs from 250 households were examined for -the
presence of T. solium larval cysts on the ventral side of the tongue. Out of these, 16
tested positive indicating an estimated prevalence of 5% (16 / 320) using the lingual
method of detection. This map indicates the percentages of positive pigs in. the
individual divisions within the sampled districts.
Figure 11: Proportion of positive cases (prevalence) by division
Source: (Mutua et al., 2006)
In Busia District (divisions Butula, Funyula and Matayos are highlighted in red in the
table below), a total of 100 pigs were sampled and of these, 2 were positive for the
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presence of cysts in the tongue using lingual examination. All of the positive cases
were found in Funyula Division, indicating the percentage of positive pigs for that
division to be 6% (2/29). The table below summarizes the number of pigs sampled
and the lingual palpation results by division.










Bumula 25 29 1 3.4
Butula 31 52 0 0
Cheptais 16 19 3 15.7
Funyula 19 29 2 6
Ikolomani 24 26 1 3
lleho 18 20 0 0
Kanduyi 16 22 0 0
Kapsokwony 2 3 0 0
Kaptama 5 7 0 0
Kimilili 18 25 4 16
Lurambi 15 17 1 5.8
Matayos 15 19 0 0
Ndivisi / webuye 22 22 2 9
Shinyalu 24 30 2 6.6
Total 250 320 16 5.0
Source: (Mutua etal., 2006)
In a more recent study, the same subject pigs (320) were tested for porcine
cysticercosis using an Ag ELISA. The results of this testing and the lingual
examination are found in the map below. The prevalence of porcine cysticercosis by
Ag ELISA was (5/320) 1.6%.
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Figure 13: Results of Porcine Ag ELISA test













0 All lingual positive and suspect pigs.dbf
A Ag elisa positive pigs.dbf
• All pigs examined.dbl
1 I Study districts.shp
2.3.3 Perception ofEpilepsy in Busia District
Epilepsy is thought to be a disease indicating possession by the devil in Busia
District. Epileptics are often kept away from the rest of society and sometimes
physically shut away. Epilepsy is known as the "burn disease" as many patients have
fallen into open fires and bear scars from burning.
At the Busia District Hospital, treatment for epilepsy falls under the Psychiatric
Nurse. It is not thought of as a neurological illness, but rather a psychological illness.
If parents are unable to cope with a child's epilepsy, the child is often sent away, to
school at a Special School which deals with mental disorders and the physically
challenged. Children who are on a therapeutic drug regime are often incapable of
attending mainstream schooling as teachers claim they fall asleep too often and are
not capable of following the same curriculum as the other children.
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Chapter 3 - Methodology - Study
Design and Diagnostics
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3.1 Study Design and Sample Size
3.1.1 Ethical Approval
Ethical approval for this study was obtained from the Kenya Medical Research
Institute and is found in Appendix A.
3.1.2 Purpose of study
The study had two major objectives, firstly to estimate the prevalence of
seropositivity for neurocysticercosis (NCC) in epileptics in Busia, Kenya and
secondly to investigate the risk factors associated with seropositivity to NCC in the
same population.
3.1.3 Study design
To estimate seropositivbity for NCC we first identified a population of epileptics and
then obtained blood samples for serology. To investigate risk factors, a questionnaire
was administered to the study population. On the basis of serology, epileptics were
divided into a group with NCC related epilepsy and a group of without NCC related
epilepsy, and these were compared with respect to hypothesized risk factors. Risk
factors included those which have an impact on the acquisition of porcine
cysticercosis and therefore neurocysticercosis and also risk factors are related to
poverty. A robust indicator of wealth/poverty was included as an independent risk
factor. This latter aspect was achieved through the results of a poverty index.
Null-Hypotheses
1. The prevalence of seropositivity for NCC in a population of epileptics is
small or negligible (<5%).
2. There is no significant association between hygiene and sanitation practices
(source and treatment of household water, presence and use of latrine,
ingestion and preparation of pork), household demographics (age, education
level, presence of tapeworm carrier in household), and seropositivity for NCC
detected in the population of epileptics.
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3. There is no significant association between factors associated with pig
keeping (occupation, grazing practices, types of feed, inspection of carcass
after slaughter), and knowledge of tapeworm (nodules observed in humans
and pigs, observation of passing of proglottids) and seropositivity for NCC
detected in the population of epileptics.
3.1.4 Sampling strategy
Our objective was not to estimate the prevalence of epilepsy in Busia, but rather the
prevalence of seropositivity for NCC among people with epilepsy. There is no
comprehensive list of epileptics in Busia and because epilepsy is a diseases
associated with stigma, it is difficult to identify sufferers. Our sampling strategy was
to collect information on as many epileptics as was feasible given the time and
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resources and then to adminsister a questionnaire to, and take serum samples from,
all epileptics identified and willing to participate in the study. In all, 1051 epileptics
were identified, 423 took part in the questionnaire survey only, 437 took part in the
serosurvey only and 191 in both.
3.1.5 Power estimatation
Because of the difficulty in establishing the location of epileptcs and the absence of a
sampling frame it was not possible to conduct probabalistic sampling. However,
given the sample size (n) of 614, plus an estimate of the total population (N), and an
estimate of prevalence (p), and a confidence level (z) of 95%, it is possible to
calculate the precsion (e) or margin of error of the estimate.
There was little information on expected prevalence ofNCC among epileptics as this
was the first serosurvey. While recent reviews have noted the absence of well-
conducted studies that can establish the importance of neurocysticercosis in epilepsy
(Pal et al., 2000), it is considered the major cause of acquired epilepsy in Latin
America (Garcia et al., 1993), and may also be so in sub-Saharan Africa (Dumas,
1989), (Nsengiyumva, 2003). In Nsengiyumva's study carried out in Kiremba,
Burundi, of the cases (people with epilepsy), 59.6% were positive for ELISA
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cysticercosis serology and of the controls (those without diagnosed epilepsy), 31.5%
were positive for cysticercosis. The sample size in this case was 324 cases and 648
controls. In a similar study conducted by Newell in Bururi, Burundi, 4.9% of the 103
epileptic cases and 4.2% of the 72 controls showed exposure to T. solium in Ag
ELISA (Newell et al., 1997). Where there is doubt about the expected proportion, but
it is believed not to be very small (i.e. less than 0.05) it is best to err towards 0.5 as
this leads to a larger sample size. Accordingly, the prevalence was assumed to be 0.5.
When the sample is large relative to the total population size (one twentieth or more
of the total population) than an adjustment can be made for a finite population. As
indicated in Table 3, prevalence rates for epilepsy in sub-Saharan Africa range from
5.2 to 74.4 per 1000 using different sample sizes in door-to-door surveys. The
prevalence rate for Kenya of 18.2% (Kaamugisha & Feksi, 1988) is based on one
study in Nakuru which is similar to the average prevalence rate for all studies in sub
Saharan Africa 1.58%. Given a population of 405,389 people in Busia, a population
of 8,828 epileptics is therefore anticipated.
Rearranging and solving the formulae for sample size calculation (n) and sample size
adjustment for a finite population (n') it can be concluded that with a sample of 614
epileptics from an estimated population of 8,828 the prevalence of seropositivity for
NCC with a precision (or margin of error) of 3.8% can be estimated.





This assumes that there was no systematic bias which would make the sub population
of 1051 epileptics identified for this study different from the population of epileptics
not identified.
3.1.6 Selection of Epilepsy Patients
Records were obtained from five centres within Busia District to make up the
numbers of 500 patients. The records were obtained from St. Martin's School for the
Physically and Mentally Disabled in Kisoko, Nangina Special School for the
Mentally Handicapped, St Catherine's Special School, Port Victoria Sub-District
Hospital and Busia District Hospital. Clinical Officers were also consulted at various
government health centres to ensure those on therapeutic drug regimes for epilepsy
but not attending the Centres or Schools previously mentioned were not missed. The
patients were selected on the basis that they were on a standard regime of epilepsy
drugs: phenobarbital, phentoin, and carbamazapine (in some cases, all drugs were
being taken, in others one or two of the cocktail). Information such as name, age, sex
and village of origin was obtained.
3.1.7 Administration of the Questionnaire (CWGESA) and household wealth
At the next stage of the investigation, those patients previously traced were found
again and a questionnaire that has been standardized by the Cysticercosis Working
Group for Eastern and Southern Africa (CWGESA) - Appendix B - was given to the
epileptic subjects to assess risk factors for neurocysticercosis or taeniasis, which
included household demographics, pig husbandry practices, presence of other
epileptics, subject knowledge of Taenia solium, tapeworms, hygiene and sanitation
practices, education levels, occupation and other factors. Not all of the same patients
who were identified in the first selection round could be found again but .the
questionnaire was administered to 500 people plus an additional 128 for a total of
628 subjects.
A second questionnaire to determine indicators of household wealth was also given
(n=625). This consisted of 19 aspects of household wellbing including: clothing,
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food, health, housing, furniture, utilities, transportation, possessions, domestic
employees and income. Each was divided into three categories of Very Poor, Not So
Poor and Non Poor based on objectively verifiable, locally relevant indicators. For
example, under the housing indicator:
Very poor: Thatch roof, no door, cloth to cover entrance
Not So Poor: Part of roof is mabati, solid front door, one floor is cement
Non Poor: All of roof is mabati, two doors, all house is cement floor
Figure 14 contrasts some characteristics of each group.
Figure 14: Poverty Assessment Checklist Example
Very Poor Not So Poor Non Poor
Sleeps on a mat on the Sleeps on a mattress on Sleeps on a mattress on a
floor the floor bed
Has no shoes Wears repaired shoes Wears good shoes
One meal a day Two meals a day Three meals a day
No children in school Boy children in school All children in school
No radio Old or damaged radio New radio
No domestic servants No domestic servants Domestic servants
No income or day labour Part time employment Full time employment
3.1.8 Collection of serological samples
Using the same subjects previously identified from the questionnaire administration,
efforts were made to trace these subjects using the GPS coordinates provided
previously. Unfortunately, as the District has no road maps, it was impossible to
align homesteads accurately with GPS coordinates and reach them so that not all of
the subjects to whom the questionnaire had previously been given were able to be re¬
traced. For this reason, more subjects were selected using the Key Informant
methodology - people of stature within the community were asked to identify
epileptics - and the snowballing technique, which is a technique for developing a
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research sample where existing study subjects recruit future subjects from among
their acquaintances (Sikasunge et al., 2007). Using these techniques, a total of 614
had serum collected from them by medical personnel from the Busia District
Hospital.
3.1.9 Subjects with Serological Test and Questionnaire
Owing to the inability to trace all of the previous patients to whom the questionnaire
was initially administered, the sample size to whom both the questionnaire was
administered and serum collected was 191 subjects. Serological diagnostic tests were
performed on all 614 samples and risk factor analysis on 628 subjects using the
questionnaire, but statistical analysis involving the association of a positive or
negative serological test and risk factor information obtained from the questionnaire
was only able to be performed on 191 subjects.
3.2 Serological Diagnostic Techniques Performed in this Study
The use of serology to diagnose NCC in humans is subject to debate (Dorny et al.,
2003). In most studies, the correlation between positive serology and neurological
symptoms and/or lesions indicative for NCC by imaging techniques is poor (Ramos-
Kuri et al., 1992). This may be explained by the unpredictable clinical outcome of
the infection and the variable immunological response of the human host to infection.
Clinical manifestations of NCC are diverse because of the number of lesions, their
size and where they manifest and the reaction of the host's immune system (Garcia
& Del Brutto, 2000a). As serological tests and imaging techniques such as CT scans
and MRI measure different aspects of the disease, in some patients both tests- may
present different results. For example, patients who manifest with cysts either
subcutaneously or intramuscularly may show a positive result when tested
serologically, but will not show any cysts in the brain (Erhart et al., 2002). In
contrast, individuals with only inactive lesions or those with a single cerebral lesion
causing clinical symptoms may test seronegative (Ohsaki et al., 1999), (Wilson et al., , '
1991).
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The general opinion is that consistent diagnostic criteria ofNCC should be based on
combined neuroimaging studies, serological tests, clinical presentation and exposure
history (Dorny et al., 2003). Several studies have shown that high seropositivity rates
for cysticercosis are significantly associated with tapeworm carrier clusters and that
seropositive persons are significantly clustered within households, particularly,', in
households in which a member reported a history of having passed tapeworm
proglottids, as well as with individuals with a clinical history of seizures (Diaz-
Camacho et al., 1990), (Sarti et al., 1992).
Immunodiagnosis is useful in identifying cysticercosis cases in tapeworm carriers
and in family members of tapeworm carriers and patients with NCC. Clinical
*.
symptoms of NCC generally occur as a result of an inflammatory reaction around
cysticerci, and are in this stage usually associated with degeneration of the cysticerci
(Garcia & Del Brutto, 2000a). Early diagnosis of NCC by serology is helpful in
identifying patients who can be helped with treatment (Dorny et al., 2003)
3.2.1 Serum Sample Collection
A 10 ml blood sample was obtained from each subject using non-anticoagulated
Vacutainer® tubes. The samples were immediately put into cold boxes with ice
packs. Each sample was centrifuged in the evening at the Busia District Hospital by
qualified laboratory technicians and the sera were transferred into cryotubes (Nunc®)
and immediately frozen at -20°C until use. The samples were then shipped to the
Institute of Tropical Medicine in Antwerp, Belgium to have serological tests
performed on the contents.
3.2.2 ETfB for Taeniasis
The EITB assay was performed on 614 serum samples collected from epileptic
patients in Busia District as described by (Wilkins et al., 1999) and in Chapter 1 -
Introduction. The samples were collected in January 2007 by medical personnel from
the Busia District Hospital. The assay uses excretory/ secretory (TSES) antigens
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collected from in vitro cultured T. solium tapeworms. To identify taeniasis-specific
antigens, an immunoblot assay with serum samples from T. solium tapeworm carriers
and cysticercosis patients was employed. Antigens were identified that reacted with
antibodies present in serum samples from taeniasis cases and not with those from
cysticercosis patients.
3.2.3 Antibody ELISA
This Ab ELISA was performed on the same 614 serum samples collected from
epileptic patients in Busia District as was performed the EITB and the Ag ELISA.
The screening for Ab was done by the Ab-ELISA as described by (Guerra et al.,
1982). The Ag used for coating the polystyrene ELISA plates was a crude soluble
extract of T. solium cysticerci. The optical density (OD) was measured at 405 nm
with a LP 400 spectrophotometer (Diagnostic Pasteur). The reaction threshold was
0.400. The OD values £0.400 were considered to be positive. This method has a
sensitivity of 86% and a specificity of 92% (Houinato et al., 1998).
The antigen protein concentration was 2.5 pg/mL in 0.05 M carbonate-bicarbonate
buffer at pH 9.6, in a volume of 100 UL per well. After overnight incubation at 4"C,
plates were washed with 1% (v/v) Tween-20TM in phosphate buffered saline
(Sigma) at pH 7.2 (PBST). The positive and negative control sera, and the study sera,
were diluted 1:200 in PBST containing 5% (w/v) bovine albumin fraction V (Sigma)
(PBSTA) and placed in the plate wells in a volume of 100 PL per well. After
incubation for 1 hour at 37°C followed by 3 washings with PBST, alkaline
phosphatase-labelled antihuman immunoglobulin (lg)G (Behring) was added in a
volume of 100 FL per well. After another incubation for 1 hour at 37°C and 3
washings with PBST, 100 PL of p-nitrophenyl phosphate substrate was added to each
well. The enzymatic reaction was stopped after 45 min by addition of 50 PL
duplicate dine-hydrogen peroxide substrate solution.
Absorption (OD) was measured at 405 nm with an LP 400 spectrophotometer
(Diagnostic Pasteur). To enhance the measurement specificity, OD values at 690 nm
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were subtracted from those at 405 nra (AOD) and the difference between the OD
values for the test sera and a pool of sera negative for cysticercosis, (AOD-AODoeg),
was calculated. The reaction threshold was the mean (AOD-AODneg) value of 100
sera from persons with other parasitic and bacterial infections (including syphilis,
malaria, toxoplasmosis, distomatosis, hydatidosis, schistosomiasis, ascariasis and
lilariasis) plus 3 SD, which was 0.400. Values 20.400 were considered to be positive.
3.2.4 Antigen ELISA
The test was performed on serum collected from epileptic patients in Busia District,
at the Institute of Tropical Medicine (Antwerp) under the supervision of Pierre
Dorny. The Ag-ELISA, which was initially developed for T. saginata cysticercosis
(Brandt et al., 1992), was performed as described by (Dorny et al., 2000).
Briefly, pre-treatment of the samples and ELISA were performed as follows: pre-
treatment of the serum samples was done by mixing an equal volume of serum and
freshly prepared 5% TCA (Sigma, Chemical Co.) w/v in distilled water and
incubation of this mixture for 20 min at room temperature. Incubation was followed
by centrifugation for 5 min at 10.OOOg. Next, the pH of the supernatant was raised by
adding an equal volume of a sodium carbonate/bicarbonate buffer (0.610M) at pH
10.0 to the supernatant. One hundred microliter of this mixture (final serum dilution
1:4) was used in the ELISA. The assay involved coating of polystyrene ELISA plates
(Nunc® Maxisorp) with 100 ml of MoAb B158C11A10 (at a protein concentration
of 5 mgml-1) in carbonate buffer, pH 9.6 per well; incubation was 1 h at 37°C and
overnight at 4°C. After washing with 0.05% Tween 20 in phosphate buffered saline
(pH 7.2) (referred to as PBS-T20) blocking was done with 250 ml per well 1% heat
inactivated new born calf serum (NBCS, Life Technologies) in PBS-T20 (1 h, 37°C).
Then, trichloroacetic acid pre-treated serum samples were incubated, after which a
second biotinylated monoclonal Ab (B60H8A4) was added. A conjugate solution
(extravidin-horseradish peroxidase) and a chromogen/substrate solution (OPD (o-
Phenylenediamine) in citrate buffer and H202) followed. All steps, except.the
application of the substrate, were done in a shaking incubator for 30 min (coating) or
15 min (other steps) at 37°C. The substrate step was incubated in the dark for 15 min.
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Plates were washed in between the steps with 0.05% PBS-Tw 20. The plates were
read after stopping the reaction with H2S04, using a spectrophotometer at 492 nm
with a reference of 620 nm. The OD of each serum sample was compared with- the
mean of negative reference serum samples (n lA 8) at a probability level of P < 0.001
to determine the result using a modified Student's t test (Sokal & Rohlf, 1981). The
ELISA values were expressed as a ratio by dividing the OD of the test sample by the
OD of the cut-off value. An ELISA ratio >1 was considered positive (Garcia et 'al.,
1998; Dorny et al., 2000).
3.3 Statistical analysis
3.3.1 Estimating apparent prevalence with exact binomial confidence intervals
The apparent or test prevalence according for each individual test was first calculated
using a Stata® routine routines for calculating binomial confidence intervals for p
that doesn't depend on the normal approximation. This use of exact confidence
intervals avoids the problems of having prevalence estimates greater than 0 or less
than 1 and results in intervals that are narrower than when the normal approximation
is used
3.3.2 Estimating true prevalence by adjusting apparent prevalence for test
performance
Next the true prevalence from test prevalence was estimated using sensitivity and
specificity estimates from the literature and the following formula:
true prevalence = (AP+sp-l)/(se+sp-l)
Because there were different estimates for sensitivity and specificity in the literature
prevalence was calculated under each set of assumptions.
True prevalence and 95% Bayesian confidence intervals (credible intervals) were
next calculated for each test using a Bayesian approach (Vose, 2000).
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It was conservatively assumed that the number of true positives (s) in the group lay
between 0 and 614 and took estimates of sensitivity (Se) and specificity (Sp) from
the literature. The likelihood function for the number of true positives (the true
prevalence) is a combination of two binomial distributions, as shown in the following
equation:
BINOMDIST (s, n, p(Se) + (l-p)(l-Sp), 0)
Where s was the number tested (614), n is the number found positive, prevalence (p)
can taken any value between 0 and 100% and Sp and Se are estimated from the
literature. This was set up as a spreadsheet model in Excel© and run for 5000
iterations using Latin Hypercube Sampling Monte Carlo simulation (@Risk).
3.3.3 Combining the results of different tests to produce a single estimate of
prevalence
The results of the tests were next combined by using different rules. Tests can- be
interpreted in parallel in two ways. The first, called "the OR rule," yields a positive
diagnosis if any testis positive and a negative diagnosis if all tests are negative. The
second rule, called "the AND rule," yields a positive diagnosis only if all tests are
positive and a negative diagnosis if any test is negative. Under the OR rule,' the
sensitivity of the combined result is higher than that of either test alone, but the
combined specificity is lower than that of either test. With the AND rule, this is
reversed: The specificity of the combined result is higher than either test alone, 'but
the combined sensitivity is lower than that of either test.
Finally, a Bayesian approach was used to combine the results of the different tests in
order to get a better estimate of prevalence. The approach of Branscum et al., (2005)
was followed. It was considered that the two antibody-based tests (Ab and EITB)
were dependent because they measure the same biological phenomenon, and the
antigen test (Ag) was conditionally independent.
The model was run in WinBugs using the following code:
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y[1:K, 1:K, 1:K] ~ dmulti(p[1:K, 1:K, 1:K], n)
p[1,1,1] <- pi*SeAg*(SeAb*SeEITB+covDp) + (1-pi)*(1-SpAg)*((1-SpAb)*(1-SpEITB)+covDn)
p[1,2,1] <- pi*SeAg*(SeAb*(1-SeEITB)-covDp) + (1-pi)*(1-SpAG)*((1-SpAb)*SpEITB-covDn)
p[1,1,2] <- pi*(1-SeAg)*(SeAb*SeEITB+covDp) + (1-pi)*SpAg*((1-SpAb)*(1-SpEITB)+covpn)
p[1,2,2] <- pi*(1 -SeAg)*(SeAb*(1 -SeEITB)-covDp) + (1-pi)*SpAg*((1-SpAb)*SpEITB-covDn)
p[2,1,1] <- pi*SeAg*((1-SeAb)*SeEITB-covDp) + (1-pi)*(1-SpAg)*(SpAb*(1-SpEITB)-covDn)
Expert opinion was used to select most feasible values for sensitivity and specificity .
3.3.4 Relation between poverty and seropositivity
Five different poverty indices were constructed reflecting diffeerent intenisties of
poverty. The first index was a sum of all the 'Very Poor' ratings across the 21 well
being indicators: this is a measure of intense poverty; the second was a sum of all the
'Not So Poor' ratings across the 21 well being indicators, this is a measure of less
intense poverty; the third was a sum of all the 'Not Poor' ratings: this is a measure of
wealth. Two poverty indices based on the correlation we found between categories
were constructed; the development of these is described under the Results Chapter.
T-tests were used to investigate the relationship between poverty and seropositivity.
3.3.5 Risk factor analysis
All data on households and putative risk factors were analysed for their association
with prevalence of taeniasis and cysticercosis. First a causal diagram was constructed
to help see how risk factors might relate to the dependent (outcome) variable of
seropositivity. Next, univariate analysis was conducted to examine the effect of each
variable separately by calculating odds ratios (OR), their 95% confidence intervals
(95% CI) and P-values using maximum likelihood methods. Possible confounding
factors were next investigated by constructing two way tables and checking for
statistical association using chi square tests.
Afterwards, multivariate analysis (logistic regression) was carried out. Data Were
first checked for clustering by geographical area using one way anova to calculate
the intra-cluster correlation coefficient. This is a measure of lack of indedependence
of putatively clustered data. The model was built using those variables that were both
causally linked to the outcome variable (seropositivity) and were significant at P
<0.1. Factors were added one at a time and those which resulted in improved model
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performance retained. Biologically plausible interactions between dependent
variables were also checked for. Model diagnostics were carried out to check for any
violations of the assumptions underlying logistic regression.
Missing data for the dependent data was dealt with as follows: The missing data was
first evaluated in order to assess if it was missing at random, missing completely at
random or missing not at random. This was done by summarising all variables
according to whether test results were present or absent and comparing these chi2 for
dichotomous variables and t-tests for numerical variables tests to see if the difference
was significant. It was assumed that if there were no important differences- in
between those epileptics with test results and those without test results then the test
results could be considered missing at random.
3.3.6 Multiple Imputation by Chained Equations (MICE)
In general, multiple imputation techniques require that missing observations are
missing at random (MAR) or missing completely at random. The idea of multiple
imputation is to create multiple imputed data sets for a data set with missing values.
The analysis of a statistical model is then done on each of the multiple data sets. The
multiple analyses are then combined to yield a set of results. Chained equations
method uses a series of conditional distributions, e.g. if we have a continuous X, a
count variable Y, and a binary Z, and some data for each are missing, we set up (1) a
linear regression ofX on Y and Z, (2) a Poisson regression of Y on X and Z, and (3)
a logistic regression of Z on X and Y. We start by fitting (1) to the observed data,
then simulate any missing X from that model. Then we fit (2) using observed Z and
X (with missing values filled out by the simulations), and simulate any missing Y.
Then we fit (3) using X and Y (with missing values filled by the simulations). We go
through multiple iterations, fitting each model in turn, and updating the simulations
with each iteration, waiting for the model to converge. We do that multiple times
producing multiple datasets.
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The drawback is that the conditionals may not specify a unique joint distribution
which can make the inferences problematic; but the simulation studies suggest it
often works quite well, so it is increasingly used.
ft
All statistical calculations were performed with Stata (Version 10, Copyright 1996—
2009 StataCorp LP).
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Chapter 4: Risk FactorAnalysis,





The chapter describes the data collected, then presents the results on prevalence of
seropositivity for neurocysticercosis (NCC) in epileptics in Busia, Kenya and the risk
factors associated with seropositivity to NCC in the same population.
4.2 Descriptive analysis
In total, 628 respondents answered the detailed questionnaire on risk factors and
other household and individual information. The section that follows gives a
characteristic profile of an epileptic living in Busia District.
4.2.1 Age/Sex Breakdown
The following figure represents the age/sex breakdown of the study subjects. The
most populous category is 11-20 year olds for both sexes with 21-30 being next.
During the study period of 2 years, 6 patients died, some of them from causes related
to their having epilepsy such as falling down in a river and drowning or falling and
hitting their head on a rock, resulting in death eventually.
Figure 15: Age/Sex Breakdown of Study Subjects
Age/Sex Breakdown of Study Subjects
■ Male □ Female
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4.2.2 Education
Most epileptics surveyed had completed Primary education (304/592) 51%. Of those
who responded to the questionnaire, almost 19% had completed secondary education
or higher and 32% had no education.
4.2.3 Hygiene and Sanitation
Of the 605 patients interviewed, the majority (499/605) responded that they had a pit
latrine. 106 did not. Of the 499 respondents who had a pit latrine, 88% used it
always, 1% used it almost all of the time, 10% used it some of the time and the
remaining 1 % never used it.








Respondents were asked about the source of their drinking water. Out of 605 asked,
603 responded, the majority of whom used a borehole (44%) Some of the
respondents (75/602) 12% live relatively near to urban areas (Busia Town primarily)
so are able to have piped water from the Busia Town Council. A further 12% obtain
their water from a well and the remaining respondents (31%) get water from the
river. Of those whose source ofwater was the river, 78% of respondents did not t;eat
their water by boiling or other means. 88% of those who obtained water from a well
also did not boil or treat their water. 27% of those who obtained water from a
»
borehole boiled water always, almost always or sometimes and 31% of those who
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obtained drinking water from the tap boiled water. It can be hypothesized that not
boiling water could be an indication of poverty as anybody who has access to tap
water lives in an urban centre and is therefore not as poor as those living in rural
areas who do not have access to piped water.
4.2.4 Pork Consumption
Of the 89% (464/520) of respondents who consumed pork, 69% consumed pork at
least once a month, and 13% ate pork at least once a year. The preferred method of
cooking was frying (342/441) 78% while the same (22%) percentage of respondents
equally also boiled or barbecued their pork.
4.2.5 Pig Husbandry Practices
Of the 602 respondents, 26% or 157 people kept pigs at the time of the survey. 19%
stated they had previously kept pigs at some time in the last five years, while 45%
stated they had kept pigs at some point in the past. 97% of all of these pigs ever kept
were native pigs. In the planting, growing, and harvesting seasons, the majority
(<56%) of farmers tether their pigs. During the fallow season this percentage drpps
to 46%. For most of the year, slightly over 25% of farmers free range their pigs with
this number increasing to 37% in the fallow season. For most of the year, slightly
less than 25% of farmers keep their pigs in pens. This number reduces slightly to
approximately 17% and 16% of farmers keeping pigs in pens during the fallow and
harvest seasons respectively. 60% of the farmers stated they fed their pigs on pasture
(foraging), while 97% stated they ate kitchen leftovers. 6% of farmers fed their pigs
commercial feed. 15% of farmers kept pigs for home consumption, while 40% kept
pigs for reproductive purposes and 61% stated they kept pigs for the purposes of
»t
trade. 61% of respondents stated they had never had their pork inspected before or
after slaughter, while only 13% stated they always had their meat inspected. 17%
stated they sometimes had their meat inspected.
4.2.6 Porcine Cysticercosis
18% of respondents claimed to have ever been told that their pigs or piglets were
infected with cysts, and of those, 50% were told in the past year. 31% (178/583) «had
seen nodules in pig carcasses. These nodules are commonly referred to as "rice" as
that is what they resemble when in pig meat. 40% of respondents said the most
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common place to find nodules was under the skin of pigs. 66% of respondents did
not know how pigs get these nodules.
4.2.7 Human Cysticercosis
78% (469/600) of respondents had heard of tapeworm infection in humans. 41% had
learnt about tapeworm infections from a friend or a family member. 53% of
respondents said the way one knows if one has a tapeworm infection is by seeing the
tapeworm in their faeces, while 4% said fever was a symptom and 13% cited
diarrhoea. Respondents were then shown a photograph of tapeworm sections or
proglottids and asked if they have ever seen these in their faeces. 46% of respondents
stated they had seen segments or proglottids in their faeces, and the course of action
upon seeing them was almost equally - 36% and 34% - to seek treatment from a
primary health care provider and a pharmacy respectively. 32% of respondents said
one gets tapeworm from not washing hands, while 22 % stated that one acquires
tapeworm from eating undercooked pig meat. Only 6% said that tapeworm is
acquired from contact with another infected person. 76% of respondents to the
question said they had never seen nodules or lumps under the skin after being shown
a photograph of a subject with obvious nodules showing under the skin.
4.2.8 Epilepsy
79% (486/596) of respondents stated they had ever had headaches lasting more than
a few days and 81% (486/599) stated they had seizures characterized by a loss of
consciousness or episodes of incontinence or foaming at the mouth. When asked
whether they considered themselves to be currently experiencing fainting episodes,
86% (492/589) stated they did. 92% of respondents said they had fainted more than
once and 92% said they had experienced uncontrollable twitching or jerking
movements of one or more limbs more than once in their lifetime. 57% of
respondents said they had experienced a brief onset of hearing or smelling things that
were not there or feeling strange body sensations and 92% said this had happened .
more than once in their lifetimes. 59% (342/581) said they had ever been told they
had epilepsy or had had an epileptic seizure while 29% (171/581) said they were not
epileptic. 78% (463/594) of total respondents, however, stated they currently had
seizures. 92% said they had had more than one seizure. 32% (175/554) stated they
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had had a head injury in their lifetime and of those, 99% stated the seizure symptoms
they experienced pre-dated the head injury. 16% of respondents claimed to have been
ill with meningitis and of those, 63% stated their seizures started after the illness.
21% stated there was another epileptic in the household.
4.3 Poverty levels
The survey of household assets collected information on 21 aspects of household
well being (e.g. clothing, housing, transport). The enumerators were asked to observe
the items in the checklist (Appendix C) and record their observations. For each of'the
aspects there were three categories: Very Poor, Not So Poor and Non Poor.
On average, households scored Very Poor on 4.96 indicators, Not So Poor on 6.77
indcators and Non Poor on 5.76 indicators. Figure 17 shows the results for different
aspects of household well-being.
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Figure 17: Table showing different categories of poverty in study population, based
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4.3.1 Poverty index
There is a positive correlation between "very poor" and "not so poor" and a negative
correlation between "very poor" and "non poor" (Figure 18). This suggests that 'very
poor' and 'not so poor' are both measures of poverty, whereas 'non poor' is a
measure of wealth. We constructed two poverty indices: in the first (Poverty Index
1), Very poor was given a weight of 2, Not So Poor of 1 and these were summed to
give a measure of poverty.
Figure 18: Correlation between the different well-being/poverty indices
verypoor Not So Poor nonpoor
verypoor 1.0000
notsopoor 0.3273 1.0000
nonpoor -0.1686 0. 0524 1.0000
S Very poor
■ Not so poor
■ Not poor
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A second poverty index was constructed which gave a greater weighting to the
category of Very Poor and a negative weighting to Non Poor. The second poverty
index was constructed as follows:
Verypoor x 3 + notsopoor x 1 - nonpoor = poverty index2
The following table (Figure 19) illustrates the dichotomous representation of the
selection of 30% of the population as "Very Poor" (based on a weighting of 3 in
poverty index 2), which results in a cut-off value of "8". The density of the
population in the categories "Very Poor", "Poor" and "Not so Poor" is shown in
Figure 20, following, with the Poverty Index 2 graph showing a "normal"
distribution.
Figure 19: Poverty Index 2 Dichotomous values table showing cut-off value of 8 based
on 30% of population calculation
Poverty Index 2 Frequency Percent Cumulative Percent
-18 3 0.64 0.64
-17 3 0.64 1.28
-16 2 0.43 1.7
-15 4 0.85 2.55
-14 2 0.43 2.98
-13 5 1.06 4.04
-12 9 1.91 5.96
-11 11 2.34 8.3
-10 3 0.64 8.94
-9 3 0.64 9.57
-8 1 0.21 9.79
-7 5 1.06 10.85
-6 3 0.64 11.49
-5 5 1.06 12.55
-4 2 0.43 12.98
-3 2 0.43 13.4
-2 5 1.06 14.47
-1 8 1.7 16.17
0 23 4.89 21.06
1 5 1.06 22.13
3 12 2.55 24.68
4 6 1.28 25.96
5 4 0.85 26.81
6 6 1.28 28.09
7 5 1.06 29.15
8 7 1.49 30.64
9 6 1.28 31.91
10 12 2.55 34.47
11 6 1.28 35.74
12 10 2.13 37.87
Cut-off point for poverty























































































































































Figure 20: Density of Study Population in Poverty Index 1 and Poverty Index 2
Poverty_lndex_1 Poverty_lndex_2
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4.4 Relation between poverty and seropositive test result •
For all four measures of poverty, the seropositive group scored higher, and for the
measure of wealth (Not Poor) the seropositive group scoed lower; however, none of
these relations were significant (ttest).
Seronegative Seropositive P
Very Poor 4.8 5.2 0.251
Not So Poor 6.6 6.8 0.646
Not Poor 5.7 5.3 0.392
Poverty Index 1 16.1 17.1 0.241
Poverty Index 2 15.2 17.0 0.238
4.6 Sero-prevalence estimates
4.6.1 Estimating apparent prevalence
Serum samples were available from 614 epileptics and three tests were used: two of
these were antibody detection tests - enzyme linked immunosorbent assay (ELISA)
and enzyme linked imuunoelectrotransfer blot tests (EIBT) - and one antigen test
(ELISA). The results of these tests are shown in table 9.
Table 8: Apparent prevalence for Taenia solium cysticercosis by three tests
No of samples Tests
Ab ELISA EITB Ag ELISA
414 ...
184 + . .
6 + +
9 +
1 + - +
0 +
614
The prevalences and associated confidence intervals for the tests are given in table
10.
Table 9: Prevalences and Associated Confidence Intervals (CI)
n Positive Prevalence Binomial exact 95% CI
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Antibody ELISA 614 191 31.07 27.46 34.94
Antigen ELISA 614 1 1.63 0.004 0.90
EITB 614 15 2.44 1.37 4.00
4.6.2 Estimating true prevalence for each test by adjusting apparent prevalence
according to test performance *.
The tests have varying sensitivity and specificity reported in the literature. When
apparent prevalence is adjusted by sensitivity and specificity estimates the following
true prevalences are obtained:
Table 10: True Prevalence of Three Tests
Ab Elisa Ag Elisa EITB
Test positive 191 191 1 1 15
Apparent prevalence 0.3111 0.3111 0.0016 0.0016 0.0244
Sensitivity 0.86 0.93 0.65 0.944 0.98
Specificity 0.92 0.89 0.92 1 1
True prevalence 0.2962 0.2452 0.1375 0.0017 0.0249
(Prado- (Sloan et (Garcia et (Erhart et (Tsang et
Jean et al., al., 1995) al., 2000) al., 2002) al., 1989)
2007)
A maximum likelihood approach to calculating true prevalence by adjusting apparent
prevalence for sensitivity and specificity and probabilistically modeling produced the
estimates shown in table 12.
Table 11: True Prevalence after Adjusting Apparent Prevalence and Probabilistic
Modelling
Ab Elisa Ag Elisa EITB
Test positive 191 191 1 1 15
Apparent 0.3111 0.3111 0.0016 0.0016 0.0244
prevalence
Sensitivity 0.86 0.93 0.65 0.944 0.98
Specificity 0.92 0.89 0.92 1 1
True prevalence 0.2970 0.2460 0.0365 0.0100 0.0264
0.2575- 0.2083- 0.0003- 0.0032- 0.0145-
0.3373 0.2844 0.0085 0.0170 0.0395
(Prado-Jean (Sloan et (Garcia et (Erhart et (Tsang et
et al., 2007) al., 1995) al., 2000) al., 2002) al., 1989)
4.6.3 Combining the results of different tests to produce a single estimate of
prevalence
Tests can be interpreted in parallel in two ways. The first, called "the OR rule,"
yields a positive diagnosis if any test is positive and a negative diagnosis if all tests
are negative. The second rule, called "the AND rule," yields a positive diagnosis only
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if all tests are positive and a negative diagnosis if any test is negative. Using the
AND then none of the patients would be considered positive for cysticercosis; using
the OR rule then 200 are positive or 32.6%.
Bayesian modelling to estimate the prevalence given three imperfect tests (two
conditionally dependent and one independent) in a single population of epileptics
gave the results summarised in table 13. The estimate of 0.38% positives is closer to
that of the results for the Antigen and EITB antibody tests.
Table 12: Prevalence of Taenia solium cysticercosis after Bayesian modelling
Mode SeAb SeAg SeEITB SpAb SpAg SpEITB prevalence
Mean 0.7988 0.7099 0.7845 0.6943 0.9885 0.9761 0.0038
SD 0.1389 0.1634 0.1635 0.0177 0.0041 0.0062 0.0035
MC_error 0.0078 0.0023 0.0098 0.0008 4E-05 0.0002 6.11E-05
val2.5pc 0.4669 0.3509 0.4008 0.6596 0.9792 0.9626 2.246E-4 0
median 0.8285 0.7301 0.8252 0.6942 0.989 0.9764 0.0028
val97.5pc 0.9811 0.9576 0.9875 0.7293 0.995 0.9869 0.0131
start 10000 10000 10000 10000 10000 10000 10000
sample 13001 13001 13001 13001 13001 13001 13001
For this model test sensitivity and specificity were assessed using expert opinion
based on the literature reports.
SeAb=0.90, SpAb=0.95, SeEITB=0.95, SpEITB=0.99, SeAg=0.85, SpAg=0.92
4.7 Risk Factor Analysis
4.7.1 Risk factors under investigation
Information was systematically collected for 625 epileptics, on the factors potentially
associated with taeniasis and cysticercosis, which arc under investigation in this
chapter. Data on demographic characteristics, social status and behavioural patterns
were collected for cases and controls at the time of the first contact with that
individual. Data were recorded on name, age, sex, occupation, education, village of
living, eating habits and diet, food preference, drinking unclean water, presence and
structure of latrine, the usual site of defecation, pig ownership, general knowledge
related to T. solium infection and its causation. Respondents were asked whether they
had ever heard of or seen cysticerci containing pork and shown a photograph of'the
same. They were also asked if they had seen nodules under the skin of humans and
shown a photo of the same. Questions were asked based on a structured
questionnaire approved by the CWGESA (Cysticercosis Working Group of Eastern
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and Southern Africa), and data regarding latrine construction and pig-raising practice
were obtained by direct observation. Data on household assets was collected by a
separate questionnaire.
4.7.2 Causal diagram
A causal diagram was developed using factors which logically should be a risk for
both pig cysticercosis and human taeniasis, based on the extensive literature review
reported earlier. These factors could be linked through human seropositivity for NCC
through directly or indirectly as shown in the diagram. Moreover, seropostivity may
be the result of cross-reactions resulting from other helminth or protozoal infections
in people and many of the risk factors for these are also risk factors for taeniasis and
cysticercosis (e.g. poor latrine use, drinking unclean water, farming as an
occupation).
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Figure 21: Causal Model for Risk Factors forTaeniasis and Cysticercosis
4.7.3 Univariate Analysis Odds Ratio
For the univariate analysis, the dependent variable was sereopositivity according to
any test (the OR rule). All data for which household information was gathered was
analysed. There were 222 variables in all, for which 211 there were enough
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responses to construct odds ratios.The odds ratios for the 22 risk factors that were
found to be significantly associated with increased or decreased risk of seropositivity
at P <0.1 are given in table 14.
Table 13: Odds Ratios for Significant Risk Factors in Univariate Analysis
., ... Cases Controls OddsVanable
(n=81) (n=129) Ratio 95% Cl P
Exposed % Exposed %
Fever a sign of
tapeworm infection
9 11 1 1 15.5 (2.01-686.05) 0.001
Latrine used 39 48 86 67 0.4 (0.18-0.81) 0.006
Seen nodules under the
skin
6 7 1 1 10.6 (1.23-490.09) 0.008
Farmer 11 14 6 5 3.7 (1.14-12.85) 0.012
Other epileptic in
household
10 12 5 4 3.6 (1.05-13.97) 0.018
Boils drinking water 13 16 8 6 3.0 (1.05-8.54) 0.02
Eats pork 9 11 4 3 3.9 (1.01-17.60) 0.022
Knows one can acquire
tapeworm from eating
pork
17 21 14 11 2.4 (0.98-5.86) 0.033
Has had a head injury 13 16 37 29 0.5 (0.21-1.01) 0.037
Has had a seizure 12 15 8 6 2.7 (0.93-7.79) 0.039
Does not use a latrine
to defecate
20 25 17 13 2.1 (0.95-4.59) 0.045
Never boils drinking
water
56 70 103 80 0.5 (0.24-1.10) 0.06
Boils drinking water
sometimes




33 41 38 30 1.7 (0.92-3.34) 0.063
Feeds pigs commercial
feed
3 4 1 1 6.7 (0.48-361.0) 0.072
Feeds pigs feed other
than pasture, kitchen
scraps or commercial
3 4 1 1 6.7 (0.48-361.0) 0.072
Gets drinking water
from the river
20 25 47 37 0.6 (0.29-1.10) 0.074
Has been told has
epilepsy
8 10 5 4 2.8 (0.75-11.06) 0.077
Lives in Nambale
Division
8 10 5 4 2.7 (0.75-10.92) 0.079
Classification as "Very
Poor" in Poverty Index




4 5 15 12 0.4 (0.09-1.27) 0.088
Never uses the latrine
to defecate
0 0 4 3 0 (0.00-1.37) 0.093
For most of the factors the effects on probability of seropositivity were as
anticipated. However for some factors, especially those associated with water use the
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direction of influence was not as predicted. In particular, never boiling water
decreased risk and boiling water sometimes or always increased risk, while drinking
from the river decreased risk. Never using a latrine also decreased risk. Eating pork
occasionally (monthly to yearly) was more risky than eating frequently (weekly to
monthly).
Table 14: Seropositivity and Predicted Risk
Effect on Risk of
seropositivity
Predicted
Latrine used (observation) Decrease Yes
History of head injury Decrease Yes
Never boil water Decrease No
Drinks water from river Decrease No
Sees or smells things during fits Decrease n/a
Never uses a latrine - report Decrease No
Consider fever a sign of tapeworm infection Increase n/a
Had skin nodules in the past Increase Yes
Farmer Increase Yes
Other epileptics in household Increase Yes
Boil all water Increase No
Eat pork monthly to yearly Increase No
Know pigs can spread tapeworms Increase No
History of seizure Increase n/a
Latrine not used (observation) Increase Yes
Boil water always or sometimes Increase No
Has seen nodules in pigs Increase Yes
Feeds pigs commercial food Increase n/a
Feeds pigs other than Increase Yes
leftovers/commercial/pasture
Had epilepsy last year Increase n/a
Lives in Nambale Increase n/a
Very poor Increase Yes
We conducted additional investigation on those factors which seemed to be
inconsistent with literature and the causal model.
4.7.3.1 Toilet Use
The questionnaire had 2 sections on use of latrines. People were first asked if they
had a latrine at home, and then if they said yes whether they used it always, almost
always, sometimes or never. Subsequently enumerators used direct observation to
see if latrine was present or not, and if present was it open or closed, and was there
evidence of use or no use.
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The results are summarised in table 16. There was a strong and significant (P < 9-1)
decrease in risk when a latrine is observed to be used and an increase in risk
(significant at P < 0.05) when a latrine is observed to be not used. However, the
relation between self-reported latrine use and risk of seropositivity was weak and
contradictory. Moreover there was no relation (p=0.205, chi2 test) between
households who claim to use the latrine and observable use of the latrine.
Table 15: Toilet Use as a Significant Risk Factor
Exposure Total Exposed % Total Exposed % Odds Ratio p
Observed
Latrine use (yes) 81 39 48.15 129 86 66.67 0.38 [0.18-0.81] 0.006
Latrine enclosed 81 28 34.57 129 47 36.43 0.86 [0.45-1.62] 0.61
Latrine open 81 9 11.11 129 12 9.30 1.16 [0.41-3.20] 0.745
No latrine present81 11 13.58 129 16 12.40 1.06 [0.42-2.60] 0.894
Latrine partially
enclosed 81 23 28.4 129 35 27.13 1 [0.51-1.97] 0.989
Latrine present
but not used 81 20 24.69 129 17 13.18 2.08 [0.95-4.59] 0.045
Respondents Answers
Latrine use
All the time 81 62 76.54 129 85 65.89 1.7 [0.57-5.70] 0.298
Almost all the time81 0 0 129 2 1.55 0 [0.00-2.80] 0.238
Sometimes 81 6 7.41 129 8 6.20 1.1 [0.30-3.82] 0.865
Very rarely 81 6 7.41 129 12 9.30 0.7 [0.20-2.16] 0.5
Never 81 0 0 129 4 3.10 0 [0.00-1.37] 0.093
4.7.3.2 Water use
Boiling water increased the risk of seropositivity in contrast to never boiling which
decreased risk. People who never boiled water, however were significantly more
likely (P = 0.008) to drink water from a well, leading to speculation that this source
of water is potentially not contaminated and could be protective vs drinking whter
from a tap, river or borehole.
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Figure 22: Correlation between boiling water and water source
I Origin: Well














































Pearson chi2(l) = 7.1318 Pr = 0.008
There is, however, a degree of ambiguity about the significance of boiling water and
the well as an uncontaminated source, as boiling water all the time increased risk and
those who did boil all the time were more likely to have well water or tap water as
the source. More research needs to be done in order to explain this anomaly.
Figure 23: Association between boiling water all the time and well source
I Origin: well














































Pearson chi2(l) = 3.1372 Pr = 0.077
Figure 24: Association between boiling water all the time and tap as source
I Origin: tap
Always boils 0 1 | Total
+ +
0 I 466 58 | 524
I 88.93 11.07 | 100.00
I 88.59 77.33 | 87.19
+ +
1| 60 17 | 77
| 77.92 22.08 | 100.00
| 11.41 22.67 | 12.81
+ +
Total I 526 75 | 601
I 87.52 12.48 I 100.00
| 100.00 100.00 | 100.00
Pearson chi2(l) = 7.4501 Pr = 0.006
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4.7.4 Multivariate Analysis
The set of probable correlates identified by univariate logistic regressions and those
that were considered to be logically associated with risk were then subjected to
multivariate logistic regression. These risk factors included:
Neurocysticercosis
• Eating pork - we included eating pork monthly to yearly as a risk factor as
the univarieate analysis suggested this was more predictive than eating mork
weekly
• Eating undercooked pork - this was not included because those replying yes
also replied yes to eating pork and there was a problem with collinearity
• Other epileptics in the household - this was included as an indicator of
common exposure
• Spatial location - this was included as NCC often occurs in spatial clusters
• Farming - this was included as a factor known to increase exposure to human
faeces
• Skin nodules noticed more than one year ago - this was included as an „
indicator they person had consumed proglottids in the past
• Shedding proglottids - this was not included because there were too few
responses
Taeniasis
• drinking unclean water - this was not included because univariate analysis
suggested the relation between drinking unclean water and seropositivity was
unclear
• poor latrine use - this was included as a major risk factor
• raising pigs - this was included
• had seen nodules in pig meat - this was included as an indicator of exposure
• having taeniasis - not included because too many missing variables
• passing proglottids: not included because too many missing variables
The model with retained variables is shown in Figure 25.
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Figure 25: Multivariate Logistic Regression Analysis
Logistic regression Number of obs = 92
LR chi2(8) 27.82
Prob > chi2 0 .0005
Log likelihood = -44.875906 Pseudo R2 0 .2366
test Odds Std. Err. P 95% Conf. Interval
Ratio
No other epileptics in household 0.22 0.13 0.01 0.07 0.68
Lives in Nambale 12.32 14.91 0.04 1.15 131.95
Skin nodules > 1 year ago 13.04 16.79 0.05 1.05 162.55
Farming 4.58 3.62 0.05 0.97 21.58
Eats pork monthly to yearly 5.12 5.21 0.11 0.70 37.67
Latrine not used 3.26 2.50 0.12 0.73 14.67
Kept pigs 1.05 0.58 0.93 0.36 3.08
Has seen nodules in pig meat 1.89 1.05 0.25 0.63 5.60
All factors were consistent with the causal model. People with no other epileptics in
the household were at less risk of seropositivity. One of the geographical
subdivisions (Nambale) had significantly more seropositives Farming as an
occupation and having seen nodules under the skin are significant at P = 0.05. The
pseudo R squared for the model was 0.24 suggesting it was reasonably predictive.
Diagnostics were then run on the linear regression model: the model was examined
for the following assumptions:
• Linearity - the relationships between the predictors and the outcome variable
should be linear
• Normality - the errors should be normally distributed - technically normality is
necessary only for hypothesis tests to be valid,
estimation of the coefficients only requires that the errors be identically and ,
independently distributed
• Homogeneity of variance (homoscedasticity) - the error variance should be
constant
• Collinearity - predictors that are highly collinear, i.e., linearly related, can cause
problems in estimating the regression coefficients
• Independence - the errors associated with one observation are not correlated with
the errors of any other observation
• Model specification - the model should be properly specified (including all
relevant variables, and excluding irrelevant variables)
• Influence - individual observations that exert undue influence on the coefficients
Diagnostic were satisfactory.
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4.7.5 Imputation ofmissing data
Respondents were divided into those with and without missing test results and then
using t-tests and chi-square tests to establish whether the two groups differ
significantly.
It was discovered that epileptics who had test results differ significantly from those
who did not with respect to:
1. Age: they are significantly older
2. Place: they are significantly more likely to come from Matayos
3. Pork consumption: they are less likely to eat pork less than once a month but
more than once a year i.e. less likely to be occasional consumers
4. Pig ownership: more likely to have owned pigs more than 5 years ago
5. Signs of a tapeworm: more likely to say that fever was a sign of tapeworm
6. Observing nodules: more likely to be unable to say when they observed skin
nodules
7. They were less likely to say they had not had a fit
8. They were less likely to say they had not had a seizure
Given that 241 variables were compared at a P of 0.05, it would be expected that 12
would be significant by chance alone. Only age, place, and having a fit were highly
significant. It is reasonable to assume that people who were older were more likely to
complete testing and that people who did not have a fit were less likely to complete
testing.
There are no major differences between those who got testing and those who didn't
and therefore the missing dependent variables (test results) could be imputed.
Next, using the multiple imputation by chained equations methodology (MICE), the
model was run again. The risk factors "Nambale" and "skin nodules seen more than
one year ago' had to be discarded as they predict success of the model perfectly. The
imputed model drew on 210 observations, whereas the model without imputed data
drew on only 92 observations. This model with imputed dependent variables gave
similar results to the model which dealt with missing data by case wise deletion,
however, this model using imputed data showed known risk factors to be 'hiore
significant. For example in the previous model, although observing that the latrine
was not used had an odds ratio of the 3.26 it was not significant. In the model using
imputed data it was significant at P= 0.05.
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Multiple imputation parameter estimates (5 imputations)










































Because the imputed model drew on a larger number of epileptics (210 rather than
92) more independent variables were able to be included in the analysis. However,
none of these additional independent variables proved to be significant. The third
model is shown below:
Figure 26: Third Model Multivariate Analysis - Multiple Imputations
Multiple imputation parameter estimates (5 imputations)
test I Coef. Std. Err. z P> 1 z | [95% Conf. Interval]
Latrine not
used I 1.119588 .4564316 2.45 0.014 .2249989 2.014178
Poverty Ind2 | -.0011918 .0118844 1 o I-1 o 0. 920 -.0244848 .0221012
Age a factor | .0048093 .0114069 0.42 0. 673 -.0175479 .0271665
Is a farmer I 1.607055 .6626896 2.43 0.015 .3082069 2.905902
Eats pork at
least 1/year | 1.438533 .8540913 1.68 0.092 -.2354554 3.112521
Kept or keeps



















the skin | .6683051 .3395602 1. 97 0.049 .0027793 1.333831
_cons I -1.101809 .4804339
210 observations (imputation 1).





Epilepsy is the most common serious neurological disorder and is one of the world's
most prevalent noncommunicable diseases. Over four-fifths of the 50 million people
with epilepsy are thought to be in developing countries; much of this condition
results from preventable causes (Scott, 2001). The World Health Assembly included
cysticercosis, human infection by the larvae of Taenia solium, in its 2003 agenda.
Cysticercosis is the single most common cause of late onset seizures in the
developing world (Garcia et al., 2003a). Taenia solium persists mainly in rural areas
because of the coexistence of poor sanitation and domestic pig husbandry (thus pigs
have access to raw human sewage or faeces). In developed countries cysticercosis
was eradicated by improving sanitation and controlling domestic pig raising. In
developing countries, however, pig husbandry methods which allow the transmission
cycle of Taenia solium to persist are largely economically motivated. Free ranging
pigs minimize or cancel feed investment. Moreover, surveillance of pigs at point of
slaughter, which is the current standard of control, relies on inspection systems being
enforced and adhered to. As infected carcasses are confiscated, thereby depriving
smallholder farmers of an income, most pigs are killed clandestinely and infedted
pork remains widely available (Gonzales, 2003). This thesis examined the risk
factors associated with neurocysticercosis and taeniasis in a population of epileptic
patients in Busia District, Kenya. Questionnaires on household information, pig
husbandry practices, hygiene and santitation, presence of epileptics and tapeworm
carriers in the household as well as knowledge and awareness regarding tapeworm
infection and cysticercosis were administered to the population of epileptics. Serum
was collected from the patients and three diagnostic tests performed to ascertain' the
prevalence of Taenia solium infection. Chapter 4 of this thesis presents the result's of
a univariate and logistic regression multivariate analysis of associated risk factors
and prevalence rates by serological testing using a Bayesian approach.
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5.2 Univariate Analysis
The variables to emerge from the univariate analysis as significantly increasing or
decreasing the risk of association with seropositivity which were in line with the
causal model and predicted risk factors were:
Latrine used Decreased Yes
History of head injury Decreased Yes
Had skin nodules in the past Increase Yes
Farmer Increase Yes
Other epileptics in household Increase Yes
Latrine not used (observation) Increase Yes
Has seen nodules in pigs Increase Yes
Very poor Increase Yes
5.2.1 Latrine used or not used
Using a latrine breaks the cycle of transmission for Taenia solium cysticercosis. This
finding is in keeping with studies carried out in China (Cao et al., 1996) and Mexico,
where infection rates of porcine cysticercosis and were habitually higher in pigs that
had access to latrines or were fed human faeces (Sarti et ah, 1992). In this study, not
using a latrine is significantly associated with seropositivity (OR = 2.1, P = 0.045) as
using a latrine prevents pigs having access to human faeces potentially contaminated
with tapeworm eggs and therefore does not allow the cycle of transmission, to
continue.
5.2.2 History of head injury
A history of head injury could signify epilepsy acquired by means other than Taenia
solium tapeworm. Epilepsy can also occur after a significant head trauma as well as
meningitis.
5.2.3 Had skin nodules in the past
Seeing nodules under the skin is also significantly associated (OR = 10.6, P = 0.008)
and this is consistent with greater logical risk as having a tapeworm infection in the
past is closely linked to the potential for acquiring neurocysticercosis. The presence
of nodules under the skin could indicate a past or ongoing infection with cysts. In a
study conducted in India, one hundred and tweny patients presenting ^vith
subcutaneous swellings, were diagnosed as cysticercus or suspicious of parasitic
inflammation (Uma et ah, 2008). In Burkina Faso, six cases were studied from 3 men
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and two women, ranging from 25 to 57 years old. Three of them had neurological
complications as convulsions and headaches. The nodules were painful in one case
(Barro-Traore et al., 2008).
5.2.4 Farmer
Raising pigs has a direct association with an increase in risk for seropositivity for
cysticercosis. In this study, a positive test result by Ab ELISA was significantly
associated with being a farmer (OR = 3.7, P = 0.012). This is to be expected as
farmers would have more exposure to soil contaminated with tapeworm eggs. The
cycle of transmission is perpetuated as long as humans and pigs live in close
proximity. In China, in a population-based case-control study of rural respondents in
Shandong Province, those who raised pigs had an almost 3 fold greater association
with seropositivity, a relationship which was statistically significant (OR = 2.6, CI =
1.2-5.7; P < 0.05) (Cao, 1997). In Peru, raising pigs, irrespective of the number, was
associated with being seropositive (232/1,562, 14.9% versus 123/1,021, 12.0%; OR
1.27; CI 1.01, 1.61; P < 0.043) (Garcia et al., 1995; Garcia et al., 2003b). In India,
where it was found that 78% of children of pig farmers passed taeniid eggs in their
stools (Banerjee et al., 1994), having no separate place to keep pigs apart from'the
household space and having epilepsy in the family were identified as risk factors for
NCC clustering in a family (Prasad et al., 2009).
5.2.5 Other epileptics in the household
The presence of other epileptics in the household can be interpreted as an indication
that the tapeworm and therefore neurocysticercosis is present. In this study, the
presence of another epileptic in the household is significant (OR = 3.6, P = 0.18)
which is consistent with more people in the household being exposed to tapeworm
eggs and genetic factors being less important than risk factors for epilepsy. Data
from the Americas indicates that the main risk for both human neurocysticercosis
and swine cysticercosis is the presence of a tapeworm carrier in the household
(Flisser et al., 2003). Other studies from Bolivia, Ecuador and Guatemala indicate
this same association (Cruz et al., 1989; Garcia-Noval et al., 1996; Bern et al., 1999).
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5.2.6 Nodules seen in pigs
The failure of people to recognize the presence of cysts in pigs as being positively
associated with cysticercosis morbidity contributes to the lack of control of the
disease. In a study in Zambia, observation of cysts by farmers was high in all
districts, but did not deter them from eating or selling pork. Most of the respondents
4
(83.3%) had observed cysts in pork. Of the respondents that observed cysts in pork,
20.1% ate and 18.3% sold the meat (Sikasunge et al., 2007). In Tanzania, farmers
regularly slaughter pigs clandestinely and consume the meat themselves or sell to a
neighbour, regardless of whether it is contaminated with cysts (Boa et al., 2006). In
this study, patients had almost a 2 fold greater odds of being seropositive for
cysticercosis if they had seen subcutaneous nodules in pigs (OR = 1.7, 0.92-3.34).
5.3 Prevalence findings
The prevalence rate in this study is lower than anticipated. Compared to studies in
other parts of Africa with similar agro-ecological studies such as a study done in
Burundi examining the correlation in seropositivity between the Ab ELISA and the
Ag ELISA which showed 40.5% and a 26.1% positive result respectively, the
prevalence rate found in this study of 0.38% when using a Bayesian approach for
three tests is very low. One explanation for this is that it is possible that in this
population of epileptics NCC was not a major cause of epilepsy and that other factors
? ■
are responsible. If this is the case, it would be important to investigate risk mitigating
practices that would explain why although many of the risk factors are present the
prevalence of NCC is low. However, other common causes of epilepsy (genetics,
infection, trauma) were not sufficient to explain more thana minority of cases and
other studies suggested cysticercosis might be a problem, given the prevalence of
porcine cysticercosis in the District (Githigia, 2000; Mutua et al., 2006). It is also
possible that the test results were not indicative of NCC as the Ab ELISA in
«r»
particular is known to cross react with other helminthic infections. As Dorny
suggests, immunodiagnosis by serology must be used in conjunction with neuro-
imaging techniques, patient history and other neurological symptoms in orde£ to
make a definitive diagnsosis (Dorny et al., 2003). The application of ELISA for the
detection of circulating parasite antigens may present some diagnostic advantages
since it demonstrates not only exposure but also active infections. Only a few of the
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current techniques have been standardised and fully validated, making comparisons
between studies difficult. In surveys on cysticercosis, antibody detection systems
have been useful in identifying the risk factors associated with transmission' of
Taenia solium and a high seroprevalence in a community can indicate a "hot spot"
and the need to look further. The potential use of immunodiagnostic tools to identify
cases of neurocysticercosis (NCC) in man is subject to debate. The correlation
between a positive serology and neurological symptoms and/or lesions indicativa.for
NCC on neuro-imaging techniques is poor to fair in most studies. This may .be
explained by the unpredictable clinical outcome of the infection and the variable
immunological response of the human host to infection (Dorny et al., 2003).
In this study, the serological results would have ideally been compared with a CT
scan to assist in validating the diagnostic techniques. Although this was originally
going to be part of this study, political problems in the country prevented this from
taking place. It would be interesting to compare serological and neuro-imaging
results at some point in the future as these neuro-imaging methods are available,
unlike in some developing countries where they are inaccessible and/or too
expensive.
5.4 Povertyfindings
Although seropositive epileptics scored higher on all 5 indices of poverty, this
association was not significant. Cysticercosis is considered a disease of poverty and
this was not in accordance with our initial hypothesis. Given that Busia District is
one of the poorest in Kenya (CBS, 2003), it is possible that poverty is so prevalent
that the association between poverty, risk factors and seroprevalence was not
significant. Again, further studies to disaggregate poverty further and examine
seropositivity and a rural/urban correlation may prove useful in looking at the role
poverty plays in cysticercosis.
5.5 Multivariate riskfactor analysis
The multivariate analysis which took into account confounding risk factors revealed
that only four factors were significant. These were, no other epileptics living in-the
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household, the respondent living in Nambale Division, seeing skin nodules more than
one year ago and farming as the principal occupation of the household.
test Odds Std. Err. P 95% Conf. Interval
Ratio
No other epileptics in household 0.22 0.13 0.01 0.07 0.68
Lives in Nambale 12.32 14.91 0.04 1.15 131.95 "
Skin nodules > 1 year ago 13.04 16.79 0.05 1.05 162.55
Farming 4.58 3.62 0.05 0.97 21.58
5.5.1 Lack of other epileptics in the household
This risk factor proved to be protective which is in keeping with other studies
previously cited indicating that having an epileptic in the household increases the
risk of association with seropositivity.
5.5.2 Lives in Nambale
Cysticercosis cases tend to cluster as transmission is related to hygiene and santiation
and other risk factors which can be prevalent throughout a community. Several
studies have shown that high seropositivity rates for cysticercosis are significantly
associated with tapeworm carrier clusters and that seropositive persons are
significantly clustered within households, particularly, in households in which a
member reported a history of having passed tapeworm proglottids, as well as with
individuals with a clinical history of seizures (Diaz-Camacho et al., 1990, Sarti et al.,
1992).
5.5.3 Skin Nodules
This risk factor is consistent with that found in the univariate analysis.
5.5.4 Farming
This risk factor is consistent with that found in the univariate analysis.
5.6 Conclusion
Although the prevalence of cysticercosis was low in this study, many of the risk
factors examined and found to be significant are comparable to those found in other
studies around the world. Cysticercosis has been found to be an emerging problem in
other parts of Africa (Mafojane et al., 2003; Zoli et al., 2003a), and it stands to
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reason that given the relative similarities between these places and Busia District, it
will become a problem soon. It would be interesting to follow up with further studies
to examine the validity of the diagnostics used and the influence of genetic factors on
the prevalence of epilepsy in the district, always keeping in mind the societal context
and sensitivities of culture when carrying out research.
5.7 Importance ofSocietal Context in Study
Many factors exist within a society with the potential to provide bias in enumeration
and to influence the researcher when drawing conclusions. These can include general
characteristics which when known about a particular culture, are helpful when
formulating questionnaires or analysing information from questions asked. Examples
of this kind of knowledge include knowing when asking whether meat is "cooked",
whether in this culture people generally eat meat rare or well cooked. If people never
eat rare meat, then "cooked" can be taken to mean well cooked. Another example
where general knowledge of a culture is useful is knowing peoples' general
demeanour- whether aggressive, confrontational or placatory. In a culture such as
that in Kenya, people generally want to be affirmative in their answers. This
tendency can arise from a variety of reasons; preserving the general harmony of a
society without confrontation, appearing knowledgeable is better than appearing
ignorant or that being helpful is considered a much better attribute than not. This
characteristic, however, can create difficulties for the researcher in that people will
answer in the affirmative whether or not they actually know what is being asked for.
Another example where the placatory tendency is illustrated is in the provision of
directions when being asked. In the rural areas ofKenya, it is considered impolite not
to be able to provide directions for a visitor, regardless of whether one knows where
the place being asked of actually is. It is considered much better to provide
inaccurate and often extremely unhelpful directions which do not assist in actually
reaching the desired destination, rather than to provide none at all. The researcher
must have a certain depth of knowledge of the culture in which the research is being
carried out in order to bring a more accurate interpretation to the planning and results
of the work.
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5.8 Opportunities for Further Research
Given that CT scans were not able to be administered to any study participants, and
that different respondents were administered different parts of the study at different
times, opportunties to explore further the accuracy of the diagnostic tests and
potential correlation between risk factors and seropositivity exist. Follow-up to this
study should include the following:
• Serological testing of all three diagnostic tests given to all those respondents
who answered the risk factor questionnaire
• CT scans given to all those respondents with a positive result from any of the
three tests
• Risk factor questionnaires administered to those respondents who have
already provided serum for testing.
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Appendix B: CWGESA Questionnaire
Last name :











Hut (house) number _







1 How old are you? (years)
2 What is your date of birth? Day Month Year
3 Sex D Male D Female
4 What is the highest schooling grade you have completed?
□ None □ Primary school
□ Middle School □ High school
5 What further education have you completed?
□ None D College
D University D Technical/Vocational
6 What is your occupation? _
7 How many days ofwork have you missed because of illness in the past month? days
8 How many days of work have you missed because of illness in the past year? days
9 Where do you usually get your drinking water?
□ River □ Bore-hole
D Well D Other (please specify)
Appendices
10 Do you boil your drinking water?
□ Always
□ Sometimes
11 How often do you eat pork?
□ At least once a month





□ Less than once a month but at least once a year
□ Never







13 Do you have a latrine at home?
□ Yes □ No (Skip to Q 14)
13.1 How often do you use a latrine when you have to defecate?
CH Always CI Sometimes CI Never
Do you keep pigs?
□ Yes □ No (Skip to Q 15)
14.1 What type of pigs do you keep?
□ Foreign CI Native
□ Both foreign and native □ Can not remember, do not know
14.2 Of the pigs that you have, how many are for? [read each choice and record the number\
Home consumption Trading
Reproduction Other (specify):
14.3 How do you keep your pigs... [read questions 14.3.1 to 14.3.4 one after the other\
14.3.1 During the planting season
□ In a pen
□ Tethering
14.3.2 During the growing season
□ In a pen
□ Tethering
14.3.3 During the harvesting season
O In a pen
□ Tethering
14.3.4 During the fallowing season
□ In a pen
□ Tethering











□ Kitchen left overs
D Other (specify):
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14.5 How often do you slaughter pigs at home?
f D At least once a month U Less than once a month but at least once a year
"S □ Less than once a year
□ Never (Skip to Q 14.6) □ Can not remember, do not know (Skip to Q 14.6)
14.5.1 If ever, how often was the meat inspected by a meat inspector?
□ Always □ Almost always
□ Sometimes □ Never
D Can not remember, do not know
14.6 . What price do you usually sell your pigs when they are ready to be slaughtered (specify the
currency used, this can be money or barter)?
14.7. What price do you usually sell your piglets (aged 4 months or less) (specify the currency
used, this can be money or barter)?
(SKIP TO Q 16)
15. Have you ever owned pigs? [Ifthey answer "yes", ask when they ownedpigs]
□ Yes, in the past year □ Yes, one (1) to five (5) years ago
□ Yes, more than five (5) years ago
□ No (skip to Q 17)
15.1. What kind of pigs were they?
□ Foreign □ Native
□ Both foreign and native □ Can not remember, do not know
16. Were you ever told that your pigs or piglets were infected with cysts (cysticercosis)?
□ Yes □ No (Skip to Q 17)
16.1. When were you told that your pig or piglets were infected with cysts (cysticercosis)?
□ In the past year □ One (1) to five (5) years ago
□ More than five (5) years ago
□ Never told (skip to Q 17) □ Can not remember, do not know (skip to Q
16.1.1 When that happened, were you able to sell your pig(s) or piglets?
{□ Sold both □ Sold pigs but not piglets□ Sold piglets but not pigs (skip to Q 16.1.3)□ Could not sell either (skip to Q 17)
□ Can not remember, do not know (skip to Q 17)
16.1.2 When that happened, what price did you sell your pigs (aged more than 4 months)
(specify the currency used, this can be money or barter)?
16.1.3 When that happened, what price did you sell your piglets (aged 4 months or less) (specify
the currency used, this can be money or barter)?
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17. Have you ever seen or heard of white nodules (rice) in pig carcasses?
□ Yes D No (Skip to 18)
17.1 Where can you find nodules on a live pig?
□ It is not possible to find them on a live pig
□ Under the skin □ Under the tongue
□ I don't know □ Somewhere else (Specify)
17.2 How do pigs get these nodules?
□ By eating human faeces □ By eating pig faeces
□ From another infected pig □ Other (Specify)
□ I don't know
17.3 What would you do if you discovered that your pig had nodules?
□ Sell the pig □ Treat it with herbs
□ Pierce the nodules □ Other (Specify)
D I don't know
18. Have you ever heard of tapeworm infection in humans?
D Yes □ No (Skip to question 19)
18.1 How did you learn about it?
□ By a doctor □ By a friend or family member
D By a traditional healer D On the radio / newspaper
D Other (Specify)
18.2 How does a person know if they have a tapeworm?
□ They can see it in their faeces □ They have diarrhea
□ They have fever □ Other (Specify)
□ I don't know
18.3 Have you ever had a tapeworm or seen small parts (segments) ofworms in your faeces? (Show
photographs ofproglottids)
□ Yes □ No (SKIP TO Q 18.4)
□ I don't know/can not remember (SKIP TO Q 18.4)
18.3.1 When that happened, what did you do? [check all that applies\
□ Went to a primary health care provider (hospital, clinic, dispensary)
□ Went to the pharmacy to get a drug to treat it
D Went to a traditional healer D Did nothing
D I can not remember, I do not know
18.4 How does a person get tapeworm infection?
□ They do not wash their hands □ They eat undercooked pig meat
D They are in contact with an infected personD Other (Specify)
□ I don't know
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19. Have you ever had skin nodules or hard lumps under the skin? (Showphotograph ofperson ivith
subcutaneous cysticercosis nodules)
□ Yes, currently has □ Yes in the past year, but not currendy
□ Yes, one year or more ago, but not currendy □ No
□ Can not remember, do not know
20. Have you ever had bad headaches that lasted more than a few days?
□ Yes, currendy has □ Yes in the past year, but not currently
□ Yes, one year or more ago, but not currendy □ No
D Can not remember, do not know
21. Have you ever had any of the following?
21.1 Sudden loss of consciousness and episodes of incontinence or foaming of the mouth or tongue
biting?
Yes, currendy has □ Yes in the past year, but not currendy
□ Yes, one year or more ago, but not currendy
D No (Skip to Q 21.2) D Can not remember, do not know (Skip to Q 21.2)
21.1.1 (If yes) How often has this happened?
D Only once □ More than once
21.1.2 How old were you when this first happened? years
21.2 A brief period of absence(s) or loss(es) of contact with the surroundings that starts suddenly?
CD Yes, currently has □ Yes in the past year, but not currendy□ Yes, one year or more ago, but not currendy□ No (Skip to Q 21.3) □ Can not remember, do not know (Skip to Q 21.3)21.2.1 How often has this happened?□ Only once □ More than once
21.2.2 How old were you when this first happened? years
21.3 Uncontrollable twitching or jerking or abnormal movements of one or more limb(s)
(convulsions) that starts suddenly and lasts for a period of a few minutes?
C □ Yes, currendy has □ Yes in the past year, but not currently
1 1=1 Yes, one year or more ago, but not currendy
□ No (Skip to Q 21.4) □ Can not remember, do not know (Skip to Q 21.4)
21.3.1 How often has this happened?
□ Only once D More than once
21.3.2 How old were you when this first happened? years
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21.4 Sudden onset of a brief period of hearing or smelling or seeing things that are not there or
feeling strange body sensations?
' □ Yes, currendy has □ Yes in the past year, but not currendy
□ Yes, one year or more ago, but not currendy
□ No (Skip to Q 21.5) □ Can not remember, do not know (Skip to Q 21.5)
21.4.1 How often has this happened?
□ Only once □ More than once
21.4.2 How old were you when this first happened? years
21.5 Were you ever told that you had epilepsy or that you had had an epileptic seizure?
D Yes, currendy has D Yes in the past year, but not currently
□ Yes, one year or more ago, but not currendy UNo
□ Can not remember, do not know
21.6 Have you ever had seizures or fits?
□ Yes, currendy has □ Yes in the past year, but not currendy
□ Yes, one year or more ago, but not currendy
□ No (skip to Q 22) □ Can not remember, do not know (skip to Q
22)
21.6.1 How often has this happened?
D Only once D More than once
21.6.2 How old were you when this first happened? years
[If the interviewee has answered "no" to questions 21.1-21.6, the interview is finished. Go to last
page and complete questions 30 & 31 based on observation.]
THANKYOU VERY MUCH FOR YOUR COOPERATION
[Otherwise, please continue with the questionnaire]
[Interviewer If they answered "yes" to any of the questions 21.1 -21.6, ask thefollowing otherwise, SKIP toQ. 25.]
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22. Have you had any of the following?
22.1 Head injury that made you lose consciousness?
22.1.1 If yes, when did your seizure symptoms start?
D Before head injury
22.2 Meningitis (brain infection) during childhood?
22.2.1 If yes, when did your seizure symptoms start?
□ Before an attack ofmeningitis
23. What happens to you when you have a seizure or a fit?
D Yes D No (skip to Q 22.2)
□ Soon after head injury
□ Yes □ No
□ Soon after an attack ofmeningitis
24. Have you ever hurt yourselfwhen you lose consciousness or during a seizure?
□ Yes □ No
□ I do not lose consciousness or have seizures (skip to question Q 25)
□ Cannot remember (skip to question Q 25)
24.1 If yes, how did you hurt yourself?
□ Fell in the fire □ Fell in the water
D Fell off your bicycle D Fell while walking along the road
□ Cut yourself □ Other (specify)
25. Is there someone in your household with epilepsy or seizures?
f n Yes, currently is D Yes in the past year, but not currently
1 0 Yes, one year or more ago, but not currently D No
25.1 (If yes) Who in your household has epilepsy or seizures? \check all that apply]
□ Mother □ Father
□ Brother/sister □ Child
□ Other relative □ Other (specify)
(Interviewer: Read the following statement)
Now I want to ask you a few questions about your treatments for [insert name ofsymptom or
condition they reportedhaving in question 21.1-21.6]
26. Have you ever consulted a health provider because of this condition?
□ No (skip to Q 27) □ Cannot remember (skip to Q 27)
□ Yes
26.2 When was the last time you consulted a health provider for your .condition?
□ Within the past month □ Within the past year
□ From one (1) to five (5) years ago □ More than five (5) years ago
□ Can not remember, not sure
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26.3 What kind of health provider(s) did you consult and how many times in the past 5 years [check
several boxes ifappropriate]?
□ A physician. times □ A neurologist times
□ A nurse . times □ A traditional healer times
□ A psychiatrist/psychologist times
□ Other (specify ) times
□ Can not remember, not sure
26.4 How much did it cost each time you consulted with one health provider [specify the currency used\?
□ A physician D A neurologist
□ A nurse D A traditional healer
□ A psychiatrist / psychologist
D Other (specify )
□ Can not remember, not sure
26.5 How far is the health provider from your house and how did you get there (foot, bicycle, bus,
train, taxi, car)?
D Physician at km reached by D Neurologist at km reached by
□ Nurse at km reached by □ Traditional healer at km reached by
□ Other (specify ) at km reached by
□ Can not remember
27. Have you ever been hospitalised because of this condition?
□ No (skip to Q 28) D Cannot remember (skip to Q 28)
□ Yes Name of Facility
27.2 How many times have you been hospitalised in the past 5 years? times
27.3 When were you last hospitalised? (month) (year)
27.3.1 How many days did you stay in hospital? (days)
27.3.2 How much did it cost (specify the currency)
27.3.3 How far is the hospital from your house? km
27.3.4 How did you get to the hospital?
□ By foot/ bicycle □ By bus □ By taxi
□ By car □ By train □ Other (specify)
c
28. Did you ever have any medical tests because of this condition?
□ No (skip to Q 29) □ Cannot remember, do not know (skip to Q 29)
□ Yes
28.2 What kind of test was it (check as many boxes as appropriate)?
□ Blood test for cysticercosis □ CT scan of the brain
D X-Ray of the brain D MRI of the brain
□ Electroencephalogram (EEG) □ Other (please specify)
D Can not remember, not sure
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28.3 When was the last time you had a medical test for this condition?
□ Within the past month □ Within the past year
□ From one (1) to five (5) years ago □ More than five (5) years ago
□ Can not remember, not sure
28.4 How much did it cost for each test (specify the currency used)?
□ Blood test for cysticercosis D CT scan of the brain
1 1 X-Ray of the brain C MRI of the brain
□ Electroencephalogram □ Other (specify)
□ Can not remember, not sure
28.5 How far from your house did you have to travel for this test and how did you get there (foot,
bicycle, bus, train, taxi, car)?
□ Blood test for cysticercosis at km at (Facility Name) reached
by
□ CT scan at km at (Facility Name) reached
by
□ X-Ray at km at (Facility Name) reached
by
□ MRI at km at (Facility Name) reached
by
□ Electroencephalogram at km at (Facility Name) reached
by
□ Other (specify ) at km at
(Facility Name) reached by
□ Can not remember, not sure
29. Were you ever treated for this condition?
□ No (the interview is finished) □ Can't remember, do not know (interview is finished)
□ Yes
29.2 When was the last time you used medication for your condition?
□ Within the past month □ Within the past year
□ From one (1) to five (5) years ago □ More than five (5) years ago
□ Can not remember, not sure
29.3 What medication was it and how many times in the past year did you have to use some (check
several boxes if appropriate)?
□ Phenobarbital times
□ Dilantin/Tegritol/ Phentoin Sodium times (tick box and underline
specific drug name)
D Valproic acid times D Traditional medicine times
□ Other (specify ) times
□ Can not remember, not sure
c
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29.4 How much did it cost each time you bought this medication (specify the currency used)?
□ Phenobarbital
□ Dilantin/Tegritol/Phentoin Sodium (tick box and underline specific
drug name)
□ Valproic acid D Traditional medicine
□ Received for free from health care provider (I did not pay for it myself)
□ Other (specify .)
□ Cannot remember, not sure
The following two items should be completed for ALL respondents after direct observation of
latrine.
30. Presence and type of latrine (to be assessed by direct observation):
□ Absent □ Present and completely enclosed
□ Present and partially enclosed □ Present and open (easily accessible to roaming pigs)
31. Is there evidence of recent use of the latrine (by anyone) (to be assessed by direct observation)?:
□ Yes D No
THIS IS THE END OF THE INTERVIEW




Appendix C: Univariate Analysis - Full List ofIndicators
Cases Controls
Exposure Total Exposed %
dx_tw_fever 81 9 11.11
lat_used_ob 81 39 48.15
skn_nd_mr_1_ 81 6 7.41
farming 81 11 13.58
other_epi_hh 81 10 12.35
boil_all 81 13 16.05
prkyrly 81 9 11.11
gettweatp 81 17 20.99
headjnj 81 13 16.05
seizure_lst_ 81 12 14.81
lat_not_usd 81 20 24.69
boil_nev 81 56 69.14
boil_all_som 81 21 25.93
seen_nod_pg 81 33 40.74
feed_comm 81 3 3.7
feed^other 81 3 3.7
drnk__river 81 20 24.69
epi_lst_yr 81 8 9.88
nambale 81 8 9.88
pv_ind_di 81 23 28.4
see_smell_du 81 4 4.94
lat_nev 81 0 0
twitch_strt_ 81 0 0
if_cyst_cut 81 4 4.94
bothpig 81 2 2.47
native_pig 81 19 23.46
kill_yrly 81 0 0
fit_mr_1_yr 81 3 3.7
see_smell_no 81 55 67.9
agelO 81 4 4.94
kill_nev 81 19 23.46
kill_any 81 1 1.23
for_pig 81 1 1.23
nat_pi9 81 19 23.46
feedjdtch 81 19 23.46
see_smelljs 81 4 4.94
falloW_pg_ro 81 6 7.41
drnk,_well 81 17 20.99
feed^Past 81 17 20.99
pgother 81 1 1.23
fit_fell_wal 81 1 1.23
fit_cut 81 1 1.23
hdjsLyr 81 8 9.88
twitch-1"10 81 12 14.81
if_cyst_trea 81 2 2.47
fit hurt_oth 81 16 19.75
Exposed % Odds Ratio P
1 0.78 15.48 [2.01-686.05] 0.001
86 66.67 0.38 [0.18-0.81] 0.006
1 0.78 10.59 [1.23-490.90] 0.008
6 4.65 3.67 [1.14-12.85] 0.012
5 3.88 3.6 [1.05-13.97] 0.018
8 6.2 2.92 [1.05-8.54] 0.02
4 3.1 3.83 [1.01-17.60] 0.022
14 10.85 2.39 [0.98-5.86] 0.033
37 28.68 0.47 [0.21-1.01] 0.037
8 6.2 2.63 [0.93-7.79] 0.039
17 13.18 2.08 [0.95-4.59] 0.045
103 79.84 0.52 [0.24-1.10] 0.06
20 15.5 1.93 [0.91-4.10] 0.06
38 29.46 1.76 [0.92-3.34] 0.063
1 0.78 6.71 [0.48-361.00] 0.072
1 0.78 6.71 [0.48-361.00] 0.072
47 36.43 0.57 [0.29-1.10] 0.074
5 3.88 2.75 [0.75-11.06] 0.077
5 3.88 2.72 [0.75-10.92] 0.079
24 18.6 1.78 [0.87-3.62] 0.085
15 11.63 0.38 [0.09-1.27] 0.088
4 3.1 0 [0.00-1.37] 0.093
0 0 2.83 [0.64-14.16] 0.105
1 0.78 5.39 [0.48-273.84] 0.108
0 0 [0.63-.] 0.115
25 19.38 0 [0.00-1.58] 0.115
4 3.1 0 [0.00-1.66] 0.122
1 0.78 4.95 [0.39-261.69] 0.13
73 56.59 1.61 [0.83-3.19] 0.132
14 10.85 0.43 [0.10-1.43] 0.136
29 22.48 4.59 [0.51-217.35] 0.139
7 5.43 0.22 [0.00-1.97] 0.139
0 0 [0.00-.] 0.154
40 31.01 0 [0.00-.] 0.154
39 30.23 0 [0.00-.] 0.159
2 1.55 3.22 [0.45-36.24] 0.161
20 15.5 0.45 [0.11-1.65] 0.176
18 13.95 1.65 [0.74-3.67] 0.178
27 20.93 2.52 [0.55-15.69] 0.188
0 0 [0.00-.] • 0.19
6 4.65 0.26 [0.01-2.29] 0.192
0 0 [0.00-.] . 0.198
7 5.43 1.98 [0.60-6.70] 0.199
12 9.3 1.73 [0.67-4.49] 0.204
6 4.65 0.35 [0.03-2.21] 0.205

















































see_smell_no 81 12 14.81
kept_pig_pre 81 17 20.99
lat_alm_al 81 0 0
see_smelljno 81 53 65.43
see_smell_on 81 5 6.17
fit_now 81 63 77.78
epi_start_le 81 60 74.07
seizure_mM 81 0 0
pg_trde 81 12 14.81
fit_no 81 6 7.41
twitch_dunkn 81 0 0
pg_hm_cnsmp 81 1 1.23
cyst_mr_5_yr 81 1 1.23
keep_pig 81 20 24.69
prk_frq 81 51 62.96
pen_all 81 4 4.94
kill_mthly 81 0 0
seizure_now 81 59 72.84
prknevertrue 81 4 4.94
otherepiany 81 24 29.63
lat_all 81 62 76.54
hd_now 81 55 67.9
hd_mr_1_yr 81 3 3.7
abl_sel_cyst 81 0 0
prk_mthyr 81 60 74.07
grow_pg_rope 81 11 13.58
lrn_tw_dr 81 12 14.81
lrn_tw_trad 81 2 2.47
faint_mr_1_y 81 3 3.7
drinkother 81 16 19.75
all_free 81 5 6.17
dx_tw_diar 81 10 12.35
skn_nod__now 81 6 7.41
skn_nod_lst_ 81 4 4.94
plant_pg_rop 81 10 12.35
pg_rePr°d 81 7 8.64
toid_cysts 81 8 9.88
if_cyst_°the 81 1 1.23
fallow_pg_pe 81 4 4.94
no_epi_hh 81 44 54.32
epi_mr_1_yr 81 1 1.23
epi_dunknow 81 1 1.23
grow_pg_free 81 5 6.17
nod_ex_other 81 5 6.17
harv_pg_rope 81 9 11.11
prk_bby 81 0 0
lrn_tw_schoo 81 3 3.7
other 81 14 17.28
latrine 81 66 81.48
get_tw_other 81 17 20.99
faint_dunkno 81 0 0
see_tw_trad 81 0 0
27 20.93 0.63 [0.27-1.41] 0.229
19 14.73 1.55 [0.70-3.41] 0.235
2 1.55 0 [0.00-2.80] 0.238
75 58.14 0.42 [0.06-2.30] 0.242
3 2.33 2.36 [0.43-15.74] 0.242
108 83.72 0.63 [0.26-1.50] 0.242
95 73.64 0.57 [0.19-1.66] 0.243
2 1.55 0 [0.00-3.05] 0.259
15 11.63 1.94 [0.53-7.40] 0.26
5 3.88 1.99 [0.49-8.55] 0.261
2 1.55 0 [0.00-3.11] 0.264
5 3.88 0.3 [0.01-3.08] 0.267
0 0 [0.00-.] 0.268
41 31.78 0.7 [0.35-1.38] 0.271
82 63.57 1.91 [0.53-8.56] 0.281
4 3.1 2.25 [0.36-13.55] 0.283
2 1.55 0 [0.00-3.49] 0.283
101 78.29 0.68 [0.32-1.48] 0.286
11 8.53 0.53 [0.12-1.90] 0.29
30 23.26 1.41 [0.70-2.82] 0.293
85 65.89 1.7 [0.57-5.70] 0.298
98 75.97 0.7 [0.34-1.47] 0.302
2 1.55 2.52 [0.28-30.70] 0.302
1 0.78 0 [0.00-.] 0.302
86 66.67 1.55 [0.62-4.14] 0.311
26 20.16 0.56 [0.16-2.01] 0.312
13 10.08 1.53 [0.60-3.88] 0.317
1 0.78 3.2 [0.16-190.31] 0.32
2 1.55 2.4 [0.27-29.28] 0.329
33 25.58 0.72 [0.34-1.'48] 0.333
6 4.65 1.89 [0.39-8.70] 0.345
10 7.75 1.57 [0.54-4.54] 0.347
15 11.63 0.62 [0.19-1.81] 0.349
11 8.53 0.57 [0.13-2.03] 0.349
25 19.38 0.6 [0.18-2.04] 0.355
16 12.4 0.58 [0.15-2.14] 0.361
8 6.2 1.63 [0.46-5.68] 0.386
3 2.33 0.37 [0.01-5.04] 0.388
5 3.88 1.89 [0.32-10.17] 0.388
78 60.47 0.76 [0.39-1.50] 0.39
4 3.1 0.39 [0.01-4.08] 0.39
4 3.1 0.39 [0.01-4.08] 0.39
6 4.65 1.78 [0.36-8.22] 0.395
4 3.1 1.85 [0.35-10.35] 0.395
22 17.05 0.63 [0.19-2.14] 0.406
1 0.78 0 [0.00-.] 0.41
8 6.2 0.57 [0.10-2.49] 0.416
28 21.71 0.73 [0.31-1.66] 0.418
100 77.52 1.38 [0.60-3.35] 0.419
33 25.58 0.74 [0.34-1 .£2] 0.422
1 0.78 0 [0.00-.] " 0.423






















































see tw_dk 81 0 0
fit_dunknwo 81 0 0
school 81 0 0
drnk_bore 81 33 40.74
fallow_pg_fr 81 8 9.88
faint__now 81 65 80.25
ad_onset_ep 81 13 16.05
harv_pg_pen 81 4 4.94
seen_tw_fece 81 27 33.33
econom_vpoor 81 46 56.79
age20to29 81 21 25.93
budalangi 81 18 22.22
lat_som_nev 81 6 7.41
lrn_tw_oth 81 4 4.94
if_cyst_vet 81 4 4.94
plant_pg_fre 81 6 7.41
skn_nod_dunk 81 3 3.7
nod_not_pos_ 81 1 1.23
hurt_when_fi 81 46 56.79
if_cyst_ 81 13 16.05
heard_hum_ta 81 60 74.07
fit_fell_fir 81 13 16.05
more_1_seiz 81 64 79.01
only_one_sei 81 7 8.64
faint_more_o 81 66 81.48
faint_once 81 6 7.41
prk_mthly 81 51 62.96
hd_dunkOw 81 2 2.47
age30up 81 14 17.28
lat_clsd_ob 81 28 34.57
twitch_lst_y 81 5 6.17
no_wrk 81 22 27.16
fit_mr_one 81 63 77.78
fit_one 81 7 8.64
plant_pg_pen 81 4 4.94
age_10_19 81 41 50.62
epi_now 81 45 55.56
dx_tw_dk 81 6 7.41
ownpig_mre_5 81 3 3.7
killjess_yr 81 1 1.23
insp_som 81 0 0
insp__nev 81 1 1.23
grow_pg_pen 81 4 4.94
ed_none 81 29 35.8
other_epi_in 81 12 14.81
meningitis 81 11 13.58
cyst_1to5_yr 81 2 2.47
other_epi_in 81 4 4.94
busiam 81 7 8.64
seizure_no 81 3 3.7
nod_ex_pig_f 81 1 1.23
harv_pg_free 81 7 8.64
1 0.78 0 [0.00-.] 0.427
1 0.78 0 [0.00-.] 0.428
1 0.78 0 [0.00-.] 0.432
46 35.66 1.26 [0.67-2.33] 0.442
13 10.08 1.54 [0.41-5.58] 0.46
106 82.17 0.72 [0.28-1.91] 0.462
15 11.63 1.35 [0.55-3.?0] 0.465
5 3.88 1.7 [0.29-9.05] 0.468
36 27.91 1.27 [0.62-2.59] 0.473
75 58.14 0.79 [0.40-1.60] 0.48
28 21.71 1.26 [0.62-2.53] 0.482
34 26.36 0.8 [0.39-1.60] 0.499
12 9.3 0.7 [0.20-2.16] 0.5
4 3.1 1.6 [0.29-8.86] 0.51
3 2.33 1.68 [0.25-12.54] 0.52
9 6.98 1.48 [0.36-5.73] 0.527
3 2.33 1.66 [0.22-12.71] 0.537
2 1.55 0.48 [0.01-9.86] 0.554
76 58.91 0.83 [0.44-1.60] 0.557
13 10.08 1.36 [0.43-4.31] 0.562
90 69.77 1.22 [0.59-2.56] 0.571
18 13.95 1.26 [0.50-3.10] 0.576
98 75.97 0.75 [0.22-2.55] 0.588
8 6.2 1.34 [0.39-4.45] 0.588
105 81.4 0.73 [0.20-2.77] 0.59
7 5.43 1.36 [0.36-4.96] 0.59
82 63.57 0.83 [0.39-1.80] 0.602
5 3.88 0.65 [0.06-4.08] 0.605
26 20.16 0.83 [0.37-1.79] 0.606
47 36.43 0.86 [0.45-1.62] 0.61
6 4.65 1.37 [0.32-5.61] 0.61
41 31.78 0.84 [0.40-1.77] 0.623
105 81.4 0.77 [0.24-2.57] 0.623
9 6.98 1.3 [0.39-4.13] 0.623
6 4.65 1.42 [0.26-6.95] 0.624
61 47.29 1.14 [0.63-2.07] 0.638
76 58.91 0.87 [0.46-1.64] 0.641
11 8.53 0.78 [0.22-2.48] 0.647
3 2.33 1.47 [0.17-12.24] 0.658
1 0.78 1.84 [0.02-148.65] 0.668
1 0.78 0 [0.00-.] 0.686
6 4.65 [0.00-.] * 0.686
6 4.65 1.33 [0.24-6.56] 0.687
50 38.76 0.89 [0.47-1.66] 0.693
22 17.05 0.86 [0.36-1.97] 0.694
19 14.73 0.85 [0.34-2.05] 0.703
3 2.33 0.67 [0.04-9.11] 0.714
8 6.2 0.8 [0.17-3.12] 0.717
13 10.08 0.84 [0.27-2.40] 0.73
6 4.65 0.78 [0.12-3.81] 0.735
2 1.55 0.66 [0.01-13.44] 0.739






















































ill_after_me 81 8 9.88
ill_pre_men 81 4 4.94
lat_open_ob 81 9 11.11
if_cyst_sell 81 5 6.17
see_smell_mr 81 1 1.23
ss_strt_m 81 0 0
nod_ex_pig 81 2 2.47
owned_pig 81 36 44.44
see_tw_nothi 81 9 11.11
lrn_tw_fmd 81 36 44.44
nod_ex_human 81 6 7.41
ownpig1to5_y 81 5 6.17
nod_dk_pg 81 10 12.35
nod_skin_pg 81 11 13.58
nod_other_pg 81 12 14.81
twitch_more_ 81 58 71.6
twitch_mr_1_ 81 2 2.47
ft_strt_mth 81 0 0
boil_some 81 7 8.64
get_tw_not_w 81 21 25.93
fit_fell_bik 81 2 2.47
ed_primary 81 33 40.74
prklessyrly 81 1 1.23
faint_lst_yr 81 3 3.7
cyst_pst_yr 81 4 4.94
lrn_tw_radio 81 1 1.23
lrn_tw_obs 81 7 8.64
boil_al_al 81 1 1.23
any_free 81 10 12.35
prkneverresp 81 20 24.69
lat_some 81 6 7.41
drnktap 81 7 8.64
nvr_sell_pig 81 1 1.23
own_pig_pst_ 81 12 14.81
skn_nod_no 81 55 67.9
lat_none_ob 81 11 13.58
epi_no 81 20 24.69
prk_boil 81 14 17.28
nod_ex_dk 81 16 19.75
kept_pg_any 81 37 45.68
hd_0 81 7 8.64
see_tw med 81 9 11.11
dx_tw_see 81 33 40.74
student 81 15 18.52
male 81 38 46.91
ed_scnd_high 81 14 17.28
funyla 81 16 19.75
seizure_dk 81 3 3.7
sell_pig 81 18 22.22
othr_wrk 81 4 4.94
get_tw_cntct 81 3 3.7
sell_pglet 81 17 20.99
13 10.08 0.77 [0.12-5.17] 0.745
5 3.88 1.3 [0.19-8.20] 0.745
12 9.3 1.16 [0.41-3.20] 0.745
7 5.43 0.81 [0.18-3.49] 0.75
1 0.78 1.56 [0.02-123.48] 0.753
0 0 1.37 [0.10-19.35] 0.756
2 1.55 1.38 [0.09-20.11] 0.758
54 41.86 1.09 [0.59-2.03] 0.761
13 10.08 1.17 [0.36-3.62] 0.768
54 41.86 1.09 [0.59-2.01] 0.77
7 5.43 1.2 [0.28-4.89] 0.772
8 6.2 0.83 [0.18-3.63] 0.784
9 6.98 1.16 [0.35-3.92] 0.784
12 9.3 0.87 [0.28-2.74] 0.794
13 10.08 0.88 [0.28-2.69] 0.798
99 76.74 1.17 [0.30-5.55] 0.803
4 3.1 0.8 [0.07-5.78] 0.804
0 0 1.13 [0.35-3.49] 0.809
10 7.75 1.13 [0.35-3.46] 0.813
32 24.81 1.09 [0.50-2.33] 0.816
4 3.1 0.82 [0.07-5.96] 0.817
51 39.53 1.07 [0.57-1.98] 0.823
2 1.55 0.76 [0.01-14.98] 0.828
4 3.1 1.18 [0.17-7.20] 0.83
5 3.88 0.8 [0.07-9.91] 0.833
2 1.55 0.78 [0.01-15.30] 0.842
12 9.3 0.91 [0.29-2.64] 0.847
2 1.55 0.8 [0.01-15.55] 0.853
19 14.73 1.11 [0.33-3.70] 0.855
32 24.81 0.94 [0.46-1.93] 0.865
8 6.2 1.1 [0.30-3.82] 0.865
12 9.3 0.93 [0.29-2.69] 0.876
1 0.78 1.25 [0.01-104.57] 0.879
18 13.95 0.92 [0.25-3.48] 0.884
91 70.54 0.95 [0.47-1.98] 0.89
16 12.4 1.06 [0.42-2.60] 0.894
31 24.03 1.04 [0.51-2.11] 0.897
20 15.5 1.05 [0.44-2.43] 0.902
22 17.05 0.95 [0.29-3.08] 0.916
60 46.51 0.97 [0.53-1.79] 0.92
11 8.53 1.05 [0.33-3.13] 0.926
14 10.85 1.05 [0.33-3.22] 0.926
48 37.21 1.03 [0.50-2.12] 0.928
26 20.16 0.97 [0.42-2.18] 0.93
62 48.06 0.98 [0.54-1.77] 0.937
23 17.83 0.97 [0.43-2.15] 0.94
26 20.16 0.98 [0.45-2.06] 0.943
5 3.88 0.95 [0.14-5.04] 0.944
34 26.36 1.06 [0.14-12.75] 0.95
7 5.43 0.96 [0.20-4.03] 0.956
5 3.88 0.96 [0.14-5.18] 0.957






















































prk_fry 81 48 59.26
prkfrybbq 81 14 17.28
dx_tw_other 81 30 37.04
see_tw_pharm 81 10 12.35
lat_prt_ob 81 23 28.4
butula 81 10 12.35
matayos 81 22 27.16
fit_lst_yr 81 5 6.17
nod_tongue_p 81 1 1.23
faint_no 81 0 0
insp_alal 81 0 0
insp_al 81 0 0
amchak 81 0 0
both_pig 81 0 0
dk_pig 81 0 0
abl_brtr_cys 81 0 0
ill_after_he 81 0 0
fit_fell_wat 81 0 0
foreing_pig 81 0 0
ill_pre_hed 81 13 16.05
Appendices
71 55.04 1.01 [0.44-2.38] 0.972
21 16.28 0.99 [0.42-2.27] 0.972
44 34.11 1.01 [0.50-2.07] 0.974
16 12.4 1.01 [0.33-2.99] 0.989
35 27.13 1 [0.51-1.97] 0.989
16 12.4 0.99 [0.38-2.48] 0.99
35 27.13 1 [0.51-1.95] 0.996
8 6.2 1 [0.25-3.62] 0.998
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1.0 Title of study
Assessing the Burden of Taenia solium Neurocysticercosis: A Case
Study of Busia District, Kenya.
2.0 The Study
2.1 Justificationfor the Study
Given that there has been an increase in pig keeping in the area in recent years, and
an accompanying increase in the prevalence of porcine cysticercosis it is suspected
that there will be an increase in the prevalence of neurocysticercosis in Busia
District. The purpose of this study is to determine that prevalence (Anyanzo 1999).
2.1.1 Emergence of pig-keeping in Western Kenya
There has been a significant increase in pig production in the Eastern and Southern
Africa region (Githigia 2002); (Thuranira 2005) during the past decade, especially in
rural, resource-poor, small holder communities. In Uganda and Kenya, the
establishment of piggeries and increased pig production by rural farmers is
encouraged by both respective governments and forms part of the plan for the
modernization of agriculture under the Ministry of Agriculture in Uganda and is part
of the Busia District Development Plan, also under the relevant government ministry
(Government of Kenya 2002; Abila 2003). In Uganda, the local governments are
supplying piglets to the rural poor communities to rear in order to promote an
alternative source of income. In these communities pigs are considered low-input
livestock which do not require the same level of care as cattle, for example. In
addition, pigs are omnivorous; and accomplished scavengers who can grow to
market size on minimal feed inputs from the farmer.
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Figure 1: Trend in the total pig population in the Eastern and Southern Africa countries of















In Uganda alone, the pig population has increased from 200,000 in 1980 to almost a
million in 2000 (FAO 2002). As Kenya and Uganda border each other and share
many of the same cultural attributes as well as ethnicities, it would be logical to
assume that there will be further increases in pig keeping likely to occur in Western
Kenya.
2.1.2 Reported Increase in porcine cysticercosis
There are indications that with the increase in pig production in East Africa, porcine
cysticercosis is also on the rise. In East Africa, porcine cysticercosis has been
reported in Tanzania, (Nsengwa 1995), (Ngowi 2004), Kenya (Githigia 2002),
(Mutua 2004) and Uganda (Anyanzo 1999), (Mafojane 2003). Ongoing work in'six
districts in Western Kenya has shown evidence of porcine cysticercosis in 'all
districts (see Map 1) (Mutua 2006) with rates as high as 36% in Kimili Division
using lingual examination - a method which is approximately 40% - 50% effective
(Ngowi 2004). In Busia District in Western Kenya, prevalence rates for pordine








| Divisions not sampled
% Positive
To provide information on the denominator used in calculating the division level
cysticercosis prevalence rates, a map indicating the number of pigs sampled in each
of the study divisions is also presented here (see Map 2 below).
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2.2 Objectives of the Study
The objective of the study is to determine the prevalence of neurocysticercosis in
Busia District and its impact (burden of disease) on the community. This burden will
be assessed in terms of Disability-Adjusted Life Years (DALYs) for humans and
livestock economic losses for pigs. To date there are almost no data available
concerning the prevalence of neurocysticercosis in Kenya - only two reported cases
(Phiri 2002). The following diagram indicates the process the study will follow:
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The principal hypothesis to be tested by this study is that given the increase in pig
keeping in Western Kenya and the increase in porcine cysticercosis, there will be
evidence of a prevalence of neurocysticercosis.
Additionally, given that the majority of the population within the study area falls
below the poverty line (CBS 2003), another hypothesis will stipulate that the poor
are more at risk of contracting zoonotic diseases. Once contracted, zoonotic diseases
have a greater impact on the poor and are less likely to be diagnosed or treated
therefore rendering the poor more vulnerable due to economic circumstances.
2.4 Assumptions
The assumptions associated with the study include the following:
• That the disease exists within the population
• The sample size used is sufficient to capture enough people to reach a reasonable
conclusion of its presence or absence
• The diagnostics used will be sufficient and specific and sensitive enough to reach
reasonable conclusions
• All measures have been taken to minimize the risks associated
To the best of our knowledge (explained in detail throughout this document) all of
these assumptions are true.
2.5 Variables
Variables in this study that could affect the assumptions are that the prevalence that
exists is significant enough to be detected and that the diagnostics used are specific





As in many aspects ofmedicine, there are both benefits and risks associated with the
use of CT (computed tomography). The main risks are those associated with
abnormal test results, for a benign or incidental finding, leading to unneeded,
possibly invasive, follow-up tests that may present additional risks and the increased
possibility of cancer induction from X-ray radiation exposure.
The probability for absorbed x rays to induce cancer is thought to be very small for
radiation doses of the magnitude that are associated with CT procedures. Such
estimates of the cancer risk from x-ray exposure have a broad range of statistical
uncertainty and there is some scientific controversy regarding the effects from very
low doses and dose rates as discussed below. Under some rare circumstances of
prolonged, high-dose exposure, x rays can cause other adverse health effects, such as
skin erythema (reddening), skin tissue injury, genetic effects, and birth defects. But
at the exposure levels associated with most medical imaging procedures, including
CT, these other adverse effects would not occur.
Estimates of the effective dose from a diagnostic CT procedure can vary by a factor
of 10 or more depending on the type ofCT procedure, patient size and the CT system
and its operating technique. A list of representative diagnostic procedures and
associated doses are given in Table 1, adapted from a report of the European
Commission (European Commission. 2000).
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Chest x ray (PA film) 0.02 1 2.4 days
Skull x ray 0.07 4 8.5 days
Lumbar spine 1.3 65 158 days
I.V. urogram 2.5 125 304 days
Upper G.I. exam 3.0 150 1.0 year
Barium enema 7.0 350 2.3 years
CT head 2.0 100 243 days
CT abdomen 10.0 500 3.3 years
1. Effective dose in millisieverts (mSv).
2. Based on the assumption of an average "effective dose" from chest x ray (PA film) of 0.02
mSv.
3. Based on the assumption of an average "effective dose" from natural background
radiation of 3 mSv per year in the United States (U.S. Food and Drug Administration. 2005).
2.6.2 Pregnant Women
All women of reproductive age will be excluded from the study. They will be asked
to provide a urine sample to determine whether pregnant or not, and if found to be
so, will be excluded.
2.6.3 Children
Unique Considerations for Radiation Exposure in Children
Radiation exposure is a concern in both adults and children. However, there are two
unique considerations in children.
1. Children are considerably more sensitive to radiation than adults,, as
demonstrated in epidemiologic studies of exposed populations.
2. Children also have a longer life expectancy, resulting in a larger window of
opportunity for expressing radiation damage.
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As an example, compared with a 40-year old, the same radiation dose given to a
neonate is several times more likely to produce a cancer over the child's lifetime.
Moreover, the same exposure parameters used for a child and an adult will result in
larger doses to the child. There is no need for these larger doses to children, and CT
settings can be reduced significantly while maintaining diagnostic image quality.
Therefore, children should not be scanned using adult CT exposure parameters.
Currently, adjustments are not frequently made in the exposure parameters that
determine the amount of radiation children receive from CT, resulting in a greater
radiation dose than necessary.
Radiation Risks from CT in Children: A Public Health Issue
Major national and international organizations responsible for evaluating radiation
risks agree there probably is no low-dose radiation "threshold" for inducing cancers,
i.e., no amount of radiation should be considered absolutely safe. Recent data from
the atomic bomb survivors and medically irradiated populations demonstrate small,
but significant, increases in cancer risk even at the low levels of radiation that are
relevant to paediatric CT scans. Doses from a single paediatric CT scan can range
from about 5 mSv to 60 mSv (see Table 2). Among children who have undergone CT
scans, approximately one-third have had at least three scans. Multiple scans present a
particular concern. For example, three scans would be expected to triple the cancer
risk of a single scan.
Although the benefits of properly performed CT examinations almost always
outweigh the risks for an individual child, unnecessary exposure is associated with
unnecessary risk. Minimizing radiation exposure from paediatric CT, whenever
possible, will reduce the projected number of CT-related cancer deaths.
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Table 2.: Radiation Doses Paediatric CT scan




















Chest X-ray (PA/lateral) Lung 0.01 / 0.15
Screening Mammogram Breast 3
* "Unadjusted" refers to using the same settings as for adults. "Adjusted" refers to settings adjusted for
body weight.
Source: (National Cancer Institute. 2006)
Immediate Measures to Minimize CT Radiation Exposure in Children
Physicians, other paediatric health care providers, CT technologists, CT
manufacturers and various medical and governmental organizations share the
responsibility to minimize CT radiation doses to children. Several immediate steps
can be taken to reduce the amount of radiation that children receive from CT
examinations:
> Perform only necessary CT examinations. Communication between paediatric
health care providers and radiologists can determine the need for CT and the
technique to be used. Although there are standard indications for CT in children,
radiologists should review reasons prior to every paediatric scan and be available
for consultation when indications are uncertain. Consider other modalities such




> Adjust exposure parameters for paediatric CT based on:
• Child size: guidelines based on individual size / weight parameters should be
used.
• Region scanned: the region of the body scanned should be limited to the
smallest necessary area.
• Organ systems scanned: lower mA settings should be considered for skeletal
and lung imaging.
• Scan resolution: the highest quality images (i.e., those that require the most
radiation) are not always required to make diagnoses. In many cases, lower-
resolution scans are diagnostic.
> Minimize the CT examinations that use multiple scans obtained during different
phases of contrast enhancement (multiphase examinations). These multiphase
examinations are rarely necessary, especially in body (chest and abdomen)
imaging, and result in a considerable increase in dose (National Cancer Institute.
2006)
While acknowledging the previously stated risks with regard to paediatric CT scans,
it is unlikely that the exposure to radiation from this one scan will do significant long
term damage and that the benefits in terms of the child's potential to be treated and
relieved of epileptic symptoms, clearly outweigh the risks.
3.0 Information on previously published research on the topic
3.1 Worldwide status ofcysticercosis
Cysticercosis was originally a ubiquitous disease occurring wherever pigs and
humans existed in association, and is probably a disease of great antiquity - Aristotle
gives a clear description of the condition as it occurs in pigs (Cook 2003). Although
cysticercosis has been known for many years, its relationship with the adult
tapeworm appears not to have been clear until it was demonstrated by Kuchenmaister
in 1855 when he fed condemned prisoners with cysticercosis-infected pork and
recovered young tapeworms at the autopsies (Henneberg 1912). There is, however,
some evidence to suggest that as early as the 6th century there may have been some
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knowledge about it as illustrated by the example of Anthinus who reported to
Theodoric, King of the Franks (511-534), that "tapeworms were excreted after the
consumption of raw fatty pork" (Gach 1926). Even if this connection had been
established, there is no evidence that a link was made between the tapeworm
transmitted and its effects on humans.
The disease has been reported in West African countries such as Benin, Burkina-
Faso, Ghana, Ivory Coast, Senegal and Togo and is expected to be present in most
pig-raising regions of other West African countries. In the Nsukka area of Enugu
State in Nigeria, over 20% of 2358 trade pigs examined were found infected with
porcine cysticercosis and the overall prevalence of taeniid ova in the 1525 human
stool samples analysed was 8.6% with most of the cases (78.6%) occurring adults
aged >30 years (Onah 1995). Although economic losses are associated with the
decreased value of a pig infected with cysticercosis (Zoli 2003), it has to be noted
that in some villages in West Cameroon, pork infected with cysticerci is considered
to have a better flavour than healthy meat. Therefore, pork harbouring cysticerci is
sometimes sold at a higher price than uninfected meat (Zoli 1992).
Map 3: Areas where cysticercosis is endemic
□ to information raitofe wen
Countries in black represent countries where cysticercosis is endemic; countries in
grey represent those where cases have been reported, (Roman 2000).
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3.1.1 History of cysticercosis in East Africa
In East Africa, the disease has been reported in Tanzania, Kenya and Uganda. In
Tanzania, a retrospective study of slaughter records in Mbulu district from 1985-
1989 indicates a prevalence increasing from 0.4 to 4.9% during that time (Nsengwa
1995). In a more recent study of the risk factors associated with cysticercosis in
Mbulu District, pigs raised in a total of 436 households were examined in the 21
selected villages in the district. Out of the 770 pigs examined, 134 had visible T.
solium larvae, giving an overall prevalence of 17.4% (95% CI = 12.5, 22.3). The
prevalence in the 21 villages ranged from 3.2 - 46.7%, showing a large variation in
villages (Ngowi 2004).
In Kenya, the disease has not been considered endemic for several decades but recent
surveys indicate that T. solium is emerging as a problem in small-holder pig keeping
communities of south-western Kenya where ante-mortem lingual examinations in
different locations in the area have indicated at least 10-14% of the pigs surveyed to
be infected (Githigia 2002). According to the Annual Reports of the Ministry of
Health (MOH), the prevalence of human taeniosis in the rural areas is estimated to be
2% (Mafojane 2003) but could be as high as 4-10% in Busia District as hospital
records suggest (Busia District Hospital 2001).
In Uganda, there is not enough data to quantify the prevalence of cysticercosis, but
according to a post-mortem survey conducted in 1999 in northern Uganda, 34-45%
of the pigs slaughtered were infected. Given the increases in pig-keeping in Uganda
over the past 20 years and the prevalence of porcine cysticercosis in neighbouring
countries, it is likely that there will soon be a public health problem (Mafojane
2003).
3.2 Neurocysticercosis (NCC)
3.2.1 General Background to NCC
Neurocysticercosis (NCC) is a parasitic infection that can affect the nervous system
caused by Taenia solium, which is common, but preventable. In both humans and
pigs, a therapeutic does of drugs is the most common form of treatment but often
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detection is under-reported (Tsang 1995) and better surveillance and monitoring is
necessary to control the infection. Infection with T. solium is widely prevalent in
human and pig hosts in many developing countries of Latin American, Africa, and
Asia (Sarti 2003).
Humans are the only natural definitive host while pigs are the intermediate host. Man
may become an intermediate host from ingestion of the eggs of the adult tapeworm,
resulting in a condition known as human cysticercosis. The cysticerci of T. solium
may lodge in the brain causing cerebral cysticercosis (neurocysticercosis), resulting
in headaches, epileptic seizures, blindness and mental disturbances (White 2000). In
addition, the cysticerci may cause other neurological afflictions such as meningitis,
encephalitis, ventricular disease, spinal disease and ocular cysticercosis, although the
most common manifestation still remains epilepsy (Cook 2003).
The T. solium taeniosis/cysticercosis complex is associated with poor sanitation and
hygiene, poor methods of pig-husbandry and lack of proper meat inspection and
disease control methods. Ingestion of larvae (cysticerci) in raw or under-cooked pork
meat results in the human tapeworm infection or taeniosis (Phiri 2003).
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Figure 3: Life-cycle of Taenia solium
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Figure 4: Description of the life cycle of Taenia saginata and Taenia solium
Humans are the only definitive hosts for Taenia saginata and Taenia solium. Eggs or
gravid proglottids are passed with feces ; the eggs can survive for days to months in the
environment. Cattle (T. saginata) and pigs (T. solium) become infected by ingesting
vegetation contaminated with eggs or gravid proglottids ©. In the animal's intestine, the
oncospheres hatch©, invade the intestinal wall, and migrate to the striated muscles, where
they develop into cysticerci. A cysticercus can survive for several years in the animal.
Humans become infected by ingesting raw or undercooked infected meatO. In the human
intestine, the cysticercus develops over 2 months into an adult tapeworm, which can
survive for years. The adult tapeworms attach to the small intestine by their scolex ©and
reside in the small intestine©. Length of adult worms is usually 5 m or less for T.
saginata (however it may reach up to 25 m) and 2 to 7 m for T. solium. The adults
produce proglottids which mature, become gravid, detach from the tapeworm, and migrate
to the anus or are passed in the stool (approximately 6 per day). T. saginata adults usually
have 1,000 to 2,000 proglottids, while T. solium adults have an average of 1,000
proglottids. The eggs contained in the gravid proglottids are released after the proglottids
are passed with the feces. T. saginata may produce up to 100,000 and T. solium may ' •




T. solium has a complex two-host life cycle. Human beings are the only definitive
host and harbour the adult tapeworm (taeniosis), whereas both people and pigs can
act as intermediate hosts and harbour the larvae or cysticerci (Garcia 2003). It is
possible, however, for someone who has never eaten pork to contract
neurocysticercosis by a process of "auto-infection". This would mean that the
individual could become infected by ingesting a tapeworm segment excreted by
themselves or another human which could be found contaminating other types of
food and not pork. The segment would then develop into cysticerci in the muscles of
the human and then move to the central nervous system (CNS) causing
neurocysticercosis (Schantz 1992).
Approximately 2.5 million people worldwide carry adult T. solium (Burneo 2001).
The prevalence of epilepsy in industrialized countries is about 3-9 per 1000
population. The prevalence in developing countries, data which is based largely on
community surveys of rural populations, is as high as 49 per 1000 population in
Liberia and 57 per 1000 in Panama (Senanayake 1993).
According to the International League Against Epilepsy (ILAE), cysticercosis is
probably the most common cause of acquired epilepsy in the developing world,
where prevalence rates of active epilepsy are twice those of developed countries
(ILAE 2006). Cysticercosis is important in smallholder farming communities
because it exacts a price by:
> Causing infections in humans affecting their physical and psychological
health, social life and productivity;




The word "epilepsy" derives from the Greek verb "epilambanein", meaning "to be
seized, to be overwhelmed by surprise" and captures well the sudden, usually
unpredictable and intrusive nature of most seizures. Neurologists define epilepsy as:
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"a condition in which individuals experience paroxysmal changes in behaviour
caused by abnormalities in the electrical activity of the brain" (Asbury 1992). In
other words, epilepsy is the name given to a group of functional disorders of the
brain that are characterized by repetitive seizures. Seizures involve abnormal,
excessive electric discharges of groups or assemblies of nerve cells (neurones) in the
brain (WHO 2004).
Epilepsy is the most common serious neurological disorder and is one of the most
prevalent non-communicable disease in the world (Scott 2001). The WHO
Neurosciences Research Protocol for studying the prevalence of neurological
disorders in developing countries defines epilepsy as two or more afebrile seizures
unrelated to acute metabolic disorders or to withdrawal of drugs or alcohol
(Senanayake 1993). According to the WHO "Out of the Shadows" - Global
Campaign Against Epilepsy, in all areas of the world, no less than three out of every
thousand people - and in several places over 40 per thousand (4%) are affected.
3.3.2 Prevalence in Sub Saharan Africa
The prevalence of epilepsy for sub-Saharan Africa varies considerably, with smaller
studies showing in general a higher prevalence and larger studies showing prevalence
nearer that in the developed world. The median prevalence found using door-to-door
studies is 15 per 1000 people (Preux 2005). The table below illustrates varying rates
of prevalence using door-to-door studies in sub-Saharan Africa.
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Table 3: Prevalence of epilepsy in sub-Saharan Africa
Country Reference Year N Prevalence % 95 % CI
Benin (Agbogbome) (Gbenou 1995) 1995 530 24.5 10.9-38.1
Benin (Savalou) (Avode 1996) 1996 1,443 15.2 8.7-21.7
Benin (Zinvie) (DeBrock 2000) 2000 3,134 33.5 22.3-44.3
Burkina Faso
(Debouverie
1993) 1993 16,627 10.6 9.1-12.2
Cameroon (Nkwi 1989) 1989 500 70.0 46.3-93.6
Cameroon (Bilomo) (Dongmo 2000) 2000 1,900 58.4 '46.9-69.1
Ethiopia (Butajira)
(Tekle-Haimanot
1990) 1990 60,820 5.2 4.6-5.8
Ivory Coast (Kouassi 1988) 1988 1,176 7.6
'
2.5-12.7



























Mali (Farnarier 2000) 2000 5,243 15.6 12.2-19.0
















1987) 1987 18,954 5.3 4.2-6.4
Senegal (Ndiaye 1986) 1986 7,682 8.3 6.2-10.4
Senegal (Diop 1996) 1996 2,803 21.0 15.5-26.5
Tanzania (Rwiza 1992) 1992 18,183 10.2 8.7-11.7
Togo(Akebou) (Grunitzky 1996) 1996 4,182 13.1
( 9.6-16.6
Togo (Kioto) (Grunitzky 1991) 1991 19,241 12.3 "10.7-13.9
Togo (Kozah) (Dumas 1989) 1989 5,264 16.7 • 13.1-20.3
Togo(Tone) (Balagou 2000) 2000 9,143 18.6 . 15.7-2.1.5
Uganda (Kaiser 1996) 1996 4,743 13.0 • 9.7-16.3




It is estimated that 10% of the burden of brain and mental disorders in the world is
caused by epilepsy, calculated in disability-adjusted life years (DALYs), which is
very significant. This calculation includes premature deaths and the loss of healthy
life due to disability (World Bank 1993). Every year, among every 100,000 persons,
there will be 40-70 new cases (WHO 2003). Of the 50 million people in the world
who have epilepsy, approximately 35 million have no access to appropriate
treatment. This is in most cases because services are unaffordable or non-existent and
in some cases because epilepsy is not viewed as a medical problem or as a treatable
brain disorder (WHO 2001b).
3.3.3 Burden of Disease Estimates for Epilepsy
The burden of disease (BOD) estimates for epilepsy include epilepsy and status
epilepticus. (Mathers 2003) estimate the DALYs for epilepsy as 6,223,000, with
slightly higher rates for males (3,301,000) than for females (2,922,000). Many risk
factors for epilepsy are linked with a lower level of economic development; thus, the
burden is highest in South Asia followed by Sub-Saharan Africa (Table 4). A notable
observation is the reportedly low burden in the Middle East and North Africa, despite
parts of that region being relatively underdeveloped. Epilepsy imposes a large
economic burden on patients and their families. It also imposes a hidden burden
associated with stigmatization and discrimination against patients and even their
families in the community, workplace, school, and home. Social isolation, emotional
distress, dependence on family, poor employment opportunities, and personal injury
add to the suffering of people with epilepsy (Jamison 2006).
Table 4: Disability-Adjusted Life Years by Cause and Region, 2001 (x1000)
Global total
Europe Latin Middle South Sub- High-
Mixed Males Females East & America & East & Asia Saharan income
sexes Asia & Central the North Africa Countries
Condition Pacific Asia Caribbean Africa Countries
AD and other
Dementias
17,108 6,092 11,016 4,110 1,612 1,215 292 1,955 450 •7,468
Epilepsy 6,223 3,301 2,922 1,303 354 737 248 1,741 1,373 4641
PD 2,325 1,124 1,202 435 228 90 81 303 100 1,086
Cerebrovascular
Disease




More than 80% of patients with epilepsy live in developing countries and most of
these live in sub-Saharan Africa (WHO 2001b). Data on the incidence of and
prognosis for epilepsy in sub-Saharan Africa are scarce but prevalence data show
that epilepsy is two to three times more common than in industrialized countries in
non-tropical areas (Preux 2005).
3.3.4 Definitions for Epilepsy Diagnosis
Epileptic seizure. A clinical manifestation presumed to result from an abnormal and
excessive discharge of a set of neurons in the brain. The clinical manifestation
consists of sudden and transitory abnormal phenomena which may include
alterations of consciousness, motor, sensory, autonomic, or psychic events, perceived
by the patient or an observer.
Epilepsy. A condition characterized by recurrent (two or more) epileptic seizures,
unprovoked by any immediate identified cause. Multiple seizures occurring in a 24-h
period are considered a single event. An episode of status epilepticus is considered a
single event. Individuals who have had only febrile seizures or only neonatal seizures
as herein defined are excluded from this category.
Status epilepticus. A single epileptic seizure of >30-min duration or a series of
epileptic seizures during which function is not regained between ictal events in a
>30-min period.
"Active" epilepsy. A prevalent case of active epilepsy is defined as a person with
epilepsy who has had at least one epileptic seizure in the previous 5years, regardless
of antiepileptic drug (AED) treatment. A case under treatment is someone with the
correct diagnosis of epilepsy receiving (or having received) AEDs on prevalence
day.
Epilepsy in remission with treatment. A prevalent case of epilepsy with no
seizures for > 5 years and receiving AED at the time of ascertainment.
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Epilepsy in remission without treatment. A prevalent case of epilepsy with no
seizures for >5 years and not receiving AED at the time of ascertainment.
Single or isolated seizure. One or more epilepticseizures occurring in a 24-h period.
Febrile seizure. An epileptic seizure as herein defined, occurring in childhood after
age 1 month, associated with a febrile illness not caused by an infection of the CNS,
without previous neonatal seizures or a previous unprovoked seizure, and not
meeting criteria for other acute symptomatic seizures.
Neonatal seizure. An epileptic seizure as herein defined occurring in the first 4
weeks of life.
Febrile seizure with neonatal seizure. One or moreneonatal seizures in a child who
has also experienced one or more febrile seizures as herein defined.
Nonepileptic events. Clinical manifestations presumed to be unrelated to an
abnormal and excessive discharge of a set of neurons of the brain, including:
• disturbances in brain function (vertigo or dizziness, syncope, sleep and
movement disorders, transient global amnesia, migraine, enuresis), and
pseudoseizures (nonepileptic sudden behavioral episodes presumed to be of
psychogenic origin; these may coexist with true epileptic seizures).
All definitions have been taken from the Commission on Classification and
Terminology of the International League Against Epilepsy (ILAE 1989).
4.0 Previous Submissions
There have been no previously submitted protocols.
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5.0 Description of Study Site
5.1 Background to Busia District
Busia District is located in Western Kenya, bordering Uganda on the west side, Teso
District to the north, Siaya and Mumias Districts to the east and Lake Victoria to the
south. Busia District falls within the Lake Victoria Basin.
The altitude varies from 1 130 m above sea level on the shores of Lake Victoria to 1
375 m above sea level in the central part. The northern divisions (Butula and
Nambale) occupy a plain characterised by low flat divides. These are often capped
by laterites and shallow incised swampy systems. The peneplain has fertile soils
suitable for growing maize, Robusta coffee and sugar cane.
The southern part, which covers parts ofMatayos Division, Funyula Division and the
northern part of Budalang'i Division is covered by a range of hills comprising the
Samia Hills, which run from northeast to southwest, culminating at Port Victoria.
The Yala Swamp is found in the extreme south of the district, an area which forms a
colony of papyrus growth broken by irregular water channels and occasional small
lakes with grassy islands (CBS 2000). Busia has long been a tsetse endemic area
(Hide 1999) and in recent years, has seen a change in livestock keeping patterns with
more market oriented livestock such as pigs on the increase. The human population
of Busia District is currently reported to be in the region of 405,000 with the most
populous division being Butula Division.
The district is divided into six divisions: Funyula, Butula, Nambale, Matayos,
Budalang'i and Busia Municipal (see Maps 4 & 5).
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Recent surveys indicate that although not considered endemic in Kenya for several
decades, with the emergence of small holder pig keeping communities in south¬
western Kenya (Busia, Kakamega), T. solium prevalence is increasing (Phiri 2003).
In addition, Tanzania is considered a cysticercosis endemic country (Roman 2000)
and the area where the disease is particularly prolific is located relatively close to the
Kenyan border (Ngowi 2004). The potential for cases of porcine cysticercosis to
increase is being attributed to poor sanitation and the relaxation of enforcement of
regulations concerning the management of pigs, in particular allowing free range pig
keeping (Githigia 2002).
Table 5: Human Population Densities by Division
Division 1999 2002 2008
Area
(km2)
Population Density Population Density Population Density
Budalang'i 306.5 53 356 174 58 363 190 69 836 • 228
Butula 245.2 95 489 389 104 450 426 124 970, 510
Funyula 281.2 73 875 263 80 808 287 96 687 344
Matayos 173.7 55 186 318 60 365 348 72 227 ' 416
Nambale 232.5 67 544 291 73 883 318 88 401 380
Township 22.2 25 158 1 133 27 519 1 240 32 926 1 483
Totals 1 261.3 370 608 294 405 389 321 485 047 385
Source: (CBS 1999) and District Statistics Office, Busia, 2001.
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The study to be conducted will be a case-control study. The sample population will
be those who have previously been diagnosed with epilepsy. The diagnosis of
epilepsy itself will not be part of the study as it will have been carried out previously
by qualified Kenyan medical staff. The cases will be those who have tested positive
serologically for exposure to T. solium and the control group will be those subjects
who have tested negatively serologically for exposure to T. solium.
Table 6: Contingency table for Case-Control Study
Diseased subjects Non-diseased Total
(+ T. solium) subjects
(- T. solium)








Total a + c b + d a + b + c+d = n
The contingency table for a case-control study assumes the following (a+c) and (b+d), are
pre-determined.
Source: (Thrusfield 1995)
All those who have tested positively will be given a CT scan at the Aga Khan
Hospital in Kisumu to determine the presence of cysts in the brain along with a
random sample of those who have tested negatively. The scans will be analysed by a
qualified Radiologist, Dr Reddi Rao, and the results given to the study subjects and





The protocol for the CT scan will be as follows:
• 5mm cuts in the posterior fossa
• 1 Omm cuts in the supratentonlotium
• Pre and post contest scans (contrast required)
• Coronal sections if required
8.2 Risk Factor Investigation
The risk factors deemed to be present or absent have been determined by
administration of a questionnaire to the same sample population of epileptic patients





> Presence and use of a latrine (enclosed totally, partially, not at all)
> Pig husbandry practices (tethered at certain times, total free range)
> Meat slaughter and inspection practices
> Familiarity with both porcine and human cysticercosis
> Familiarity with Taenia solium
> Diagnosis of epilepsy
> Symptoms of epilepsy
A follow-up set of questions designed to firstly, validate some of the answers to the
first questionnaire and, secondly, determine whether even if they are not directly
exposed to pigs themselves, their physical proximity to pigs in the area (Appendix
IX). At this time, an Asset Index (Appendix X) will also be discussed with the
respondents to establish their economic status.
9.0 Number of Participants - Statistically Determined
As indicated in Table 1, prevalence rates for epilepsy in sub-Saharan Africa range
from 5.2% to 74.4% using different sample sizes in door-to-door surveys. The
prevalence rate for Kenya set out in this table for epilepsy is 18%. Infections are the
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cause of epilepsy in up to 26% of the patients included in Table 1 (Preux 2005).
While recent reviews have noted the absence of well-conducted studies that can
establish the importance of neurocysticercosis in epilepsy (Pal 2000), it is considered
the major cause of acquired epilepsy in Latin America (Garcia, Gilman et al. 1993),
and may also be so in sub-Saharan Africa (Dumas 1989), (Nsengiyumva 2003). In
Nsengiyumva's study carried out in Kiremba, Burundi, of the cases (people with
epilepsy), 59.6% were positive for ELISA cysticercosis serology and of the controls
(those without diagnosed epilepsy), 31.5% were positive for cysticercosis. The
sample size in this case was 324 cases and 648 controls. In a similar study conducted
by Newell in Bururi, Burundi, 4.9% of the 103 epileptic cases and 4.2% of thd'72
controls showed exposure to T. solium in Ag ELISA (Newell, Vyungimana et al.
1997). The following table illustrates some of the risk factors for acquiring epilepsy
in sub-Saharan Africa.

















Burundi et al. 1997) 1997 103 72 4.6
(Newell,
Vyungimana .
Burundi et al. 1997) 1997 110 82
(Nsengiyumva
Burundi 2003) 2003 324 648 3.3 1.9 4.1
(Dongmo
Cameroon 2004) 1998 93 81 NS
(Druet- /
Cabanac
CAR 1999) 1999 187 374
(Farnarier




Nigeria 1989) 1989 155 155 11.0 13.0
Tanzania (Matu|a 2001) 2001 174 174 2.9 3.3 4.5
OR=odds ratio; FS=febrile seizures; FH=family history; Hl=head
injury;





In the proposed study approximately 600 epileptic patients will be tested for
exposure to T. solium using Ag ELISA. Those who test positively will be given a CT
scan as well as a doubled random number of those who test negatively for exposure
to T. solium.
A sample size of around 600 patients is sufficient to detect a prevalence of 15%
(Kaamugisha 1988); (Kaiser 1996); (Rwiza 1992)), (estimated from the literature)
with an error of 5% at 95% confidence, based on an estimated population in Busia
District of 400,000 (CBS 2000).
From this sample of epileptics, a case control study will be designed to determine
risk factors for NCC induced epilepsy among epileptics in Busia. The exact nature
of the study design for this section of the study will depend in part on the results of
the serology; either a matched or un-matched case control design will be used,
requiring 205 or 294 cases respectively.
10.0 Exclusion or Inclusion of Subjects
The only participants who will be excluded from the study are women who test
positively for pregnancy or express that they intend to becom pregnant during the
course of the study.
11.0 Process ofRecruitment
A pilot phase of the study has already been carried out which involved identifying
study subjects based on their attendance at a facility that treats epileptics. This part of
the study is intended as the pilot phase on the feasibility of the overall study. ^The
Chief Medical Officer, Dr James Mukabi was informed of the study and provided a
letter of introduction to facilitate collecting information from the records of health
facilities (Appendix III). In this pilot study, approximately 400 patients were
identified at six facilities around Busia District. These facilities were St Catherine's
Special School in Butula, St Martin's Special School in Kisoko, Nangina Special




The diagnosis for epilepsy was therefore carried out by a qualified physician and the
patients were on a regime of anti-epileptic drugs (AEDs). The intention of the study
is to recruit at least 600 patients using this method to have an adequate sample size.
It must be noted, however, that as the patients are attending a health facility, they
must have the ability to pay for these services. This method of recruitment clearly
precludes those who have epilepsy but lack the means to seek treatment. As poverty
is a risk factor associated with the transmission of T. solium (Garcia 2003; Ngowi
2004), it may be assumed that this excluded population may in fact be one most at
risk of infestation. It will then be necessary to recruit subjects who are perhaps
known by other epileptics but not by the health officers or who are known by their
communities. If these patients are on drug therapy prescribed for epileptics they will
be classified as diagnosed epileptics.
One of the objectives of the study is to administer a questionnaire (Appendix II) to
determine risk factors for the transmission of T. solium. This questionnaire will
include questions regarding symptoms of epilepsy to assess whether a subject has
epilepsy but has not been formally diagnosed by a qualified physician but in fact has
epilepsy.
11.1 Steps taken to assure confidentiality during recruitment
As many of the patients will be identified by fellow epileptics as having similar
problems as theirs, it will be impossible for the identity of epileptic patients to be
suppressed entirely. Care will be taken, however, to confine the questionnaire to.the
epileptic patient and/or their guardians and to preserve confidentiality
when interviewing patients.
12. Samples of the Standardized Case Report Forms
Appendix IV
13. Liability for research-related disability or death
The research involved does not carry more than a minimal risk of physical injury.
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14. Medical Care for Subjects
Prior to the collection of sera from the epilepsy patients, a training session will be
held in Busia District for clinical officers, psychiatric officers and others who are
responsible for care of epileptic patients and Taenia solium related conditions. The
training session will be conducted by Professor Erastus Amayo, a neurologist with














How to manage complications during treatment
At the end of Day 2, the groups may be split up and a separate session will be held
for Lab technicians in order to ensure that the sera collected is collected properly and
stored and labelled in the correct fashion.
The epileptic patients who have a confirmed diagnosis either by CT scan or serology
will then be referred to the trained clinicians for management of their condition and
the drugs necessary for treatment will be funded by the University of Edinburgh. It is




The benefit of the study to the respondents would be an affirmative diagnosis for
neurocysticercosis, if present by either serology or CT scan, thus enabling those
afflicted to receive treatment. According to the diagnostic criterion set out in "The
Current Consensus Guidelines for the Treatment of Neurocysticercosis" (Garcia
2002), patients who exhibit cystic lesions showing the scolex of the parasite on a CT
scan or an MRI fit the "absolute" criterion. The presence of cysts in the brain
indicates a definitive diagnosis.
Definitive diagnosis - these are patients who have one absolute criterion or those
who have two major plus one minor and one epidemiologic criterion, or
Probable diagnosis - those patients who have one major plus two minor, those who
have one major plus one minor and one epidemiologic condition, and those patients
who have three minor plus one epidemiologic condition (Del Brutto 2001).
There is no standard regimen for the treatment of neurocysticercosis but the
treatment varies with the type of involvement and the presence of other factors.
Management of neurocysticercosis includes the use of symptomatic medication
(including anticonvulsants), anti-inflammatory drugs, anti-parasitic drugs, or surgery




Figure 5: Treatment Management Guidelines for Cysticercosis
Parenchymal neurocysticercosis
Viable (Live cysts)
One to five cysts Anti-parasitic treatment, with corticosteroids
More than five cysts Anti-parasitic treatment, with corticosteroids
Anti-parasitic treatment, with high-dose corticosteroids.
Alternatively, chronic steroid management No anti-parasitic
treatment, neuro-imaging follow-up
Enhancing lesions (degenerating cysts) *
Mild or moderate No anti-parasitic treatment. Neuroimaging follow-up-
Alternatively anti-parasitic treatment with corticosteroids
and as a second alternative anti-parasitic treatment '
Corticosteroids only if side effects develop
Heavy (cysticercotic encephalitis) No anti-parasitic treatment High dose corticosteroids and
osmotic diuretics
Calcified cysticerci
Any number No anti-parasitic treatment
Extraparenchymal neurocysticercosis
Ventricular cysticercosis Neuroendoscopical removal, when available If not available
then CSF diversion followed by an anti-parasitic treatment
with corticosteroids, and as a second alternative, open
surgery (mainly for cysts in the fourth ventricle)
Subarachnoid cysts including giant cysts Anti-parasitic treatment, with corticosteroids Ventricular
or "racemose" cysts on neuroimaging shunt if there is hydrocephalus
Hydrocephalus with no visible cysts on Ventricular shunt No anti-parasitic treatment
neuroimaging
Other locations
Spinal cysticercosis. intra or extramedullary Primarily surgical. Anecdotal reports of successful use
of albendazole with corticosteroids





16. Expected Benefits to General Population
The expected benefits to the general population will be much more knowledge
gained on porcine cysticercosis, epilepsy and epilepsy acquired from Taenia solium
(NCC). In addition, pig husbandry practices designed to limit the risk of continuing
the cycle of cysticercosis will have been explained to the farmers in the context of
the two-day workshop to be held for District Health personnel and others.
17. Involvement of Research Subjects with Limited Capacity
In the event that a research subject is deemed to have limited capacity, a suitable
guardian will assist in the obtaining of informed consent and all care will be taken to
minimize risks and discomfort to such subjects. The justification for involving a
vulnerable subject would be that they have been shown to have a diagnosis of
epilepsy and that the knowledge that their epilepsy is acquired from exposure to T.
solium and therefore subsequent potential for treatment would outweigh the
discomforts in obtaining the diagnosis.
*
18. Individual Informed Consent
The informed consent for serological sampling for Taenia solium will be requested in
English, Kiswahili or the local language. It will be translated by the enumerators and
the respondent will reiterate the consent in the presence of a witness to confirm
comprehension. The witness, enumerator and respondent patient will sign the form to
confirm the context of the respondent's participation in this study has been
understood by all parties. In the case of a subject to be sampled who is considered a
minor (under 16), a parent or legal guardian will be required to give consent.
Additionally, the minor will be asked for oral consent. In cases in which participants
are illiterate, the form will be read to them and the understanding of its content will
be ensured. The witness will be selected by the patient and will only sign the form -,
when s/he is convinced that the patient has understood the objectives of the study, the
sampling procedure as well as the risks, rights and benefits involved in the study.
All participants involved in the collection of serology and accompanying questions




subsequent Informed Consent Form (CT scan) for those participants who are to
undergo a CT scan (Appendix VI).
19. Information Arising From the Study on Harm, Benefit and
Other Research That Could Affect Participation
All information concerning benefits and risks to participants including that from
other studies will be communicated to the subjects at the time of obtaining informed
consent. It is not anticipated, however, that this issue is pertinent.
20. Plans to Inform Subjects Ultimately About the Results of the
Study
As medical personnel in Busia District are already participating in the serology
collection, CT scans and subsequent follow-up treatment, they will assist in
informing participants of the results of the study.
21. Confidentiality of Personal Data Including Subjects'Privacy
The patients' information is considered confidential and to be used only for purposes
of this study. Patients will be assigned a unique identifying number and information
concerning their status with respect to neurocysticercosis, taeniosis and exposure or
lack of exposure to T. solium will be reported using only this identifier. All
enumerators and technicians are required to sign a confidentiality agreement
(Appendix VII) acknowledging the patients' rights to protect their privacy. There are
no genetic results being sought in this study.
22. Further Uses for Research Materials
While it is not immediately foreseen that the biological samples will be used for
further research, should a possibility arise for using these biological samples to
enhance the control of cysticercosis, further the objectives of the study, or improve
diagnostics, permission has been sought in the Informed Consent for Serology
(Appendix V) The research results pertaining to information sought about risk factors
for exposure to T. solium (Appendix II) may be used in comparison with similar




23. Plans for Statistical Analysis
The study will be analysed using standardized logistical regression techniques
(Woodward 1999), (Dohoo 2003), (Thrusfield 2005) and will suppose that all
assumptions in these techniques remain constant. The statistical power will be
calculated at 80% as the sample size is statistically significant and the data that
previously exists concerning prevalence rates for neurocysticercosis supports the
hypothesis that similar rates will be found in this study. The study will be terminated
if the sample size reaches below 350 tested based on an exposure rate of 3% for
controls, 10% for cases (95% CI and power of 80%).
24. Sponsor Organization
The University of Edinburgh
Centre for Infectious Diseases





The International Livestock Research Institute
PO Box 30709 00100
Nairobi, Kenya
Both of these institutions have a long working history together. The investigators
have been previously cited and their curriculum vitaes included as Appendix I.
25. Source and Funding
The source of the funding for the research:






Assessing the burden of cysticercosis, with relevance to both human health and
livestock production economics, on smallholder communities in western Kenya.
The amount of the award is £20,000. (See Appendix VIII for grant information).
26. Conflict of Interest
There are no conflicts of interest.
27. Adequate Facilities
Biological materials will be stored at the International Livestock Research Institute in
Nairobi, prior to being sent to a laboratory in Belgium for analysis. This laboratory is
housed within the Prince Leopold Institute for Tropical Medicine in Antwerp. The
sera will be analysed using an antigen detecting ELISA which has reported a
t.
sensitivity rate of 85% and a specificity of 92% (Garcia, Parkhouse et al. 2000), A
study done in Vietnam evaluating the Ag ELISA found a very high agreement
between an ELISA for detecting circulating antigen, computerised tomography
scanning and biopsy examination of subcutaneous cysticerci (Erhart 2002). The
analysis of the samples will be performed under the supervision of Professor Pierre
Dorny, Department of Animal Health, Institute of Tropical Medicine in Antwerp,
Belgium. Depending on the results of this diagnostic test, further diagnostic tests
may need to be carried out to better diagnose cysticercosis or taeniasis.
28. Declaration of Helsinki and CIOMS Guidelines •
All principles set out in the Declaration of Helsinki and the Council for International
Organisations of Medical Sciences (CIOMS) International Ethical Guidelines for
Biomedical Research Involving Human Subjects will be strictly adhered to and
implemented.
29. Code for Subjects' Identities
The code for the subjects' identities will be assigned by the principal investigator and
stored separately from the responses to the survey. Individual responses will
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thereafter be referred to by codes alone. The name of the subject and the names of
household members will not be shared with individuals outside the survey
organization and the identifying information linking names to codes will '.be
destroyed once the information is compiled into a computer. The code can be broken
either by the principal investigator or by Professor Sue Welbum, whose contact
details appear in Appendix I in the event of an emergency.
30. Time schedule
Serology data collection will take place in the month of December 2006, the samples
then sent for analysis during January and February of 2007 and the CT scans will
take place at the end of February or the beginning ofMarch 2007. The final write-up
and results of the study will be published by June 2007.
31. Instructions for staff involved in the trial
All enumerators, clinical officers, drivers and others involved in the study will be
asked to sign a confidentiality agreement guaranteeing anonymity for the study
participants (Appendix VII) and will attend a training course prior to serum
collection and analysis.
32. Ethical Issues
The investigators are fully aware of all ethical issues pertaining to this study and
believe that the benefits to the patients obtaining a diagnosis with respect to their
epilepsy and therefore the occasion to treat it, clearly outweighs any of the
anticipated risks. The participants in the study are volunteers who are fully informed -
and will derive no benefit other than an opportunity to improve their health status.
The participants' integrity and rights to privacy have been taken into consideration
and all reasonable care is being taken to ensure confidentiality of data. JTe
participants have all been informed of their right to withdraw from the study at any •
time with no punitive action being taken against them or their families. All care will
be taken to preserve the accuracy of the results of this study and negative as well as
positive results will be published and publicly available.
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33. Rights to Publish v
As the study is being funded by the DFID through University of Edinburgh, this
institute holds the data. The principal investigator owns the results of the study, the
raw data and any analysis of that data can only be done with the express permission
of the principal investigator. This study is a part of the principal investigator's PhD
research and will be published by that individual, although all collaborators who
make a significant contribution to the scientific development of the project will be
given the opportunity to participate in the publication process.
34. Proposed Research Summary
The aim of this proposed research is to determine how many people out of a
population of epileptics in Busia District have epilepsy as a result of exposure to
pork tapeworm (Taenia solium). This will be determined using patients' blood and
testing it to see if there are any parasite antigens present and also by a CT scan which
will scan the brain to see if there are any cysts present. In this way, we will be able to
have an idea of the prevalence of epilepsy caused by the pork tapeworm in Busia
District. In addition, we would like to see if there are any common practices,
conditions or habits in the way that they live and in the way in which they keep pigs
amongst the people who have been exposed to the tapeworm which may be
contributing factors to their exposure. These common practices, conditions or habits
are called risk factors. We will ask the participants in the study a series of questions
about how they manage their pigs, their hygiene practices and other factors that are
of interest.
Once the data about the risk factors has been collected and their status with regard to
exposure to the tapeworm has been established, we will be able to draw conclusions
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Programme Management
My programme management experience is in public health and water and sanitation.
At the African Medical and Research Foundation (AMRBF), I was in charge of the
administrative and financial aspects of grant management for 2 projects in different
areas of Somalia a project in Luuq, Somalia and one in North West Galgaduud,
Somalia, both funded by the European Community Humanitarian Office (ECHO). The
projects involved management of a team of health care workers - physicians, nurses
and auxiliary health personnel, running Primary Health Care (PHC) Centres in these
districts. My responsibilities included developing job descriptions; conducting
training; financial management; report writing, and proposal writing.
*
Financial Management
My consultancy company (KJD Consulting Limited) was contracted to provide financial
management to Maji na Ufanisi (formerly WaterAid UK). My role included financial
management of the institution and its projects. I was responsible for all financial
reporting to the donors, development of budgets and development of financial
reporting and budgeting systems. My tasks also included all proposal writing and
supervision of administrative and technical staff.
Research Experience
My primary area of research has been zoonotic disease, in particular, the human health
impact of Taenia solium neurocysticercosis. The study has involved determining tt)e
burden of this condition using DALYs as well as the livestock economic losses
associated with affected a/vine. Risk factors such as pig husbandry practices, hygiene
and sanitation practices and poverty have been taken into consideration as contributors
to neurocysticercosis-acquired epilepsy. Intervention strategies for prevention of the
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For this period I provided consultancy services to ILRI in the
capacity of the Special Assistant to the Director General. The
position demands managing the Institute Management Committee,
writing research papers, speeches, concept notes, PowerPoint
presentations and other documents as the Director General
requires. It necessitates an in depth knowledge of development
issues and the instruments by which poverty alleviation-can be
achieved. It also entails managing the budgets for the office,
supervising staff and travelling with the Director General as
necessary. In 2002-2003, ILRI underwent an organisational change
and restructuring. During this period I was involved in the
development of various documents, including "Livestock, a
pathway out of poverty - ILRI's strategy to 2010".
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August 2001 - present KJD Consulting Limited
PJ Place, Enterprise Road, Industrial Area, Nairobi, Kenya
Managing Director
KJD Consulting Limited expertise is based largely on experience gained by working in the
Livestock, Public Health and Development arenas over the past 15 years. Consultancy jobs
range from proposal writing, monitoring and evaluation of projects to financial reporting to
donors.
Have started own consultancy business focusing on financial
management, business plan writing for private individuals and
businesses for venture capitalists or other interested investors,
proposal writing for NGOs and Community based organisations,
strategic plan development and use of other business planning tools
for both public and private sector. In addition, consultancies have
been undertaken performing analysis on various development tools
such as Participatory Urban Analysis, Baseline Surveys and other
Monitoring and Evaluation Impact Assessment strategies.
July 1999 - July 2001 Water and Development/Maji na Ufanisi
Chiromo Access Road, Nairobi, Kenya
Finance Administrator
Responsibilities
financial management of institution and its projects (donors
include DFID, SIDA, Oxfam, WaterAid and other smaller
ones)
development of sound financial systems
supervision and development of budgets




donor reports as required
supervision of administrative staff
administration of the Nairobi office
all proposal writing within the organisation
editing and writing of all narrative donor reports
March 1994 - June 1999 African Medical and Research Foundation (AMREF)
Wilson Airport, Nairobi, Kenya
Programme Officer/Project Manager - Somalia Projects
Nomadic Health Unit
Clinical Department
This job required an in-depth knowledge of Public Health and Development issues to be capable
of writing comprehensive proposals for various donors.
Responsibilities
- Co-ordination and financial management of two projects dealing
with Primary Health Care funded by the European Union in Luuq
and NW Galgaduud Districts, Somalia;
- Developing financial systems to ensure accurate knowledge of
project expenditure accruals, projected expenditure and final
expenditure meeting specific conditions from donors.
- Writing project proposals to secure funding including drawing up
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- Preparing financial and narrative reports in compliance
with donor requirements (this involved developing new
accounting procedures as AMREF was not familiar with
EU reporting);
- Writing workshop and seminar proceedings, annual
reports, workplans;
- Corresponding with national offices and donors;
- Assuming financial responsibility for unit funds and .
operation of two project bank accounts;
- Conducting training sessions on Primary Health Care
(PHC) and the development of job descriptions for use
in Somalia;
Acting Programme Co-ordinator when necessary
- Member of the Somalia NGO Consortium and Somalia
Health Co-ordination Group




- Co-ordinating supplies between Nairobi and project site
in Somalia;
- Implementing inventory and stock systems;
- Compiling quarterly expenditure reports for donors .
based on supply acquisition.
January 1993 - August 1993 Research Officer
Women and Development Unit
Community Health Department
Responsibilities
- Assisted in the development of AMREF's gender policy;
- Conducted a survey of health related NGOs to establish
an inventory of NGOs, government departments and
donor agencies dealing with women's health and
development.
1991 - 1992 Canadian Executive Service Organisation (CESO)
Toronto, Canada
Project Administrator (Africa, Asia, Caribbean)
Responsibilities
- Co-ordinating the details of project volunteers' overseas
assignments;
- Liaising with the client in the project country and the
volunteer;
- Contributing editor to the monthly CESO News Bulletin.
Liaison - Women and Development Programme
Responsibilities
- Assisted in the development of the mission statement
and policy objectives of CESO's Women and
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Development (WID) programme;
Member of the Women and Development Steering
Committee;
CONFERENCES AND WORKSHOPS ATTENDED/ORGANIZED
15th - 18th June 2005 Zoonoses: From Science to Policy
Organised by the Health Protection Authority, Liverpool,
UK
- Participated under the auspices of the University of
Edinburgh in a conference which examined translating
policy frameworks and modelling concerning zoonoses
control in a developed country setting
21st - 25th April 1997 Training/Continuing Education Working Group
Workshop: Towards a National Training Programme for
Somalia
Nairobi
- Co-organised and co-facilitated this workshop which
aimed to develop a training plan for Somali health
workers and to ratify job descriptions for different
cadres of Primary Health Care workers
- Developed job descriptions for different cadres of
Primary Health Care service providers
Project Cycle Management: Developing a logical
framework (European Union)
- Development of projects using tools such as
stakeholders' analysis, logical framework, baseline
survey and participatory rural appraisal
UNICEF Somalia Health Strategy Workshop
Nairobi
- Was a member of both Essential Drugs and Training
Curricula development working groups;
- Developed Plan of Action for Training Curricula
development in Somalia
27th June - 2nd July 1994 Workshop to Develop the 1995-1997 Luuq District
Hospital Strategic Plan and Operational Plan
Luuq, Gedo Region, Somalia
- Responsible for organisation of workshop and
production of final workshop document;
March 1996




Training/Continuing Education Workshop Report: Towards a National Training Programme
for Somalia. Downie, Katie and Lucy Wood, April 1997.
Gedo Region Workshop Report. Nomadic Health Unit, April 1994.
Rational Use of Drugs, MCH and OPD Drug Lists and revised reporting formats. UNICEF
Somalia, January 1995.
Luuq District Hospital Strategic and Operational Plans 1995-1997, July 1994
CONSULTANCIES
Japan International Cooperation Agency (JICA)
Nairobi, Kenya
Rapporteur Asia-Africa Knowledge Co-Creation
Program (AAKCP) Rural Development
Sub-Program (RCDS)
Final Seminar
Responsible for producing the Proceedings
for the Asia-Africa Final Seminar
Held at AICAD, Jomo Kenyatta University
of Agriculture and Technology, Juja, Kenya
27th - 29th June 2006
Editing:
Report on the Operationalisation of the
Water Act 2002 in Water Resources
Management, Republic of Kenya,
Ministry of Water and Irrigation in
collaboration with the Water Resource$
Management Authority, October 2005.
Supported by the Swedish International
Development Cooperation Agency (Sida)
Maji na Ufanisi/Water and Development Analysis of Nairobi Slum Programme
Participatory Urban Analyses -August
2001
Maji na Ufanisi/Water and Development Staff Rules and Regulations: An
Operational Manual
ISP Kenya Ltd ISP Kenya Ltd - A Business Proposal - January 2001
ISP Kenya Ltd MailAfrica International - A Business Proposal - January 2001
ISP Kenya Ltd ISP Kenya Ltd and MailAfrica International - Five Year Business Plan ' •
for Strategic Investment - January 2001
Maji na Ufanisi/Water and Development Proposal to Ford Foundation - Nairobi Slum
Programme: Building Democratic
Institutions and Community Assets within





Maji na Ufanisi/Water and Development
Maji na Ufanisi/Water and Development
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Proposal to CORDAID/SIDA - Nairobi Slum
Programme: Developing Water and
Environmental Sanitation Through
Community- Based Organisations - A three-
year proposal - April 2000-March 2003 -
March 2000
Proposal to DFID (Department for
International Development (UK)
Developing ASAL Water Through Local
Organisations - A three year proposal
April 2000-March 2003 - April 2000
SIDA Quarterly Report - Capacity building of community-based organisations to improve
the management of access to safe water and sanitation in Nairobi
slums. Maji na Ufanisi (Water and Development Kenya).March
1999.
Developing Arid and Semi-Arid Lands' Access to Water Through Local Organizations.
Proposal for funding for Maji na Ufanisi (WaterAid Kenya) to the European
Union. January 1999.
Rapporteur Health and Nutrition Workshop - Rational Use of Drugs, MCH and OPD Drug
Lists and Revised Reporting Formats. UNICEF Somalia, 18-22 November
1994.
- Responsible for production of minutes and draft document.
ASSISTED IN THE PREPARATION OF
Building Technical Capacity and Gender Advocacy in Young Professional African Women.
Conference Proceedings, ICIPE Science Press, Nairobi, July 1993.
Luuq District Hospital Master Plan 1995-1997 and Operational Plan 1995. Nomadic Health
Unit, July 1994.
Tangulbei Division Health and Health Care Inventory and Feasibility Study, Oyaya,
Charles, Heering, N. J., Begley, Fr. Michael G., King, Basil, February 1994.
OTHER SKILLS
Languages English - fluent spoken and written
German - medium proficiency spoken
spoken
French - fluent spoken
Swahili - medium proficiency










Professor of Medical and Veterinary Molecular Epidemiology
Centre for Infectious Diseases ,






1988-1991 PhD, Faculty of Medicine, University of Bristol
1980-1984 BSc, University of the West of England, Bristol
Degrees awarded
1991 PhD, Faculty of Medicine, University of Bristol
' The Rickettsia-like organisms ofG/ossina ssp.'
1984 BSc Applied Biological Science, Class 2.1 Flons.
Career since graduation
2006 - Professor of Medical and Veterinary Molecular Epidemiology, Centre of
Infectious Diseases, Royal (Dick) School of Veterinary Studies, College of
Medicine and Veterinary Medicine,
2002 - 2006 Reader, Centre of Infectious Diseases, Royal (Dick) School of Veterinary
Studies, College of Medicine and Veterinary Medicine, The University of
Edinburgh.
1999 - 2002 Senior Research Fellow (Research Grade AR3), Centre for Tropical
Veterinary Medicine, Division of Tropical Animal Health, Royal (Dick) School
of Veterinary Studies, The University of Edinburgh.
1998 - 1999 Visiting Scientist, International Livestock Research Institute, Nairobi, Kenya.
1996 - 2000 Wellcome Trust Career Development Fellow, Centre for Tropical Veterinary
Medicine, Royal (Dick) School of Veterinary Studies, The University of
Edinburgh, Easter Bush, Roslin, UK & previously Division of Molecular
Genetics, University of Glasgow, Anderson College, 56 Dumbarton Road,
Glasgow Gil 6NU.
1991 - 1996 Post-Doctoral Research Assistant, Tsetse Research Group, School of
Veterinary Science, University of Bristol, Langford, Bristol.
1986 - 1991 Research Assistant, Tsetse Research Group, School of Veterinary Science,
University of Bristol, Langford, Bristol.
1984 - 1986 Research Associate, Tsetse Research Group, School of Veterinary Science,
University of Bristol, Langford, Bristol.
Major research interests
My research interests have focused on understanding the interactions between parasites and
their vectors and hosts that lead to transmission of human disease. Studies follow four lines
of research, epidemiology of human sleeping sickness, zoonotic infectious disease (sleeping
sickness, rabies, cysticercosis, brucellosis and bovine TB) and transgenic insect control. This
involves a dissection of the mechanisms of innate resistance of vectors to parasite infections
and the complex interactions between host, vector and parasite that result in parasite
differentiation and disease transmission. Research has resulted in over 100 peer reviewed
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publications to date including 7 book chapters, 18 peer refereed reviews and original peer
reviewed papers.
Principal research grants awarded
Title of project
Using e-learning to build capacity for in-country
delivery of medical and healthcare professional
education in Malawi (Co-PI)
E-learning networks for Asia and Africa
(With Prof Pfeiffer, Dr Eisler)
Roll back sleeping sickness campaign phase I (PI
with Dr Eisler).
Assessment of overlap between T.b.rhodesiene
and T.b.gambiense sleeping sickness in Uganda
(PI)
Assessment of optimal channels of
communication for effective message delivery on
nagana and human sleeping sickness in Uganda
(PI).
Enabling e-distance learning in International
Animal Heath (PI with Dr Eisler)
University Shared scholarship scheme (MSc) -
Miss Pratij Raj
Development of Masters programme in
International Animal Health (Co-PI)
Methods for control of zoonotic Sleeping sickness
in SE Uganda. (PI)
Domestic animals as reservoirs of T. b.
gambiense in S. Sudan (Co-PI)
Cistercercosis and human health in W. Kenya.
(Co-PI)
Pigs as a reservoir for human sleeping sickness
(Co-PI)
MRC studentship - Harriet Auty
Refining and extending DALY calculations for
sleeping sickness. (PI)
Impact assessment of FITCA intervention trials in
SE Uganda (PI)
University Shared scholarship scheme (MSc) -
Miss Gudeep Lall
Decision support system for the control of
Sleeping sickness in SE Uganda. (PI)
Symbiosis - Infection without disease.
Sleeping sickness surveillance W. Nile (PI)



































































Development of a novel technique for
differentiating Trypanosoma bruceiparasites (PI)
The Impact of Control Products on Insect
Populations: A Mathematical Approach
Gin-Model1) (Co-PI)
Development and incorporation of
Bacteriophages as pest control agents (Co-PI)
Variant surface glycoproteins expressed by
Trypansoma brucei in endemic areas (Co-PI)
Bacteriophage - next generation insecticides (PI)
Decision support system for the control of
Sleeping sickness in SE Uganda (PI)
Isolation and characterization of genes encoding
secretory proteins of the ixodid tick (Co-PI)
Molecular analysis of programmed cell death and
differentiation in T. b. rhodesiense (Fellowship -
4 year Career Development Award)
DNA sequencer University of Glasgow - Research
Equipment Initiative
The role of lectins in the transmission of






SMART Scotland 2002-2003 78,272




Leverhulme Trust 2000-2003 97,165
Wellcome Trust 1996-2000 255,000
Wellcome Trust/ 1997 97,010
MRC
Wellcome Trust 1991-1995 140,271
3,246,800
Research status:
My research was included as International. I have published over 90 primary research
papers, the most significant for RAE being three publications in the Lancet and one in
The British Medical Journal on the molecular epidemiology of sleeping sickness
and role of domestic livestock in sleeping sickness epidemiology and one in PNAS
on molecular evolution of pathogenesis in symbionts. I have also had eleven peer •
reviewed review articles published in the past 5 years including 6 in Trends Journals and
1 in Lancet Infectious Diseases. I have been successful in the acquisition of over
2,578,519 million pounds of research funding since 2001.
Research supervision experience:
Postdoctoral training -I have mentored seven post doctoral staff members: Dr Colin Dale
(now working US); Dr Kevin Arnold (now working US); Dr Alistair Darby (now working in
Sweden); Dr Aimee Tilley; Dr Eric Fevre; Dr Simon Young; Dr Euan Macloed, Dr Kim Picozzi.
Postgraduate Research training -16 completed PhD and 2 completed MSc students.
Colin Dale (1997). The secondary (S) Symbionts ofG/ossina. PhD University of Liverpool -
2nd supervisor.
Simon Lillico (1999). Characterisation ofgenes identified during a RADES-PCR screen of
concanavaiin A - treatedprocyciic Trypanosoma brucei rhodesiense. PhD University
of Glasgow - Principal supervisor.
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Simon Young (2002). Genetic features ofSodaIis g/ossinidus - a symbiont bacterium of
tsetse flies'. PhD University of Glasgow - Principal supervisor.
Eric Fevre (2002). The epidemiology of trypanosomiasis, a re-emerging zoonosis in
Uganda'. PhD University of Edinburgh - 2nd supervisor.
Martin Odiit (2003). Epidemiology of Trypanosoma brucei rhodesiense sleeping sickness in
Eastern Uganda. PhD University of Edinburgh - 2nd supervisor
Magai Kaare (2004). Sleeping sickness in the Serengeti ecosystem/ MSc Sokoine
University, Tanzania - 2nd supervisor
Karine Delroux (2004). Cloning ofgenes expressed in the salivaryglands during feeding of
the tickAmbiyoma variegatum. - PhD University of Edinburgh - 2nd supervisor
Noreen Machila (2005). Improved targeting and appropriate use of trypanocidal drugs for
the control ofAfrican bovine trypanosomiasis in tsetse endemic areas ofwestern
and coastal Kenya within the context ofprimary veterinary care. PhD University of
Edinburgh - Principal supervisor.
Christine Thuranira (2005). Socio economic factors influencing livestock keeping dynamics
on a smallholder crop-livestock system in Western Kenya. PhD University of
Edinburgh - Principal supervisor.
Gurdeep Lall (2005). Development ofamplified fragment length polymorphism (AFLP)
marker analysis for the study ofG/ossina paiiidipes population genetics'. MSc
University of Edinburgh - Principal supervisor.
Ewan Macloed (2005). Factors affecting transmission of trypanosomes through tsetse flies
PhD University of Edinburgh - Principal supervisor.
Hachemi Zerria (2006) Molecular analysis of insect stage Trypanosoma brucei. . PhD -.
University of Edinburgh - Principal Supervisor.
Francis McOdimba (2006) Competition between T. brucei in domestic livestock in S.E
Uganda'. - PhD University of Edinburgh - 2nd supervisor.
Olga Tosas (2002-2005). Tick borne disease interactions in cattle in EastAfrica. University
of Edinburgh - 2nd supervisor
Andrew Cox (2003- 2006) Development ofmolecular tools for the diagnosis of
trypanosomiasis'\Jnwers\ty of Edinburgh - Principal supervisor.
Caroline Mathews (2003-2006). The mechanisms ofSodaUs g/ossinidius symbiosis in
tsetse died University of Edinburgh - Principal supervisor.
Magai Kaare (2003-2006). Assessment of wild animals in cycle ofrabies transmission in .
the Serengeti. University of Edinburgh - 2nd supervisor
Tziana Lembo (2003-2006) Genetic diversity ofcirculating Rabies strains in Tanzania.
University of Edinburgh - 2nd supervisor.
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Ongoing postgraduate supervision -Involvement in postgraduate training ofsixteen
registeredpostgraduate students at the University ofEdinburgh (including nine veterinarians
and one medic) '
%
Beatrix Wisseman (2003- 2006). Zoonotic disease transmission in sleeping sickness foci in
EastAfrica. University of Edinburgh - Principal supervisor
Jenna Fyfe (2003- 2006). Interventions for control ofhuman sleeping sickness. University
of Edinburgh - Principal supervisor.
Andrew Brownlow (2003-2006). Restricted application of insecticides on cattle and
impact on animal health. University of Edinburgh - 2nd supervisor
Neil Anderson (2004-2007) Wildlife as reservoir ofhuman and animal trypanosomiasis
Luangwa Valley, Zambia. University of Edinburgh - Principal supervisor.
Joseph Mubanga (2004 - 2007). Trypanosomiasis and animal health in Zambia. University
of Edinburgh - 2nd supervisor.
Kohei Makita (2004 - 2007). Peri-urban livestock, human and animal disease transmission.
University of Edinburgh - Prinicipal supervisor.
Harriey Auty (2004-2007). Reservoirs ofhuman steeping sickness in Serengeti wild life.
University of Edinburgh - Principal supervisor
Lucas Matamba (2004-2007). Human Health andsleeping sickness in Tanzania.
University of Edinburgh - Principal supervisor
Katie Downie (2004-2007). Cysticercosis pig keeping and impact on human health.
University of Edinburgh - Principal supervisor
Heba Ahmed (2005 - 2008). Competition between T. brucei subspecies and impact on
epidemiology of trypanosomiasis in EastAfrica. University of Edinburgh - Principal
supervisor
Raj Prashanti (2006-2007). MSc. Insects as environmental sensing tools. Principal
supervisor
•» .
Ceasar Lubaba (2006-2009). Mixed infection disease modelling in East African cattle - 2nd
supervisor
Wandee Kongkaew (2006-2009). Risk analysis for Avian Influenza in Thailand - 2nd
supervisor.
Ayo O Majekodunmi (2006- 2009). Sleeping sickness and animal trypanosomiasis in •
Nigeria Principal supervisor





As a Professor in the Centre for Infectious Diseases I teach on our Tropical Animal Health
Elective to final year students. This involves lectures on aspects of Tropical Zoonotic
Medicine, principally zoonotic and infectious diseases. I supervise 2 honours students per
year for the Medical Microbiology Honours course. I also offer a short course option on
trypanosomatid diseases of animals and humans for the Medical Microbiology course. I also
participate in the Medical Microbiology seminar series for Final Year students. Chair
examining boards for distance learning Masters Programme in International Animal Health
and Infectious Diseases (3 year e-distance learning master's course). Awarded GBP 130,000
in scholarship and training e-tutors in Makerere Vet School. Learning materials developed
for this course will feed into our Tropical Animal Health and other electives for the Vet
Students and add to the Medical Microbiology programme. I run various Transferable
(Transkills) option courses for postgraduate students on report writing and thesis
preparation and participate in Wellcome sessions for new postgraduate students.
Administration
2000 - GMSO representative Easter Bush Vet Site
2004 - Biological safety officer Easter Bush Site.
2002 - Company Director In-Phage - University of Edinburgh spin-out
2000 - 2004 Treasurer British Society for Parasitology
2001- Postgraduate representative for Animal Health and Welfare -
divisional representative for all student progress assessments.
Membership of societies where academic distinction is the criterion of
membership
2006 - Council, British Society of Parasitology
2005 - Member steering committee of AUVEC
2000-2004 Treasurer British Society for Parasitology
1991 - Member British Society of Parasitology
Membership of committees relevant to research
2005 - Management committee Royal Zoological Society Edinburgh for Research
and Conservation activities of Budongo Forest, Uganda
2005 - Organizer British Society Parasitology Autumn Symposium, Linnean Society,
London.
2005 - Member, Steering Committee Distance Learning Initiative, University of
Edinburgh
2004 - Member, Organizing committee 31st Trypanosomiasis and Leishmaniasis
Seminar •
2002 - Meeting organizer 30th Trypanosomiasis and Leishmaniasis Seminar
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2002 - Member, Research and Postgraduate Committee.
2002 - Divisional Postgraduate representative, AHW.
2001 - 2004 Treasurer British Society for Parasitology
1999 - Member, Veterinary Faculty Post Graduate Committee
1999 - Member, Research Committee, Equipment Committee
International ScientificMeetings organized:
2005 - Programmed Cell Death and the Protozoan Parasite, Autumn Symposium, British
Society of Parasitology and the Linean Society London (Organizer)
2005 - Capacity building for the African animal health sector: addressing the need for
new learning opportunities. ICPTV/DFID, Naivasha, Kenya (Organizing
Committee)
2004 - 31st Trypanosomiasis and Leishmaniasis Symposium, British Society of
Parasitology,
Ceske Budovice. Czech Republic (Organizing committee)
2002 - 30th Trypanosomiasis and Leishmaniasis Symposium, British Society of
Parasitology, Edinburgh (Meeting organizer)
Reviewer for the following journals. Nature Genetics, British Medical Journal, FEMS
Microbiology Letters; Microbiology, Trends in Microbiology, Trends in Parasitology, Trends in
Microbiology, Acta Tropica, Parasitology, Experimental Parasitology. PLOS Medicine
Reviewer for the following grant awarding bodies. Wellcome Trust, BBSRC, MRC, and
National Institutes of Health, EU.
Items of esteem at International symposia and congresses.
2005 Invited Speaker. Cell death and differentiation - Death and Differentiation of
trypanosome infections in tsetse - Cell Death and the Protozoan Parasite. November
2005. The Linnean Society, London.
2005 Invited Speaker. Control of Zoonotic Disease - a route to poverty alleviation .World
Health Organization, 20 -21 September, 2005, Geneva, Switzerland.
2004 Invited speaker. Fitness costs associated with resistance to human serum in
Trypanosoma brucei rhodesiense. theoretical predictions and field data. 31st
Trypanosomiasis and Leishmaniasis Symposium, Cezske Budowize, Czech Republic.
2003 Invited Speaker. Control of sleeping sickness in domestic and world animal
reservoirs. World Parks Congress, ICUN, September 2003, Durban, South Africa.
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2003 Invited Speaker. Molecular methods for epidemiology of human sleeping sickness.
ICPTV, Nairobi, Kenya
2003 Invited talk. Soda/is g/ossinidiustsetse friend or human foe? IV international
Congress on symbiosis, International Symbiosis Society, Halifax. Canada.
2003 Speaker. Livestock demography and the risk and the risk of spreading T. b.
rhodesisens'm Uganda - implications for policy. ICPTV, Nairobi, Kenya
2002 Speaker. SRA as a marker for human infectivity in the domestic and wild-animal,
reservoir in East Africa. 30th Trypanosomiasis and Leishmaniasis Symposium, .
Edinburgh.
2002 Invited Speaker. Sleeping sickness - human health problem, animal health solution.
Infectious Diseases Symposium, The Royal Society, Edinburgh.
2002 Invited Speaker - Soda/is gtossinidius - Tsetse friend or human foe? Vllth European
Congress of Entomology. Thessaloniki, Greece.
1998 Invited Speaker. Death and the single trypanosome, International Colloquium -
Sleeping Sickness Rediscovered, Institute of Tropical Medicine, Antwerp, Belgium.
1998 Speaker. Programmed Cell death in procyclic T. b. rhodesiense. 29th
Trypanosomiasis and Leishmaniasis Symposium, Arachon, France.
1998 Programmed Cell Death in T. b. rhodesiense. 1998 2nd International Internet
Conference
1997 Invited Speaker. Life and Death of Trypanosome brucei rhodesiense. XIII Meeting
Brazilian Society of Protozoology, Brazil.
1997 Programmed cell death in T. b. rhodesiense is associated with up regulation of
mRNAs. Apoptosis and Programmed Cell Death, Keystone Symposia Conferences,
U.S.A.
1996 Control of maturation in tsetse. Conference of Entomology, Florence.
1995 Regulation of trypanosome infections in tsetse. British Society of Parasitology,
Edinburgh.
1995 Control of infections in tsetse. 28th Trypanosomiasis and Leishmaniasis Seminar._
Glasgow
1994 Differential transmission of human infective and non-infective trypanosome stocks,
from Uganda. XXIIISCTRC Meeting, Kampala, Uganda.
1993 PCR Identification of Rickettsia-like symbionts in tsetse flies, 27th Trypanosomiasis
and Leishmaniasis Seminar, London.
1993 Molecular epidemiology of Trypanosoma brucei stocks from Uganda: evidence for a




1993 Genetic transformation of non-Drosophilid insects: 'Transformation of insect
symbionts', Second International Symposium on Insect Molecular Science, Flagstaff,
Arizona, USA.
1992 Inheritance of refractoriness of trypanosome infection in tsetse. Proceedings
International Symposium on management of insect pests. IAEA-SM-327/21 195-200.
IAEA, Vienna, Austria.
1991 Lectin mediated stimulation of maturation of trypanosome infections in Giossina.'
20th Meeting of the International Scientific Council for Trypanosomiasis Research
and Control, Mombassa, 1989, OAU/STRC, Nairobi, Kenya.
1990 The role of cattle in the epidemiology of sleeping sickness in Uganda. VII
International Congress of Parasitology, Paris, France.
1990 Lectins, differentiation and the control of parasite maturation by signals from the
tsetse fly. VII International Congress of Parasitology, Paris, France.
Appointments as external examiner for the award of doctoral degree
University of Salford PhD Aimee Tilley 2003 (Examiner); Brunei University PhD Francis
Odongo 2004 (Examiner); University of Makerere, Uganda. Charles Waiswa, 2002
(Appointment to Supervisor role); University of Sokoine, Tanzania. Magai Kaare 2004
(Appointment to Supervisor role). Zachara 2006, Makerere University (Appointment to
supervisor role)
Articles in Popular Scientific Press & Radio and TV Interviews
• New Scientist - Jan 1988 - Sugar pills for tsetse flies.
• New Scientist - Feb 1995 - Cell death in parasitic protozoa.
• Science - 30 July 1993 - Bacteria may provide access to the tsetse fly.
• Science Now - Feb 1996 - Programmed Cell Death in unicellular organisms
• BBC WorldService - Feb 1996 - Programmed Cell Death in unicellular organisms
• CNN - Feb 1996 - Programmed Cell Death in Unicellular organisms
• NewAgriculturalist - January 2001 - Human sleeping sickness Waking up to reality
http:ll\mrw. new-aari.co.uk/01-1/focuson/focuson4.html
• BBCRadio 4 - August 2001 -Interview for Parasite series.
• BBC1 Parasite series - December 2003 - Featured research on human sleeping
sickness.




• NewAgriculturalist - November 2005 - Education and training for the African animal
health sector http://www.new-aqri.co.uk/05-6/pov.html
• SciDev- December 2005 - Double parasite threat of sleeping sickness in Uganda
http://www.scidev.net/News/index.cfm?fuseaction=readNews&.itemid=25078
• ID21 - December 2005 - Uganda faces double threat from sleeping sickness
http://www.id21.org/health/h4kplql.html
• SciDev- March 2006 - Africa's vets to gain from web-based training
http://www.scidev.net/News/index.cfm?fuseaction=readNews&itemid=2726
• NewAgriculturalist - July 2006 - The need to control sleeping sickness
http://www.new-aqri.co.uk/06-4/perspect.html
• Research for Development - 2006 - Sleeping sickness: waking up to reality?
www.research4development.info/caseStudies.asp?ArticlelD=189
• Picozzi, K., McOdimba, F., Tilley, A., Fevre, E., Coleman, P., Magona, J., Odiit, M.,
Eisler, M.C. and Welburn, S. (2003). Diagnosis of Trypanosoma brucei infections
in cattle: applications of novel technologies for estimating disease risk. ICPTV
Newsletter, 8, 24-25.
• Magona, J., Anderson, I., Olaho-Mukani, W., Jonsson, N., Revie, C. and Eisler,
M.C. (2003). Diagnosis of endemic diseases in village cattle herds in southeast
Uganda: a low technology decision support system. ICPTV Newsletter, 8, 43-46.
• Fevre, E., Magona, J., Coleman, P., Woolhouse, M. and Welburn, S. (2003).
Livestock demography and the risk of spreading T. brucei rhodesiense in Uganda:
implications for policy. ICPTV Newsletter, 8, 21-22.
• Machila, N., Thuranira, C., Eisler, M.C., Maudlin, I., Shaw, A. and Welburn, S.
(2003). Seasonal and socio-economic effects on animal healthcare practices of
smallholder farmers in tsetse endemic areas of western and coastal Kenya. ICPTV
Newsletter, 8, 47-49.
PUBLICATIONS
a) Books/ book chapters published (7)
Darby A. and S.C. Welburn (2006) Symbiont Culture. In. Insect Symbiosis, Volume II, Eds.
Kostas Bourtzis and Tom Miller CRC Press. In press
Welburn, S.C., Picozzi, K., Kaare, M., Fevre, E.M., Coleman, P.G and T. Mlengeya (2005J.
Control Options for Human Sleeping Sickness in Relation to the Animal Reservoir of Disease.
In Conservation and Development Interventions at the Wildlife/Livestock Interface:
Implications for Wildlife, Livestock and Human Health. Eds. Osofsky, S. A., Cleaveland, S.;
Karesh, W. B., Kock, M. D., Nyhus, P. J., Starr, L., and A. Yang. IUCN, Gland, Switzerland
and Cambridge, UK. 220 pp.
Appendices 210
-64-
Dale, C, Aksoy, S., Welburn, SC Maudlin I and A Oren (2005) Ge/7£/sSodalis Dale and
Maudlin 1999, 26/p. In Volume 2 Bergey's Manual of Systematic Bacteriology, The
Proteobacteria. 2nd Edition. Eds. George M. Garrity, Editor-in-Chief. Springer, New York
ISBN 0-387-95040-0
Welburn, S.C., Fevre, EM, Coleman, PG and I Maudlin I (2004). The epidemiology of human
sleeping sickness in Uganda. In The Trypanosomiases'. Eds. Maudlin, I., Holmes, P and M.
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GRANTS:
Awarded Conference venue at Rockefeller Foundation's International Conference Center
in Bellagio, Italy for 3 day conference on "Implementing a Global Campaign for
Combating Cysticercosis" which includes use of the conference facilities, meals,
accommodation and international travel for participants coming from developing
countries (September, 2006).
$1.4 million from DANIDA for "Cross-Disciplinary Risk Assessment of Taenia solium
Cysticercosis in Eastern and Southern Africa" (2006-2009).
Awarded Conference venue at Rockefeller Foundation's International Conference Center
in Bellagio, Italy for 3 day conference on "Establishing a Global Campaign for
Combating Cysticercosis" which included use of the conference facilities, meals,
accommodation and international travel for participants coming from developing
countries (September, 2004).
$50,000 from the Izumi Foundation for "Establishing a Surveillance and Diagnosis
Framework for Cysticercosis in Eastern and Southern Africa" (2004-2005).
$130,000 from Danida supported Agricultural Research fund in Mozambique for the
project "Improving Smallholder Pig Production and Health" (2004 - 2005).
$30,000 from Danida for formulating a project proposal on "Improving Smallholder Pig
Production and Health in Eastern and Southern Africa" (2003 - 2004).
$15,000 from WHO Headquarters for "Assessing the Global Burden and Impact of
Taenia solium Cysticercosis" (2003-2004).
$200,000 from Danida-funded Institutes and Projects, World Bank, WHO, FAO,
Wellcome Trust, National Research Foundation of South Africa, Stiftelsen Adiutor
Foundation, and Virbac Pharmaceutical Company for "International Action Planning
Workshop on Taenia solium Cysticercosis/Taeniosis with Special Focus on Eastern and
Southern Africa" held in Arusha, Tanzania from 19 - 22 August, 2002.
$1.1 million from DANIDA for ENRECA Livestock Helminths Research Project in
Eastern & Southern Africa (4th Phase, 2001-2004).
$1.6 million from U. S. National Institutes of Health for "Ecology and Transmission of




Invited Speaker and Session Chair, 5th European Congress on Tropical Medicine and
International Health, Amsterdam, Netherlands, May, 2007.
Invited Participant, International Conference on Neglected Infectious Diseases "How to
meet the challenge for Europe's international research cooperation in the field of
Neglected Infectious Diseases" in Brussels, Belgium, November, 2006
Invited Consultant to the "WHO Consultation on Formulating Strategy for Assessing the
Burden of Food Borned Diseases" in Geneva, Switzerland, September, 2006.
Invited Expert to the "WHO/DFID-AHP Meeting on the Control of Zoonotic Diseases:
A Route to Poverty Alleviation" at WHO Headquarters in Geneva, Switzerland,
September, 2005.
Photograph "Female farmer in Mbulu District, Tanzania with pigs" placed on cover of
international journal Trends in Parasitology, July 2005 issue.
Invited Consultant to the "WHO/FAO/OIE Expert and Technical Consultations on
Strengthening Regional Capacity for Surveillance and Control of Zoonoses" in Rome,
Italy, June, 2005.
Invited Expert to the "WHO/FAO/OIE Consultation on Emerging Zoonoses" in Geneva,
Switzerland, May, 2004. Appointed Rapporteur for the Consultation.
Invited symposium organizer ("Livestock Helminthoses of Public Health Significance")
for the International Congress ofZoology in Beijing, China, 23 - 27 August, 2004.
Invited Scientific Committee Member and Symposium co-organizer ("Cysticercosis in
Asia and Africa") for the Food-Borne Parasitic Zoonoses meeting in Bangkok, Thailand,
December, 2003.
♦'
Invited Expert to the "FAO Expert Consultation on Community-based Veterinary Public
Health" in Rome, Italy, October, 2003. Appointed Secretary for the Expert Consultation.
Invited symposium organizer for symposium on "Assessing the Burden of Taenia solium
Cysticercosis and Echinococcosis" at the Conference of the World Association for'the
Advancement ofVeterinary Parasitology, New Orleans, Louisiana, USA, August, 2003.
Invited speaker to the International Task Force for Disease Eradication Meeting to speak
on the status of Taenia solium cysticercosis, Carter Center, Atlanta, Georgia, USA, 16
April, 2003.
Invited speaker to the Centenary Symposium to Celebrate the Discovery of Schistosoma
japonicum, Kurume, Japan, 31 March, 2003.
Appointed advisor for WHO-funded initiative on the assessment of the burden and
impact of Taenia solium cysticercosis around the world, 2003 - 2004.
Invited to serve as section editor for WHO/FAO/OIE Manual on Taeniosis and




Invited Keynote Speaker to European Tropical Medicine to speak on "Initiation cff a
Regional Programme for Surveillance, Prevention and Control of Taenia solium
Cysticercosis/Taeniosis in Eastern & Southern Africa", Lisbon, Portugal, 9-12
September, 2002
Chief organizer "International Action Planning Workshop on Taenia solium
Cysticercosis/Taeniosis with Special Focus on Eastern & Southern Africa" held in
Arusha, Tanzania from 19-22 August, 2002
Serving as coordinator for "Research on Animal Reservoir Hosts" component' for
Strengthening Regional Network of Asian Schistosomiasis project funded by
WHO/TDR
Invited speaker for Workshop on "Cysticercosis", International Tropical Medicine
Congress, Lisbon, Portugal, September, 2002
Invited speaker for Symposium on "Water & Food-borne Parasitic Zoonoses",
International Congress of Parasitology (ICOPA), August, 2002
Invited as consultant for Danida-funded Wastewater Reuse Project in Vietnam to assist
Vietnamese scientists formulate a review of cysticercosis in Vietnam, January, 2002
Served as Organizer and Moderator for WHO/FAO/UNEP Panel of Experts on
Environmental Management of Vectors workshop on "Environmental modification and
livestock management for control of zoonotic schistosomiasis in the Philippines",
November, 2001.
Invited as an author for DIFID-funded document on "Livestock Health Research
Opportunities for Poverty Alleviation" for the section devoted to meat-borne and other
parasitic zoonoses.
Appointed as Deputy Director of new WHO/FAO Collaborating Centre for Research and
Training on Emerging and Other Parasitic Zoonoses, April, 2001.
Invited to attend National Experts meeting in China on reviewing and evaluating a draft
plan for a new national survey on the current status of important parasitoses (other than
malaria, schistosomiasis and filariasis) with emphasis on geohelminths and parasitic
zoonoses organized by the Chinese Ministry of Health, Beijing, People's Republic of
China, 2001.
Awarded a grant from the Department ofMicrobiology, Royal Veterinary & Agricultural
University to participate in the 3rd Conference on Food-Borne Parasitic Zoonoses held in
Bangkok, Thailand and then go to Kathmandu, Nepal to do a situation analysis >yith
regard to porcine cysticercosis and assist in formulating a proposal for epidemiological
studies on the zoonosis in a rural smallholder farming community where pig keeping is
popular, Kathmandu, Nepal, 2000.
Invited to attend an experts meeting on parasitic zoonoses in underdeveloped western
China, Chengdu, Sichuan Province, People's Republic of China, 2000.
Invited as a Visiting Professor to the Sichuan Institute of Parasitic Diseases, Chengdu,
Sichuan Province, People's Republic ofChina, 1999.
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Appointed to the Cysticercosis Working Group of the European Commission's Scientific
Committee on Veterinary Measures relating to Public Health, 1999.
Invited to serve as a Session Chairman at the Scandinavian Symposium for Parasitology,
Reykjavik, Iceland, 1999.
Invited to serve as Co-Chairman of a session on parasitic zoonoses, 17th International
Conference of the World Association for the Advancement of Veterinary Parasitology,
Copenhagen, Denmark, 1999.
Invited to participate as a veterinary consultant at the World Health Organization's
Informal Consultation on Schistosomiasis Control at WHO Headquarters, Geneva,
Switzerland, 1998.
Appointed veterinary advisor to the People's Republic of China/Republic of the
Philippines Regional Networking Group on Schistosomiasis, 1998.
Selected as an alternate candidate for U. S. Centers for Disease Control and Prevention
Epidemic Intelligence Service (EIS) Program, 1997.
Awarded AAVP Outstanding Graduate Student Award by the American Association of
Veterinary Parasitologists, 1996.
Awarded Samuel F. Scheidy Memorial Award by the American Veterinary Medical
Foundation for Excellence in Quality of Veterinary Medical Research Reported at the
World Veterinary Congress, 1995.
LANGUAGES:
English: mother tongue
Danish: Read - good; Write - fair; Speak - fair
Spanish: Read - fair; Write - slight; Speak - slight
French: Read - fair, Write - slight: Speak - slight
Arabic (Moroccan dialect): Read - slight; Write - slight; Speak - slight
PROFESSIONAL AFFILIATIONS /MEMBERSHIPS:
American Veterinary Medical Association
Omega Tau Sigma Veterinary Fraternity
Danish Society of Parasitologists
Scandinavian Society of Parasitology
American Society of Parasitologists
American Association ofVeterinary Parasitologists
American Society of Tropical Medicine & Hygiene
World Association for Advancement of Veterinary Parasitology
Advisor, Regional Network for Asian Schistosomiasis
Advisor, Cysticercosis Working Group in Eastern and Southern Africa
Friends ofMorocco




Prof. Stig Thamsborg, Director Danish Centre for Experimental Parasitology & Head
WHO/FAO Collaborating Centre for Research & Training on Parasitic Zoonoses, Royal
Veterinary & Agricultural University, Frederiksberg, Denmark (tel: +45 35282775; fax: +45
35282774; e-mail: smt@kvl.dk)
Dr. Peter Schantz, Veterinary Director Parasitic Diseases Division, National Center for
Infectious Diseases, U. S. Centers for Disease Control & Prevention, 4770 Buford Hwy NE,
Atlanta, Georgia, USA 30341 (tel: +1 770 488 7767; fax: +1 770 488 7761; e-mail:
pmsl@cdc.gov)
Dr. Niels 0rnbjerg Christensen, Director, DBL - Institute for Health Research and
Development, Jaegersborg Alle 1 D, 2920 Charlottenlund, Denmark (tel: +45 77337733; fax:
+45 77337732; e-mail: nornbjerg@dblnet.dk)
Dr. Lorenzo Savioli, Director, Department of Control ofNeglected Tropical Diseases
(NTD), Division of Communicable Diseases Control, Prevention and Eradication, World
Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 79
12664/14729; fax: +41 22 79 14869; e-mail: saviolil@who.int)
Dr. Carlos Eddi, Senior Officer Parasitology, Animal Health Service, Animal Production and
Health Division, Food and Agriculture Organization, Room C-528, Viale delle Terme di




Prof. Erastus Olonde Amayo
Curriculum vitae as at October 2006
PERSONAL DATA
Name: Prof. Erastus Olonde Amayo M.B, Ch. B,M. Med (Internal Medicine)
Certificate in Medical Anthropology
Nationality: Kenyan
Date of Birth: 14th November 1957
Age: 48 years
Marital Status ; Married with 3 children
Qualifications
Mb.ChB, M. Med(Internal Medicine), Certificate in Tropical Medicine, Certificate in
Health and Behavior Research ( Harvard)
UNIVERSITY EDUCATION
1999 March- May Harvard Medical School Fellowship in Medical Anthropology,
Department of Social Medicine USA
1996-1997 Harvard Medical School Fellowship in Medical Anthropology ,
1992-1993 University of Edinburgh Fellowship in Clinical Neurology at the,
Western General Hospital Scotland U.K
1985-1988 University ofNairobi Masters in Medicine (Internal Medicine)
1977- 1983 University ofNairobi, qualified with a Mb, Ch.B degree .
ACADEMIC CERTIFICATES
1997 Certificate In Health and Behavior Research, Harvard Medical School
U.S.A
1988: Masters ofMedicine( Internal Medicine) University ofNairobi
1983: Bachelor of Medicine , Bachelor of Surgery . University ofNairobi
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1976: East African Advanced Certificate ofEducation "A" levels passed with
3 principles and one subsidiary
1974: East African Certificate of Education"0" level certificate with 1st Division
1970: Certificate of Primary Education Passed
CURRENT APPOINTMENT
Associate Professor - Department of Clinical Medicine and Therapeutics
Honorary Consultant Physician and Neurologist Kenyatta National Hospital
Thematic head Clinical Medicine
PREVIOUS POSITIONS
1997-2004 Senior Lecturer , Department of Medicine University ofNairobi
1988-1997 Lecturer , Department of Medicine University OfNairobi
1986-1988 Tutorial Fellow Department of Medicine University ofNairobi «■
1985-1986 Senior House Officer Kenyatta National Hospital
1984-1985 Medical Officer Nanyuki District Hospital
1983-1984 Medical Officer Intern Machakos hospital
PROFESSIONAL TRAINING
1996-1997 Clinical Electroencephalography and EMG Brigham and Women
Hospital Boston U. S. A
May 1992 - May 1993 Training in Clinical Neurology Western General Hospital
Edinburgh Scotland
OUTSTANDING PERFORMANCE AND AWARDS
1) M.B.Ch.B Distinction in Biostatistics ,Credit passes in Medicine, Physiology,
Biochemistry, General Pathology and Human Anatomy.
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2) Certificate in Tropical Medicine Credit pass
3) Wellcome Trust Prize for the best M. Med dissertation in Medicine in 1998.
4) Commonwealth Medical Association fellowship to study clinical Neurology
5) Carnegie Co-operation Fellowship to study social Medicine at Harvard
Medical School USA







MEMBERSHIP OF SOCIETIES AND PROFESSIONAL BODIES
1) American Academy ofNeurology
2) American Heart Association (Stroke council Member)
3) Kenyan Association of Physicians
4) Kenya Medical Association ».




Amayo E. O. Neurological letter from Kenya
Practical neurology 2006 ;6;261-262
Lwai-Lume L, Ogutu E. O. Amayo E. O, Kariuki S. Drug susceptibility pattern of
helicobacter Pylori in patients with dyspepsia at the KenyattaNational
Hospital Nairobi East African Medical Journal 2005Vol 82; 12,603-608
Hooker JA, Muhindi DW, Amayo EO, Mc'ligeyo SO, Bhatt KM, Odhiambo JA
Diagnostic utility of cerebrospinal fluid studies in patients with clinically
suspected tuberculous meningitis.
Int J Tuberc Lung Dis. 2003 Aug;7(8):787-96.
Nyamu PN, Otieno CF, Amayo E O, McLigeyo S O
Risk factors and prevalence of Diabetic foot ulcers at Kenyatta National
Hospital, Nairobi East African Medical Journal 2002 Vol. 80 1,36-43
Amayo E. O, Jowi J. O, Njeru E.K
Headache associated disability in Medical students at the Kenyatta National
Hospital East African Medical Journal 2002 Vol. 79,10,519-523
Amayo E. O, Kayima J. K, Joshi M. D
Platelet functions in patients with meningococcal meningitis at the Kenyatta
National Hospital, Nairobi
East African Medical Journal 2002 Vol.79:8: 405-407
Wanjohi F. W, Otieno F. C. F, Ogola E. N, Amayo E. O
Nephropathy in patients with recently diagnosed type 2 diabetes mellitus in
Black African
East African Medical Journal 2002 Vol. 79:8: 399-404
Amayo E. O, Kwasa T. O, Otieno C. F
Herpes zoster myelitis: report of two cases
East African Medical Journal 2002: Vol.79,5,;279-280
Lule G. N, Amayo E.O
Irritable Bowel syndrome in Black Kenyans
East African Medical Journal 2002 Vol 79,7,360-363
Amayo E. O, Kwasa T. O, Musau C. K, Mugo G, Wambani. J
Primary intracerebral hemorrhage complicated by cerebral abscess: Case
report and review of literature
East African Medical Journal 2002.Vol 79,3; 163-164
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Karari E. M, Lule G. N, Mcligeyo S. O, Amayo E. O.
Endoscopic findings and the prevalence of Helicobacter pylori in chronic
renal failure patients with dyspepsia.
East African Medical Journal 2000: Vol 77. 406-409.
Mary-Jo DelVecchio Good, Amayo E O, Machoki J. M, Mwaikambo E.
Clinical realities and moral dilemmas. Contrasting perspectives from
Academic medicine in Kenya, Tanzania and America
Journal Of the American Academy ofArts and Sciences 2000: Vol
128,6,167-196.
Amayo E. O, Kayima J. K, Amayo A. A.
Transient Focal neurological deficits in patients with hypoglycemia and
hyperglycemia; report of 4 cases
East African Medical Journal 1998:Vol.75;53-54
Amayo E. O, Jowi J. O, Njeru E. K.
Migraine headaches in a group of medical students at the Kenyatta National
Hospital Nairobi
East African Medical Journal 1996: Vol 73;594-597 ,
Mbuya S. O, Kwasa T. O, Amayo E. O, Kioy P. G, Bhatt S. M.
Peripheral Neuropathy in AIDS patients at Kenyatta National Hospital
East African Medical Journal 1996:Vol 73;538-539
Mcligeyo S. O, Mbui J, Kungu A, Amayo E O, Ogendo S. W. O.
Fibrosarcoma of the lung with extrapulmonary manifestation; A scase report
East African Medical Journal 1995: Vol 72;465
Kwasa T O, Jowi J O, Amayo EO
Efficacy and tolerability of oral sumatriptan in the treatment of acute
migraine
East African Medical Journal 1995. Vol 72;479
Lindley RI, Amayo E O, Marshall J, Sandercock P AG, Dennis M, Warlow CP
Acute stroke treatment in UK Hospitals; The stroke Association Survey of
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Amayo E O, Riyat M S, Okelo GBA, Adam MA, Toroitich K
Disseminated histoplasmosis in a patient with AIDS . A case report
East African Medical Journal 1993.Vol 70,93-94. -
Amayo E O, KwasaT O.
HIV and acute peripheral facial nerve palsy
East African Medical Journal 1991:68:948
Amayo E O, Owade J N, Aluoch J R, Njeru E K
Neurological complications of Sickle Cell Anaemia at the Kenyatta National
Hospital: A 5 year retrospective study
East African Medical Journal 1992: 69,660
Ogutu E, Amayo E. O, Okoth F G, Lule G N
The prevalence of Hepatitis B surface antigen( HbsAg). anti-hepatitis B
surface (anti-Hbs) and anti-hepatitis b core (anti-Hbc) in patients with AIDS.
East African Medical Journal 1990; 67,355
Amayo E, O
Some aspects ofAIDS at Kenyatta National Hospital
Medicus 1988 Vol. 7 No.7
Amayo.E. O
Clinical manifestation ofAIDS at the Kenyatta National Hospital
M. Med(Internal Medicine) Dissertation 1988
CONFERENCES ATTENDED AND PAPERS PRESENTED
1) 58th Annual Meeting of the American Academy ofNeurology San Diego
California April 1 -8th 2006
2) World congress ofNeurology Sydney Australia 5-11 November 2005: Impact of
backache on medical workers at the Kenyatta National Hospital
3) 57th Annual Meeting of the American Academy ofNeurology
Miami Beach Florida April 9th-16 2005
4) Cysticercosis working group of Eastern and South Africa
11 -13th November 2004 Maputo Mozambique
5) 56th Annual Meeting of The American Academy OfNeurology
April 24th -May 1st 2004 San Francisco California U. S.A
6) 13th ICASA conference 21st to 26th September 2003 Nairobi Kenya
7) Neurological society ofKenya April 2003.What is the evidence for surgical
evacuation of intracerebral heamorrhage?
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8). Kenya Association ofPhysicians
Seventh annual Scientific conference 26th to March 2003 Nairobi
Papers presented
1. Is it possible to have ethical practice in resource poor setting?
2. Prevention of stroke beyond Aspirin.
3. Health and social change in East Africa April 14-15 1999 Boston USA. Paper
presented.Medical practice in the era of scarcity and HIV/ AIDS
4. World Federation of Public Health Association Conference 12-17th October
1997, Arusha Tanzania.
5. 5.th Inter-Faculty Collaborative Program annual conference 17-22nd August
1997 Matuu. Paper presented; Adherence in therapy in chronic disease.
6. Health and social Change in East Africa. Paper presented; socio-cultural
aspects of Epilepsy; implication on treatment adherence 25th April 1997 Boston
USA
7. 49th Annual Meeting of the American Academy ofNeurology 12-19th April
1997 Boston USA
8. 14th International Conference on the Social Sciences and Medicine. 2-6th
September 1996. Peebles Scotland UK
9. Inter-Faculty collaborative Program annual meeting August 1996. Machakos.
Paper presented: Impact of headache on Medical students at KNH
10. 2nd Conference ofMedical Associations and Societies of Kenya. 27th -29th
September Nairobi Kenya. Paper presented; Platelet function in patients with
meningococal meningitis at KNH.
11. 2nd International Stroke Conference 12-15 May 1993 Geneva, Switzerland.
Paper presented: Survey into the care ofAcute Stroke by Physicians in the United
Kingdom.
12. British Brain Research Group Meeting March 1993 Birmingham U.K
13. Epilepsy Europe l-5th September 1992, Glasgow Scotland UK




15. 35th Association of Physicians of East Africa Conference. 2nd -5th September
1989, Arusha Tanzania
16. 3rd International Conference on AIDS and associated cancers in Africa ,
Arusha Tanzania , 14th-16th September 1988.Paper presented; Neurological;
manifestation ofAIDS at the Kenyatta National Hospital
COURSES ATTENDED
1. CWGESA Cycticercosis/Taeniosis awareness and training workshop
University of Transkei Umtata Eastern Cape Province , South Africa 7th to 11th
June 2004.
2. Leadership and management program workshop 21 May 2004 Nairobi
3. HIV update: Cotemporary Issues in management Boston USA 2-4th May
1999.
4. Grant writing workshop 30th March 1997 Boston USA
5. 15th advanced Clinical Neurology course 31st March to April 1993 Edinburgh
Scotland
6. Epidemiology for Clinician Course 4th-8th January 1993 Southampton United
Kingdom
7. Stroke course, University of Edinburgh 9th-13th November 1992.
8. Elementary data analysis course at the University Of Edinburgh October,
November, December 1992.
9. SPSS course University of Edinburgh Scotland UK.
10. dbase 3 plus at the University of Edinburgh 3rd October 1992
CURRENT RESEARCH
Low backache among health workers at Kenyatta National Hospital.
EEG abnormalities in Patient with sickle cell Anemia
Adherence of therapy to antiretroviral









1) Member of the Committee for Drug Registration of the Pharmacy and
Poisons Board Ministry of Health.
ADMINISTRATIVE EXPERIENCE
Secretary Association of Physicians of East and Central Africa 1990 -1992
Member of the steering Committee of the Inter-Faculty collaborative program
Secretary Kenya Society of Epilepsy.
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Appendix II: CWGESA Questionnaire
Last name :













Hut (house) number _







How old are you?
What is your date of birth?
Sex □ Male
(years)
. Day Month Year
D Female
What is the highest schooling grade you have completed?
□ None □ Primary school
□ Middle School □
What further education have you completed?
□ None □
□ University □




How many days ofwork have you missed because of illness in the past month? .
How many days ofwork have you missed because of illness in the past year?





10 Do you boil your drinking water?
□ Always
D Sometimes
11 How often do you eat pork?
□ At least once a month
□ Less than once a year
□ Bore-hole
□ Other (please specify).
D Almost always
□ Never




12 How is the pork that you eat prepared? Check all that apply•]
□ Boiling d Barbeque
□ Fried d Others (specify)
13 Do you have a latrine at home?
□ Yes d No (Skip to Q 14)
13.1 How often do you use a latrine when you have to defecate?
d Always d Sometimes d Never
14 Do you keep pigs?
d Yes d No (Skip to Q 15)
14.1 What type of pigs do you keep?
d Foreign d Native
d Both foreign and native d Can not remember, do not know
14.2 Of the pigs that you have, how many are for? [read each choice and record the number]
Home consumption Trading
Reproduction Other (specify):
14.3 How do you keep your pigs... [read questions 14.3.1 to 14.3.4 one after the other]
14.3.1 During the planting season
d In a pen d Free ranged
d Tethering d Other (specify):
14.3.2 During the growing season
d In a pen d Free ranged
d Tethering d Other (specify):
14.3.3 During the harvesting season
d In a pen d Free ranged
d Tethering d Other (specify):
14.3.4 During the fallowing season
d In a pen d Free ranged
d Tethering d Other (specify):
14.4 What do your pigs eat? [Check all that apply.]
d Pasture d Kitchen left overs
d Commercial feeds d Other (specify):
14.5 How often do you slaughter pigs at home?
d At least once a month d Less than once a month but at least once a year
d Less than once a year
d Never (Skip to Q 14.6) d Can not remember, do not know (Skip to Q 14.6)
14.5.1 If ever, how often was the meat inspected by a meat inspector?
d Always d Almost always
d Sometimes d Never




14.6 . What price do you usually sell your pigs when they are ready to be slaughtered (specify the
currency used, this can be money or barter)?
14.7. What price do you usually sell your piglets (aged 4 months or less) (specify the currency
used, this can be money or barter)?
(SKIP TO Q 16)
15. Have you ever owned pigs? [If they answer "yes", ask when they ownedpigs]
D Yes, in the past year □ Yes, one (1) to five (5) years ago
□ Yes, more than five (5) years ago
□ No (skip to Q 17)
15.1. What kind of pigs were they?
□ Foreign □ Native
□ Both foreign and native □ Can not remember, do not know
16. Were you ever told that your pigs or piglets were infected with cysts (cysticercosis)?
□ Yes □ No (Skip to Q 17)
16.1. When were you told that your pig or piglets were infected with cysts (cysticercosis)?
J □ In the past year □ One (1) to five (5) years ago
More than five (5) years ago
r D Never told (skip to Q 17) □ Can not remember, do not know (skip to Q
M 7)
f 16.1.1 When that happened, were you able to sell your pig(s) or piglets?
♦
□ Sold both □ Sold pigs but not piglets
□ Sold piglets but not pigs (skip to Q 16.1.3)
□ Could not sell either (skip to Q 17)
□ Can not remember, do not know (skip to Q 17)
16.1.2 When that happened, what price did you sell your pigs (aged more than 4 months)
(specify the currency used, this can be money or barter)?
16.1.3 When that happened, what price did you sell your piglets (aged 4 months or less) (specify
the currency used, this can be money or barter)?
17. Have you ever seen or heard of white nodules (rice) in pig carcasses? * .
□ Yes □ No (Skip to 18)
17.1 Where can you find nodules on a live pig?
□ It is not possible to find them on a live pig
□ Under the skin □ Under the tongue




17.2 How do pigs get these nodules?
□ By eating human faeces □ By eating pig faeces
□ From another infected pig □ Other (Specify)
D I don't know
17.3 What would you do if you discovered that your pig had nodules?
□ Sell the pig □ Treat it with herbs
□ Pierce the nodules □ Other (Specify)
□ I don't know
18. Have you ever heard of tapeworm infection in humans?
□ Yes □ No (Skip to question 19)
18.1 How did you learn about it?
□ By a doctor □ By a friend or family member
□ By a traditional healer □ On the radio / newspaper
□ Other (Specify)
18.2 How does a person know if they have a tapeworm?
□ They can see it in their faeces □ They have diarrhea
□ They have fever □ Other (Specify)
□ I don't know
18.3 Have you ever had a tapeworm or seen small parts (segments) ofworms in your faeces? (Show
photographs ofproglottid.s)
□ Yes □ No (SKIP TO Q 18.4)
□ I don't know/can not remember (SKIP TO Q 18.4)
18.3.1 When that happened, what did you do? [check all that applies\
□ Went to a primary health care provider (hospital, clinic, dispensary)
□ Went to the pharmacy to get a drug to treat it
□ Went to a traditional healer □ Did nothing
□ I can not remember, I do not know
18.4 How does a person get tapeworm infection?
□ They do not wash their hands □ They eat undercooked pig meat
□ They are in contact with an infected personD Other (Specify)
□ I don't know
19. Have you ever had skin nodules or hard lumps under the skin? (Showphotograph ofperson with
subcutaneous gsticercosis nodules)
□ Yes, currently has □ Yes in the past year, but not currently
□ Yes, one year or more ago, but not currently □ No
□ Can not remember, do not know
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20. Have you ever had bad headaches that lasted more than a few days?
□ Yes, currently has □ Yes in the past year, but not currently
D Yes, one year or more ago, but not currendy □ No
D Can not remember, do not know
21. Have you ever had any of the following?
21.1 Sudden loss of consciousness and episodes of incontinence or foaming of the mouth or tongue
biting?
Cf □ Yes, currendy has □ Yes in the past year, but not currendyI 1=1 Yes, one year or more ago, but not currendy□ No (Skip to Q 21.2) □ Can not remember, do not know (Skip to Q 21.2)21.1.1 (If yes) How often has this happened?D Only once □ More than once
21.1.2 How old were you when this first happened? years
21.2 A brief period of absence(s) or loss(es) of contact with the surroundings that starts suddenly?
D Yes, currendy has □ Yes in the past year, but not currendy
□ Yes, one year or more ago, but not currendy
□ No (Skip to Q 21.3) □ Can not remember, do not know (Skip to Q 21.3)
21.2.1 How often has this happened?
□ Only once □ More than once
21.2.2 How old were you when this first happened? years
21.3 Uncontrollable twitching or jerking or abnormal movements of one or more limb(s)
(convulsions) that starts suddenly and lasts for a period of a few minutes?
f* □ Yes, currendy has □ Yes in the past year, but not currendy
1 D Yes, one year or more ago, but not currendy
□ No (Skip to Q 21.4) □ Can not remember, do not know (Skip to Q 21.4)
21.3.1 How often has this happened?
D Only once D More than once
21.3.2 How old were you when this first happened? years
21.4 Sudden onset of a brief period of hearing or smelling or seeing things that are not there or
feeling strange body sensations?
□ Yes, currendy has □ Yes in the past year, but not currendy
□ Yes, one year or more ago, but not currendy
□ No (Skip to Q 21.5) □ Can not remember, do not know (Skip to Q 21.5)
21.4.1 How often has this happened?
□ Only once □ More than once
21.4.2 How old were you when this first happened? years
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21.5 Were you ever told that you had epilepsy or that you had had an epileptic seizure?
□ Yes, currendy has D Yes in the past year, but not currendy
□ Yes, one year or more ago, but not currendy □ No
□ Can not remember, do not know
21.6 Have you ever had seizures or fits?
currendy has D Yes in the past year, but not currendy
one year or more ago, but not currendy
□ No (skip to Q 22) □ Can not remember, do not know (skip to Q
22)
21.6.1 How often has this happened?
D Only once D More than once
21.6.2 How old were you when this first happened? years
[Ifthe interviewee has answered "no" to questions 21.1-21.6, the interview is finished. Go to last
page and complete questions 30 & 31 based on observation.]
THANKYOU VERY MUCH FOR YOUR COOPERATION
[Otherwise, please continue with the questionnaire]
[Interviewer. If they answered "yes" to any of the questions 21.1 -21.6, ask thefollowing, otherwise, SKIP toQ. 25.]
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22. Have you had any of the following?
22.1 Head injury that made you lose consciousness? □ Yes □ No (skip to Q 22.2)
22.1.1 If yes, when did your seizure symptoms start?
D Before head injury D Soon after head injury
22.2 Meningitis (brain infection) during childhood? □ Yes D No
22.2.1 If yes, when did your seizure symptoms start?
□ Before an attack ofmeningitis □ Soon after an attack ofmeningitis
23. What happens to you when you have a seizure or a fit?
24. Have you ever hurt yourselfwhen you lose consciousness or during a seizure?
□ Yes d No
Q I do not lose consciousness or have seizures (skip to question Q 25)
D Cannot remember (skip to question Q 25)
24.1 If yes, how did you hurt yourself?
D Fell in the fire D Fell in the water
□ Fell off your bicycle □ Fell while walking along the road
□ Cut yourself □ Other (specify)
25. Is there someone in your household with epilepsy or seizures?
I D Yes, currently is Q Yes in the past year, but not currently
□ Yes, one year or more ago, but not currently □ No
25.1 (If yes) Who in your household has epilepsy or seizures? [check all that apply]
□ Mother □ Father
□ Brother/sister □ Child
□ Other relative □ Other (specify)
(Interviewer: Read the following statement)
Now I want to ask you a few questions about your treatments for [insertname ofsymptom or
condition they reported having in question 21.1-21.6]
26. Have you ever consulted a health provider because of this condition?
□ No (skip to Q 27) □ Cannot remember (skip to Q 27)
□ Yes
26.2 When was the last time you consulted a health provider for your condition?
□ Within the past month □ Within the past year
Q From one (1) to five (5) years ago D More than five (5) years ago
□ Can not remember, not sure
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26.3 What kind of health provider(s) did you consult and how many times in the past 5 years [check
several boxes ifappropriate]?
□ A physician times □ A neurologist times
□ A nurse times d A traditional healer times
□ A psychiatrist/psychologist times
□ Other (specify ) times
□ Can not remember, not sure
26.4 How much did it cost each time you consulted with one health provider [specify the currency usedfy
□ A physician d A neurologist
□ A nurse d A traditional healer
d A psychiatrist / psychologist
d Other (specify )
d Can not remember, not sure
26.5 How far is the health provider from your house and how did you get there (foot, bicycle, bus,
train, taxi, car)?
d Physician at km reached by d Neurologist at km reached by
c
d Nurse at km reached by d Traditional healer at km reached by_
d Other (specify ) at km reached by
d Can not remember
27. Have you ever been hospitalised because of this condition?
d No (skip to Q 28) d Cannot remember (skip to Q 28)
d Yes Name of Facility
27.2 How many times have you been hospitalised in the past 5 years? times
27.3 When were you last hospitalised? (month) (year)
27.3.1 How many days did you stay in hospital? (days)
27.3.2 How much did it cost (specify the currency)
27.3.3 How far is the hospital from your house? km
27.3.4 How did you get to the hospital?
d By foot/ bicycle d By bus d By taxi
d By car d By train d Other (specify)
28. Did you ever have any medical tests because of this condition?
d No (skip to Q 29) d Cannot remember, do not know (skip to Q 29)
d Yes
28.2 What kind of test was it (check as many boxes as appropriate)?
d Blood test for cysticercosis d CT scan of the brain
d X-Ray of the brain d MRI of the brain
d Electroencephalogram (EEG) d Other (please specify)
d Can not remember, not sure
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28.3 When was the last time you had a medical test for this condition?
□ Within the past month □ Within the past year
□ From one (1) to five (5) years ago □ More than five (5) years ago
□ Can not remember, not sure
28.4 How much did it cost for each test (specify the currency used)?
D Blood test for cysticercosis D CT scan of the brain
□ X-Ray of the brain □ MRI of the brain
□ Electroencephalogram _ □ Other (specify).
□ Can not remember, not sure
28.5 How far from your house did you have to travel for this test and how did you get there (foot,
bicycle, bus, train, taxi, car)?
D Blood test for cysticercosis at km at (Facility Name) reached
by




. km at (Facility Name), reached
□ MRI at.
by
_ km at (Facility Name),







. km at (Facility Name), .reached
-) at- km at
.reached by_
□ Can't remember, do not know (interview is
c
□ Can not remember, not sure
29. Were you ever treated for this condition?
□ No (the interview is finished)
finished)
□ Yes
29.2 When was the last time you used medication for your condition?
□ Within the past month □ Within the past year
□ From one (1) to five (5) years ago □ More than five (5) years ago
□ Can not remember, not sure
29.3 What medication was it and how many times in the past year did you have to use some (check
several boxes if appropriate)?
□ Phenobarbital times
times (tick box and underline□ Dilantin/Tegritol/ Phentoin Sodium.
specific drug name)







□ Can not remember, not sure
29.4 How much did it cost each time you bought this medication (specify the currency used)?
□ Phenobarbital
□ Dilantin/Tegritol/Phentoin Sodium (tick box and underline specific
drug name)
□ Valproic acid □ Traditional medicine
□ Received for free from health care provider (I did not pay for it myself)
□ Other (specify )
□ Cannot remember, not sure
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The following two items should be completed for ALL respondents after direct observation of
latrine.
30. Presence and type of latrine (to be assessed by direct observation):
D Absent D Present and completely enclosed
□ Present and partially enclosed □ Present and open (easily accessible to roaming pigs)
31. Is there evidence of recent use of the latrine (by anyone) (to be assessed by direct observation)?:
□ Yes □ No
THIS IS THE END OF THE INTERVIEW













When replying please quote BUSIA (K)
Date.4/06/200S
OFFICE OF THE DISTRICT
MEDICAL OFFICER
BUSIA DISTRICT
P O BOX S7
RefNo.BSA/
All Rural Health facilities In charges
Re: Record search hv Katherine Ngini in regard to Mental Health Conditions.
This letter serve to introduce Katherine Ngini from the International Livestock
Research Institute (ILRI) who is conducting a study on links between porcine
cysticercosis and epilepsy.
She would like to examine the OPD mental health records at your facility.
Please accord her the necessary assistance with her enquiries.
MEDICAL OFFICER OF HEALTH
SlioiA DISTRICT
Dr. Mukabi K.J. HSC
District Medical Officer ofHealth,
Busia District.
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Patient ID No: KDN
Date of Birth: day/ mtn/ yr
Sample No: S
(same as Patient ID No)
Name of person collecting sample:
(printed clearly)
Date Sample Collected: day/ mth/ yr
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Appendix V: Informed Consent Form - Serology (English and Swahili)
INFORMED CONSENT FORM FOR SEROLOGICAL
SAMPLING FOR TAENIA SOLIUM
Patient's Name:
Patient's Identification Number:
Project Title: Assessing the Burden of Taenia solium
Neurocysticercosis: A Case Study of Busia District
Principal Investigator: Katharine Downie-Ngini
Enumerator:
This study is being carried out in collaboration with University of Edinburgh
based in Edinburgh, Scotland, UK and the International Livestock Research
Institute (ILRI) based in Nairobi, Kenya.
We are asking you to participate in a study to know the importance of the
Taenia solium tapeworm and neurocysticercosis acquired epilepsy. As you
have been identified previously as having symptoms of epilepsy, we would
like to take a small sample of your blood from a vein in your arm to confirm if
you have epilepsy as a result of the tapeworm found in pork (called Taenia
solium). In order to do the test successfully, we will need to take
approximately 5cc of your blood. This is the same amount as a teaspodn.
Your blood sample will be taken by a qualified medical officer or laboratory
technician. If you agree to be interviewed and examined, we would also like
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to ask you some questions about your health. You are not required to
participate in this study and you may leave the study at any time.
Once blood has been collected from you, we will send it to a laboratory in
Belgium which is called The Institute of Tropical Medicine in Antwerp, to be
tested to determine whether you have been exposed to Taenia solium
tapeworm. Your blood sample will ONLY be tested for this and nothing else
at this time. We will NOT be testing your blood for HIV or AIDS related
illnesses. If this test is not conclusive, we may require further tests to be done
on the same sample of blood. In view of this, we would like to retain your
sample for use in the future to improve the health of your community and. to
improve methods of finding out whether a person has a pork tapeworm or to
better control the pork tapeworm.
Expected benefits: If you are found to be positive for Taenia solium either by
a blood test or by a CT scan, you will be referred to a qualified medical health
practitioner and will be given drugs to treat your condition free of charge. This
medical practitioner will explain to you more about your condition and how to
complete the treatment effectively so you can be free of epilepsy or
cysticercosis related conditions. Everybody who participates in the study will
be informed of the outcome of the study. This means that all people who test
positively for exposure to Taenia solium from their blood sample will be told,
those who test negatively for exposure will be informed and those who are
given a CT scan will be informed as to whether cysts are present or not.
Statement of confidentiality: Your clinical and laboratory examination and
everything that you tell us remains confidential, and you will not be identified
by name as a participant in this study. Any information we collect from you
will be recorded and identified only by a number, and any publications
resulting from this study will not contain your name. Following analysis your
blood sample will be destroyed.
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In case of complaints: If you experience any problems in relation to your
participation in this study you should contact Katharine Downie-Ngini, ILRI,
PO Box 30709 00100, Nairobi, Tel: 0204223065.
Investigator's statement. I confirm that I have fully explained to the subject
the nature and purpose of the procedures described above and such risks as
i
are involved in its performance. I have asked the subject if he or she has any
further questions, and answered these questions to the best of my ability.
Investigator's Signature Investigator's Name (Print Clearly)
Enumerator's Signature Enumerator's Name (Print Cearly)
Patient's statement: I understand what has been requested in connection
with my participation in this study, and I agree to participate and to give a
blood sample. I understand that I may be asked to have a CT scan at a later
date and have agreed to this also. I understand that my blood will be taken to
a laboratory in Belgium and will only be tested for the purposes outlined in
the study and will not at any time by tested for HIV. I do not mind if this
sample is used at a later date to further the objectives of this particular study.
I understand that if I am a woman between the ages of 15-49 I will be asked
to submit a urine sample to determine if I am pregnant or not. If I am
pregnant, I will not be asked to participate in the CT scan phase of the study.
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I also understand that I may withdraw this consent at any time without any
adverse effect.
Date
Patient's Signature Patient's Name (Printed Clearly)
Witness' Signature Witness' Name (Printed Clearly)
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FOMU YA KUONYESHA MAKUBAL1ANO YA VIPIMO VYA DAMU BAADA
YA KUELEWA LENGO LA UTAF1TI WA MINYOO AINA YA TAENIA
SOLIUM
Jina la Mgonjwa:
Nambari ya utambulisho ya Mgonjwa:
Jina la Mradi: Kuainisha matatizo yatokanayo na Ugonjwa wa
Minyoo/Uvimbe katika mishipa ya fahamu (neurone) kati ya wagonjwa
wa kifafa katika: Mfano kutoka Wilaya ya Busia
Mtafiti Mkuu: Katharine Downie-Ngini
Mtafiti Msaidizi:
Utafiti huu unafanyika kwa kushirikiana na Chuo kikuu cha Edinburgh
kilichopo Edinburgh, Scotland, Uingereza na shirika la kimataifa la utafiti wa
mifugo (ILRI) lililopo Nairobi, Kenya.
Tunakuomba ushiriki katika utafiti huu ili kujua umuhimu wa aina ya minyoo
wanaotokana na kula nyama ya nguruwe katika kueneza ugonjwa wa kifafa,
minyoo hawa wana fahamika kwa jina la kitaalam kama Taenia solium. Kwa
kuwa utafiti wa awali umeonyesha kuwa wewe una dalili za ugonjwa wa
kifafa, tungependelea kuchukua kiasi kidogo (sampo) cha damu yako kutoka
katika mshipa wako wa mkono ili kupima kama una ugonjwa wa kifafa
uliotokana na minyoo inayopatikana kwenye nyama ya nguruwe (iitwayo
Taenia solium). Ili kuweza kupata vipimo sahihi, tutahitaji kutoa CC tano
(5cc), hii ni sawa na kijiko kimoja cha chai. Damu hiyo itatolewa na dakfari
wa binadamu aliyehitimu au mtaalam wa maabara aliyehitimu. Kama
utakubali kuhojiwa na kupimwa, tungependa pia kukuhoji maswali machache
kuhusiana na afya yako. Kuhusika katika utafiti huu ni kwa hiyari yako,
hautalazimishwa hata kidogo na hata baada ya kukubali na kuwa mmoja wa
watu wanafanyiwa utafiti, kama utajisikia, kuwa hupendi kuendelea kuhusika
unaweza kujitoa wakati wowote.
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Baada ya sampo ya damu kutolewa kutoka kwako, itapelekwa katika
maabara kufanyiwa uchunguzi kuangalia kama damu yako ina minyoo ya
Taenia solium katika maabara nchini Ubelgiji iitwayo " Taasisi ya madawa
katika nchi za Tropik" iliyopo katika mji wa Antwerp. Damu hii itapimwa
kuwepo kwa minyoo hii tu na sio ugonjwa mwingine wowote. Hatuta tumia
damu yako kupima Ukimwi (HIV or AIDS) au magonjwa yoyote
yanayohusiana na ukimwi.Tungependa kukuuliza kama uko tayari tutumie
damu yako katika siku za baadae katika utafiti wa kutambua kama mgonjwa
ana minyoo ya nguruwe na kuendeleza mbinu bora za kupingana na minyoo
hao.
Faida zinazotarajiwa kutokana na utafiti huu: Kama ukikutwa na minyoo
ya Taenia solium kwa njia ya kupimwa damu au au kwa kipimo cha CT scan,
utapelekwa kumuona daktari aliyehitimu na utapewa huduma ya matibabu
pamoja na dawa bila malipo. Madaktari hawa watakueleza zaidi kuhusu afya
yako na jinsi ya kukamilisha matibabu ipasavyo na kupona kabisa kifafa au
magonjwa yanayo husiana na uvimbe katika ubongo. Kila atakaye shiriki
kwenye utafiti huu ataelezwa matokeo ya utafiti huu. Hii ina maana kwamba
watu wote watakaogundulika kuwa na minyoo hii katika damu zao
watelezwa, na pia watakao pimwa kwa kipimo cha CT scan wataelezwa
kama kuna uvimbe katika ubongo wao au hakuna.
Tamko la kuhufadhi siri: Afya yako na matokeo ya vipimo vyako katika
maabara (Laboratory examination) na chochote ambacho umetueleza
kitabaki kuwa siri. Hatutatumia jina lako mshiriki katika utafiti huu. Kila
maelezo tutakayo pata kutoka kwako tutayaandika na kuyatambua kwa
nambari tu, na matokeo yoyote katika utafiti huu hayatakuwa na jina lako.
Mara baada ya utafiti huu sampo yako ya damu itaharibiwa na haitatumika
tena kwa dhumini lingine lolote.
Kama utakuwa na malalamiko au matatizo voyote: Endapo utakumbana
na matatizo yoyote kuhusiana na ushiriki wako katika utafiti huu tafadhali




Tamko toka kwa Mtafiti: Nina uhakika nimemueleza muhusika kiundani nia
na madhumuni pamoja na mambo yanayoambatana na utafiti huu. Pia
nimemweleza madhara yanayoweza kujitokeza wakati wa utafiti. Nimempa
muhusika nafasi ya kuuliza maswali kuhusiana na uafiti huu na nimeyajibu
kadri ya uwezo wangu.
Sahihi ya Mtafiti Jina la Mtafiti (Liandikwe kihusahihi)
Sahihi ya Msaidizi wa mtafiti Jina la Msaidizi wa mtafiti (Liandikwe
kihusahihi)
Maelezo ya Mgonjwa: Nimeyaelewa vyema maelezo kuhusiana na utafiti
huu na mambo ninayohitajika kufanya kama mshiriki katika utafiti huu,
ninakubali kutoa kiasi kidogo cha damu (sampo) itakayo tumika katika utafiti
huu. Ninaelewa kwamba nitahitajika kuchukuliwa kipimo cha CT scan hapo
baadae. Nimeelewa kwamba damu yangu itatumika tu kwa madhumuni
yalioelezwa katika utafiti huu na kwa wakati wowote haita tumika kupima
ukimwi (HIV or AIDS). Ninaruhusu sampo ya damu yangu itumike hapo
baadae kwa madhumini ya utafiti huu. Ninaelewa kwamba kama mimi ni
mwanamke mwenye umri kati ya miaka 15-49 nitahitajika kutoa sampo ya
mkojo kuangalia kama nina mimba au la! Kama nina mimba, sitahitajika
kushiriki katika vipimo vya CT scan kama sehemu ya utafiti. Na pia naelewa
kwamba ninaweza kujitoa wakati wowote. bila matatizo.
Tarehe
Sahihi ya Mgonjwa Jina la Mgonjwa (Liandikwe kihusahihi)
Sahihi ya Shahidi Jina la Shahidi (Liandikwe kihusahihi)
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Appendix VI: Informed Consent Form - CT Scan
INFORMED CONSENT: CT Scan
Instructions for Obtaining Informed Consent
Fieldworker: Identify yourself and introduce the purpose of the survey by
reading from the following script (this script appears at the beginning of each
survey packet for your convenience):
Invitation and Purpose:
"Hello and good morning/afternoon. My name is and I
am here to ask if you would mind participating in a CT scan which is a follow-
up from our previous survey which took place in December of last year."
(If patient is a woman of reproductive age, she must provide urine for a
pregnancy test).
I would like first of all to ask you to give us some of your urine so that we can
test to see if you are pregnant. If you are pregnant, you will not be asked to
go for a CT scan (If not pregnant or male, proceed as follows).
Following the testing of the blood and the determining of whether or not you
have been exposed to Taenia solium and have antibodies to Taenia solium
present in your blood, we will ask some of you (both positive and negative) to
undergo a CT scan to determine whether there may be any cysts in your
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brain. This scan is not painful and simply involves a machine taking a picture
of your brain to see if there are any cysts present. Cysts in your brain may be
a cause of your epilepsy. If there are cysts present, we will be able to send
you for treatment for these cysts.
«
Please remember that you do not have to participate in this study if you do
not want to. Also, if you have any questions, please ask.
All information, including your name and your health status (whether you
have cysts or have been exposed to the pork tapeworm) will be kept
confidential by everyone participating in this study. We will also let you know
whether you have cysts or not, or whether you have been exposed to the
tapeworm.
Procedures:
You will be taken, along with others participating in this study, to the Aga
Khan Hospital in Kisumu so that a machine can take a picture of your brain.
Computed tomography (CT) is a diagnostic procedure that uses special x-ray
equipment to obtain cross-sectional pictures of the body. The CT computer
displays these pictures as detailed images of organs, bones, and other
tissues. This procedure is also called CT scanning, computerized
tomography, or computerized axial tomography (CAT).
During a CT scan, the person lies very still on a table. The table slowly
passes through the center of a large x-ray machine. The person might hear
whirring sounds during the procedure. People may be asked to hold their
breath at times, to prevent blurring of the pictures. You may be asked to let
the doctor inject some dye into your vein in order that different parts of your




Having your picture taken does not hurt at all and will be carried out by a
trained medical health professional. The information we obtain regarding your
scan will be shared with you but kept confidential from others participating.
Again, you are under no obligation whatsoever to participate in this study. If
you have any questions about this, please ask them now.
Risks. Discomforts and Inconveniences:
We estimate that the trip to Kisumu and the scan will probably take the entire
day. We will drive you there and bring you back home.
Some people may be concerned about the amount of radiation they receive
during a CT scan. It is true that the radiation exposure from a CT scan can be
higher than from a regular x-ray. However, not having the procedure can be
more risky than having it, especially if cancer is suspected. People
considering CT must weigh the risks and benefits.
Computed tomography scans do not cause any pain. However, lying in one
position during the procedure may be slightly uncomfortable. The length of
the procedure depends on the size of the area being x-rayed; CT scans take
from 15 minutes to 1 hour to complete. For most people, the CT scan is
performed on an outpatient basis at a hospital or a doctor's office, without an
overnight hospital stay.
Benefits:
The benefits to having this scan done are that if we detect cysts in the picture
that has been taken, you will be referred for treatment afterwards.
Privacy and Confidentiality:
The information gathered in the interview will be kept confidential and will not
be shared with any persons or agencies not affiliated with this study. The
results of your scans will be combined with others who participate in the
study in such a way that it is not possible to associate these responses with
others. You will be assigned a code, and this code will be stored separately
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from the results of the survey. Individual responses will thereafter be referred
to by codes alone. The names of household members will not be shared with
individuals outside the survey organization and the identifying information





To be completed PRIOR to conducting interview. Interview CANNOT take
place unless this form is completed.
INTERVIEWER'S STATEMENT
has been informed of the nature and
purpose of the procedures described above including any risks involved in its
performance. He or she has been given time to ask any questions and these
questions have been answered to the best of the investigator's ability. A
signed copy of this consent form will be made available to the subject.
Investigator's Signature
Investigator's Name (printed clearly) Date
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I have been informed about this research study, its possible benefits, risks,
and discomforts. I hereby agree to take part in this research as a subject. I
recognize that my participation is voluntary and that I am free to withdraw this
consent and quit this project at any time, and that doing so will not cause me
any penalty or loss of benefits that I would otherwise be entitled to enjoy. I
may also skip any question that I do not wish to answer.
Subject's Signature (or Print) Date
(Not needed if oral consent is given)
Witness to Oral Consent Date




Appendix VII: Enumerators' Confidentiality Agreement (English and Swahili)
CONFIDENTIALITY AGREEMENT:
To be completed PRIOR to collecting serology sample or conducting
interviews. Neither of these two actions can take place unless this form is
completed.




I, understand that all
information and data gathered from subjects or patients during this study
shall be kept confidential. This means that I shall not discuss any information
or results emanating from this study with anyone, including colleagues who
have participated in the study. A signed copy of this confidentiality agreement
will be made available to the subject.
Investigator's Name





MKATABA WA SIRI NA MTAFITI MSAIDIZI
Mkataba huu unatakiwa kujazwa KABLA ya kuchukua vipimo vya damu au
kuwauliza wananchi maswali. Hakuna kati ya mambo haya miwili linaloweza
kufanyika kabla mkataba huu haujasainiwa.
Kujazwa na wafanyakazi wa utafiti: (chagua moja)
Daktari wa binadamu/mtabibu: .
Mtaalamu wa maabara (laborator
Mtafiti msaidizi:
Mimi , ninaelewa kuwa
maswala yoyote yanayowahusu wananchi watakaofanyiwa utafiti, ikiwa ni
pamoja na majibu watakayotoa kufuatia maswali tutakayowauliza na
matokeo yote ya vipimo tutakavyochukua yatakuwa siri. Hii ina maana
kwamba mimi sitamwambia mtu yeyote jambo lolote kuhusiana na matokeo
ya utafiti huu hata kama ni wananchi wengine waliohusika kwenye utafiti huu
(wagonjwa wengine). Nitaweka sahihi kwenye mkataba huu na kumpatia kila
mwananchi atakayefanyiwa utafiti.
Jina la Mtafiti Kazi au cheo cha Mtafiti (kama vile
daktari mtabibu, mtaalamu wa
maabara, n. k)
Sahihi ya mtafiti Tarehe
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(to be assigned by AHP)
Project Title:
AHP-BO-05/05
Assessing the burden of cysticercosis, with relevance to both human health and livestock
production economics, on smallholder communities in western Kenya
Abbreviated Title: (max. 30 characters)
Cysticercosis in Western Kenya
The completed form should be submitted to The Programme Manager,
Animal Health Programme, Centre for Tropical Veterinary Medicine,
The University of Edinburgh, Easter Bush Veterinary Centre, Roslin,
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Each section contains headings only. You should expand the space under each
heading to suit your text. Youmay expand the tables or forms contained, if
necessary, but notalter their format.
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International Livestock Research Institute
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Dr Thomas Randolph, Human Health Impacts, ILRI, Nairobi, Kenya
Stella Massawe, Targeting Pro-Poor Interventions, ILRI, Kenya
Dr Samuel Githigia, Veterinary Faculty, University ofNairobi, Kenya
Florence Mutua, Veterinary Faculty, University ofNairobi, Kenya
Dr Erastus Amayo, Medical Faculty, University ofNairobi, Kenya
Dr Eric Fevre, CTVM, University of Edinburgh, Scotland
Dr Sue Welburn, CTVM, University of Edinburgh, Scotland
Full Title Assessing the burden of zoonotic disease (cysticercosis) with relevance to
both human health and livestock production economics, on smallholder
communities in western Kenya
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Appendix IX: Supplementary Risk Factor Questions
Last name :. First Name :


















1. How old are you?
2. What is your date of birth?
3. Sex D Male
14. Do you keep pigs?
□ Yes





□ No (Skip to Q 15)
□ Native
□ Both foreign and native □ Can not remember, do not know
14.2 Of the pigs that you have, how many are for? [read each choice and record the number]
Home consumption Trading
Reproduction Other (specify):
14.3 How do you keep your pigs?[read questions 14.3.1 to 14.3.4 one after the other]
14.3.5 During the planting season
□ In a pen
□ Tethering
14.3.6 During the growing season
□ In a pen
□ Tethering
14.3.7 During the harvesting season
□ In a pen
□ Tethering
14.3.8 During the fallowing season
□ In a pen
□ Tethering
□ Free ranged









14.4 What do your pigs eat? [Check all that apply]
□ Pasture □ Kitchen left overs
□ Commercial feeds □ Other (specify):
14.5 How often do you slaughter pigs at home?
f □ At least once a month □ Less than once a month but at least once a year
□ Less than once a year □ Never (Skip to Q 14.6)
^ □ Can not remember, do not know (Skip to Q 14.6)
14.5.1 If ever, how often was the meat inspected by a meat inspector?
D Always D Almost always D Sometimes
D NeverD Can not remember, do not know
14.6. What price do you usually sell your pigs when they are ready to be slaughtered (specify the
currency used, this can be money or barter)? (skip to Q 32)
14.7. What price do you usually sell your piglets (aged 4 months or less) (specify the currency used,
this can be money or barter)? (skip to Q 32)
15. Have you ever owned pigs? [Ifthey answer "yes", ask when they ownedpigs]
□ Yes, in the past year □ Yes, one (1) to five (5) years ago
□ Yes, more than five (5) years ago □ No (skip to Question 32)
15.1. What kind of pigs were they?
□ Foreign □ Native
□ Both foreign and native O Can not remember, do not know
32. Do your neighbours keep pigs currently?
□ Yes D No
33. Have your neighbours or people close to you in the village kept pigs in the last five years?
□ Yes D No
34. Do pigs ever come on your compound?
D Yes D No
21.5 Were you ever told that you had epilepsy or that you had had an epileptic seizure?
□ Yes, currently has D Yes in the past year, but not currently
□ Yes, one year or more ago, but not currently □ No (skip to question 21.6)
□ Can not remember, do not know
21.5.1. If yes, then by whom?
□ Health professional □ Traditional Healer
□ Relative □ Friend, neighbour
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21.6 Have you ever had seizures or fits?
□ Yes, currently has □ Yes in the past year, but not currently
I D Yes, one year or more ago, but not currently
□ No (skip to question 18) □ Can not remember, do not know (skip to question 18)
21.6.1 How often has this happened?
□ Only once D More than once
21.6.2 How old were you when this first happened? years
18. Have you ever heard of tapeworm infection in humans?
□ Yes □ No (Skip to question 19)
18.1 How did you learn about it?
□ By a doctor □ By a friend or family member
□ By a traditional healer □ On the radio / newspaper
□ Other (Specify)
18.2 How does a person know if they have a tapeworm?
□ They can see it in their faeces □ They have diarrhea
□ They have fever □ Other Specify)
□ 1 don't know
18.3 Have you ever had a tapeworm or seen small parts (segments) ofworms in your faeces? (Show
photographs ofproglottid.s)
□ Yes □ No (skip to q 18.4)
□ I don't know/can not remember (skip to q 18.4)
18.3.1 When that happened, what did you do? [check all that applies)
□ Went to a primary health care provider (hospital, clinic, dispensary)
D Went to the pharmacy to get a drug to treat it
□ Went to a traditional healer □ Did nothing
□ I can not remember, I do not know
18.4 How does a person get tapeworm infection?
□ They do not wash their hands □ They cat undercooked pig meat
□ They are in contact with an infected person
□ Other (Specify)
D I don't know
36. Has anyone in your household had a tapeworm infection?
□ Yes, currently has □ Yes in the past year, but not currently
□ Yes, one year or more ago, but not currently
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